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During preterm birth, lung development is interrupted at a premature and
vulnerable stage. Consequently, preterm infants often develop respiratory insufficiency
for which they require ventilatory support at the neonatal intensive care unit (NICU).
The premature transition from a safe intra-uterine environment to a relatively harmful
environment in room air, containing higher levels of oxygen with or without ventilator
support, is often complicated by acute (respiratory distress syndrome (RDS)) and
chronic pulmonary diseases (chronic lung disease of prematurity (CLD)). Long-term
respiratory morbidity and dysfunction depend on the degree of prematurity, perinatal
complications, respiratory disease severity, and therapeutic interventions. In this
chapter, normal human lung development will be discussed followed by a summary of
respiratory complications related to prematurity.
1.1. Normal human lung development
1.1.1. Antenatal lung development
During human foetal lung development four stages can be identified: (1) the
embryonic period, occurring between conception and the 5th week of gestation; (2)
the pseudoglandular period, lasting from the 5th week to the 17th week; (3) the
canalicular period, lasting from the 16th week to the 24th week; and (4) the terminal
sac period, lasting from the 24th week until term. There is overlap from one stage to
the next and the transition between stages occurs gradually (Figure 1)121.
From the laryngotracheal groove in the caudal end of the ventral wall of the
primitive pharynx the lung bud becomes apparent at the end of the 4th week of
gestation.121 As it grows caudally, two bronchial buds develop, which will be further
branched into smaller bronchi.4 By 8 weeks gestation about 6 generations of branches
exist consisting of 1 right and 1 left main bronchi, 5 lobar bronchi and 10 segmental
bronchi. The thick epithelial wall of this tree of narrow tubules is composed of
columnar or cuboidal epithelium.121
During the pseudoglandular period the primitive bronchi branch further until the
bronchi terminalis (20th generation of branches) are developed in the 16th week of
gestation.121,275 These pre-acinar airways may increase in size as further growth of the
lung occurs, but new branches cannot be formed after the 16th week.121 Besides the
development of the bronchial tree, the respiratory system starts developing with
cuboid epithelial cells being (immature) type II alveolar cells at about 11 to 12 weeks
of gestation.254 Bronchial smooth muscle, covering the branching epithelial tubules
from early gestation, becomes innervated and spontaneously contractile from early on
in gestation. Since the developing lung resembles an exocrine gland while intra-
uterine, elements involved with gas exchange are not formed yet. Consequently,
foetuses born during the pseudoglandular period cannot survive.4 
Perinatal lung development
___________________________________________________________________
4
Fi
gu
re 
1.
 N
or
m
al 
pe
rin
at
al 
lu
ng
 d
ev
el
op
m
en
t.
Chapter 1
___________________________________________________________________
5
In the early canalicular stage from the 16th week of gestation,275 the early acini,
i.e. the gas-exchanging portions of the tracheobronchial tree, become visible. Starting
around 19 weeks of gestation, type II cells start to contain lamellar bodies, i.e.
intracellular storage bodies of surfactant, and, partly, differentiate into flat type-1
epithelial cells.224 Although gas-exchange is possible, the saccules are not true alveoli,
because they are larger, lack the smooth outline of the alveoli, and they are separated
by thick septa containing large quantities of lipid and glycogen as well as a double
capillary system surrounding a central core of loose connective tissue.121 Preterm
infants born during this period predominantly depend upon these (sub)saccules to
function as alveoli for pulmonary gas exchange.275 
During the fourth developmental period, the (sub)saccular or terminal sac
period, from 24 weeks to term, further differentiation of the respiratory portion of the
lung occurs. The saccules enlarge and form additional generations, of which the last
generation is called the terminal saccule. From as early as the 29th week, the first
alveoli may be recognized,115 but from 36 weeks gestation alveoli are uniformly
developed with thin septa containing little glycogen and, eventually, one capillary
plexus.108,121 The number of alveoli present at term varies between 10–149 million.144 
For normal antenatal lung development, the lungs need space, amniotic and
foetal lung liquid, intraluminal fluid secretion and the stimulus of foetal breathing
movements.144,224 The foetal lung, like the postnatal lung, has a tendency to recoil and,
in order to grow, must be actively maintained in an expanded state.109 Overdistension
of the foetal lungs with luminal liquid leads to an acceleration of tissue growth and an
increased rate of thinning, or structural maturation, of the alveolar wall.177 Pulmonary
surfactant is a surface-active material formed by alveolar type II cells lining the
alveolar surface area of the lung and is stored in intracellular lamellar bodies. It is a
lipid-protein complex, which consists of about 90 per cent lipids and 10 per cent
surfactant-specific proteins. Surfactant proteins (SP)-B and SP-C are detectable early
in gestation, before recognizable mature type-2 cells or surfactant phospholipid can be
detected (i.e. before 19 weeks of gestation).224 Although the function of all separate
elements of surfactant is not yet completely elucidated, SP-B and SP-C seem to be
involved in the regulation of surfactant phospholipid metabolism, accelerating the
adsorption of phospholipid to the air-liquid surface lining the alveolar surface to
reduce surface tension,108 whereas  SP-A and SP-D are believed to have an important
role in the defence of the lung against bacteria and viruses and parallel the
development of the phospholipids from 20 to 24 weeks of gestation during which the
type-2 cells with lamellar bodies appear.108 The phospholipid content of surfactant
consists for a major part (≈76 per cent) of lecithin (saturated phosphatidyl-
ethanolamine).281 To assess degree of prenatal lung maturation determination of the
lecithin/sphingomyelin ratio (L/S ratio) in amniotic fluid has become common
practice. To correct for changes in amniotic fluid volume the concentration of lecithin
is standardized to the concentration of sphingomyelin, which remains relatively
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constant throughout gestation. In normal pregnancy, the L/S ratio displays a
remarkably stable pattern, increasing slowly to 1.0 at 32 weeks, rising more rapidly to
2.0 at 35 weeks, and accelerating rapidly thereafter to reach a mean value of 5.0 at
term.107 Saturated phosphatidyletanolamine content in the lung increases after about
24 weeks. During the latter part of gestation, there is an increase in lung adrenergic
receptors, increasing the response to catecholamines followed by a stimulation of
surfactant secretion. The density of adrenergic receptors is increased by cortico-
steroids, thyroid hormone, and oestrogen.108 
1.1.2. The transition during birth
Before birth, the placenta is the organ of respiration and pulmonary vascular
resistance is maintained at a very high level by the muscular pre-capillary vessels to
shunt away all the venous return to the right heart through the oval foramen and the
arterial duct. At birth, the umbilical cord is tied and cut, and the lungs must take over
all respiratory function from the placenta within seconds or the baby will perish. The
lung must convert from a secretory to an absorptive organ. The first step consists of
inhibition of secretion of lung liquid by increased concentrations of catecholamines
and other hormones. Subsequently, reabsorption occurs passively, secondary to
differences in oncotic pressure between air spaces, the interstitium, and blood vessels,
and actively, secondary to active transport of sodium out of the air space. Infants born
prematurely or those born without labour do not have the opportunity for early lung
liquid clearance, and they begin their extra-uterine life with excess water in the lungs.
After birth, water in the air spaces moves rapidly to the extra-alveolar interstitium,
where it pools in perivascular cuffs of tissue and in the interlobar fissures. It is then
cleared gradually from the lung by lymphatic drainage or by absorption directly into
the small blood vessels.107 Increase of circulating catecholamines also stimulates
surfactant secretion, decreasing surface tension of the alveolar air-liquid surface and
facilitating the recruitment of pulmonary air spaces after birth. The first breath results
in vasodilatation by the mechanical effect of traction on the vasculature as the chest
wall expands, by oxygen entering the lungs for the first time, cyclo-oxygenase
metabolites and endothelin. Also, functional closure of the foetal shunts, i.e. oval
foramen and arterial duct, occurs quickly, followed by a permanent anatomical
closure. If the baby becomes even minimally hypoxic or acidaemic the pulmonary
vascular resistance may rise steeply, causing reopening of the foetal shunts and right-
to-left shunting with profound hypoxemia, a situation called ‘persistent pulmonary
hypertension of the neonate’.224
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1.1.3. Postnatal lung development
To describe postnatal lung development from birth to adulthood, it may be
useful to draw an analogy with the mathematical model of height development of
Karlberg and colleagues.133,224 A three-phase model of height development in
postnatal life was described: (1) a nutrition-dependent phase comprises a very rapid,
but rapidly decelerating, growth lasting until the end of the second year equating the
phase of alveolar multiplication; (2) a growth hormone-dependent childhood phase
with almost linear growth until approximately 10 years of age without further
multiplication of alveoli or change in airway numbers, but merely enlargement and
elongation of already existing structures, producing linear changes in lung function
with height; (3) a pubertal phase with a rapid change in height, which will slowly
plateau off by approximately 20 years of age and is related to a three-dimensional
enlargement of the lung without multiplication.224
Early postnatal lung growth is characterized by further formation of alveoli,
maturation of lung structures, and production and secretion of a variety of substances
within the lung. The age at the end of alveolarization is controversial. The current
consensus is that alveolar formation starts at 26 weeks, that by term only 15 per cent
of the adult component are present and that the bulk of the process of forming new
alveoli is completed by 6 months and virtually complete by 2 to 3 years of age.224,275
There are indications that, after this age, alveolar multiplication is limited or even
absent and that alveoli only increase in size.215,257 
Airways elongate and enlarge, while the relative amount of bronchial smooth
muscle gradually increases at all levels until 8 months of age.115 After this age, the
muscular coat of the peripheral bronchioles thins and is lost altogether in the terminal
and respiratory bronchioles. This is thought to occur in a manner similar to fingers
extending through a mitten glove, namely that the muscle coat stays where it is as the
airways grow through them.224 Due to progressive alveolarization, early postnatal
volume increase of air spaces is relatively larger then that of the airways, which is
called dysanaptic or nonisotropic growth.121 As laminar airflow is inversely
proportional to the fourth power of the radius and turbulent airflow is inversely
proportional to the seventh power of the radius, very small changes in airway size
have profound effects on airflow.224 
Although methodological differences may exist between older children and
young infants concerning assessment of bronchial responsiveness,146,147 it is suggested
that bronchial responsiveness decreases with age. Contractile forces of the airway
smooth muscle, geometry of the airways, and impedance against which the airway
smooth muscle must contract (cartilage and elastic recoil of the lung) change with age
and affect airway reactivity.179 Additionally, forces of interdependence between
pulmonary airways and parenchyma increase with age, limiting airway narrowing,252
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and the number of cholinergic muscarinic receptors and their affinity for muscarinic
agonists decrease with age while airway acetylcholinesterase activity increases.176
1.2. Factors affecting lung development in preterm infants
As was described in paragraph 1.1., growth and development of the lung follow a
specific pattern. Consequently, environmental changes prior to the 16th week of
intrauterine life can affect the number of conducting airways, while changes occurring
after the 16th week will affect the size rather than the number of airways. Numbers of
alveoli are modified if environmental changes occur during the period between the
prenatal canalicular stage and postnatal completion of alveolar multiplication.121
Hence, pulmonary sequelae of preterm birth and their severity depend on the
developmental stage at which preterm birth and ante- and postnatal interventions
occur, but will never affect airway number, although it may affect subsequent airway
growth.127 Respiratory problems following preterm birth mainly bear on the
interruption of parenchymal development during a critical stage of alveolarization and
vascularization.56,127 As a consequence, fewer and larger alveoli will develop.
Additionally, capillary configuration will be abnormal and an adaptive dysmorphic
pattern of vascular organization often exists. Since both the number of alveoli and
capillaries are reduced, the alveolar-to-arterial ratio may be normal,257 but the
significant and permanent loss of alveoli may not be catched up later on. So, the
earlier lung development is interrupted, the higher the degree of alveolar hypoplasia
will be.56 Furthermore, surfactant proteins are decreased relative to the lipids,
surfactant function is decreased, and it is more sensitive to inhibition by serum
proteins. Surfactant metabolism in the preterm newborn is characterized by slow
secretion, minimal catabolism, and an efficient reuse of phospholipid and protein
components.129
1.2.1. Factors affecting antenatal lung development
In the foetus, lung development can be affected by a range of physical,
metabolic, endocrine and inflammatory factors affecting the intra-uterine environment
(Figure 2).109,110 The impact of various congenital malformations on antenatal lung
development depends on the time of occurrence. A congenital diaphragmatic hernia
may develop during conducting airway formation very early during gestation and may
therefore cause a reduction of the number of bronchial divisions. Since a hernia
remains present during the latter stages of lung growth, airway size will also be
diminished. Other examples include: congenital cystic lung disease or congenital
bronchopulmonary-foregut malformations, including pulmonary sequestration,
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congenital cystic adenomatoid malformation, and congenital bronchogenic cysts, and
deformations of the thorax wall, like osteogenesis imperfecta.121  
Factors affecting both lung development and foetal growth or preterm birth
include foetal nutrient restriction, foetal hypoxemia, elevated circulating cortisol levels
and intra-uterine infection. Because lung liquid secretion is an active process, it is
possible that foetal hypoxemia or hypoglycaemia reduce amniotic fluid volume via
reduced foetal production of urine and lung liquid. Additionally, foetal breathing
movements are inhibited by acute hypoxemia and hypoglycaemia, although they may
be normal in chronical situations of deficiency. Hypoxemia may inhibit growth and
DNA synthesis,109 and may increase circulating concentrations of cortisol,23 which
may affect the duration of gestation and organ development in the foetus,109 but may
also stimulate lung maturation by increasing surfactant levels.110
Severe undernutrition can cause degenerative changes in the lung110,228 and an
association has been described between maternal malnutrition during mid and early
gestation and developing obstructive airway disease in adulthood.156 Besides dietary
lipids that are important for normal development of surfactant synthesis and anti-
oxidant systems, vitamin A and selenium are considered to be important for normal
lung development.109 According to studies in small-for-gestational-age infants,109,110
effects of undernutrition on the developing lung include: reduction in lung weight,
DNA or protein content, reduced surfactant content of lungs and its surface activity,
impaired maturation of type-2 alveolar cells, decreased alveolar formation, reduced
surface area for gas exchange, immature, thicker air-blood barrier and alveolar wall,
reduced elastin content, and reduced acid phosphatase in alveolar macrophages.
Besides dietary lipids that are important for normal development of surfactant
synthesis and anti-oxidant systems, vitamin A and selenium are considered to be
important for normal lung development.109
Familial predisposition to asthma also seems to affect foetal airway develop-
ment.243 There is increasing interest in the possibility of antenatal sensitization of the
foetus, not merely to ingested allergens but even possibly to aeroallergens.224,276
Figure 2. Factors affecting ante- and postnatal lung development.
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Maternal smoking during pregnancy has been found to be adversely related to
postnatal airway function, suggesting that cigarette smoke limits foetal airway growth.
118,155,243 Surgical procedures including amniocentesis may also adversely affect foetal
airway development.88 
Preterm labour is associated with intra-uterine infection in 45 percent of preterm
births before 37th week of gestation.104 Increased degrees of prematurity are
associated with an even higher incidence of intra-uterine infection. Bacteria in the
genital tract and foetal membranes produce interleukines, IL-1 and TNF-α, releasing
chemokines, colony stimulating factors and prostaglandines that induce labour.129 The
presence of intra-uterine infection increases the risk of foetal pulmonary
inflammation. Postnatally, increased levels of pro-inflammatory cytokines IL-1, IL-6,
IL-8 and TNF-α have been found in lavage fluid of preterm infants. Neutrophil
counts are increased and chemotactic activity is initiated. As a consequence of this
pulmonary inflammation, increased capillary permeability causes protein leakage into
alveoli that inhibit the local activity of surfactant. On the other hand, there is
increasing evidence that intra-uterine pulmonary inflammation may result in increased
pulmonary maturation,104 decreased RDS severity and improved lung mechanics.
Increased IL-1α is found to be associated with increased pulmonary compliance, and
increased amounts of phospholipids and SP-B.159 At the same time, later progression
to CLD may result from progression of the antenatal pro-inflammatory
exposure.126,222,277 
Multiple hormones and growth factors can modulate lung maturation in vitro
systems. However, consistent and large effects have only been reported for in vivo
evaluations of antenatal corticosteroid therapy and not for thyroid hormone or growth
hormone.38,129,147 Antenatal corticosteroids are frequently and appropriately
administered to mothers in preterm labour to mature the foetal lung and to decrease
the risk of developing RDS. Glucocorticosteroids function primarily as modulators of
development,129 promote differentiation of alveolar type II cells and increase the
number of surfactant-containing lamellar bodies in these cells. Steroids up-regulate
surfactant proteins A, B and C at the transcriptional level.129,224 However, this effect is
transient, because mRNA levels return to baseline values within several days.10
Improved postnatal lung mechanics result from long-term effects, like thinning of the
alveolar wall and increased potential lung gas volume, rather than from an increase of
surfactant quantities or function.134 Furthermore, antenatal glucocorticoid
administration also stimulates the direct transcription of epithelial sodium channels,
improving fluid absorption at birth. One of the unwanted effects is that
corticosteriods inhibit the growth of new interalveolar septa, probably as a
consequence of reduced DNA and protein synthesis,109 resulting in an
emphysematous state of the lung with a reduced number of enlarged alveoli.261
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1.2.2. Factors affecting postnatal lung development: respiratory distress syndrome (RDS)
As a consequence of respiratory problems and diseases following prematurity,
intensive therapeutic measures are required which herald risks for postnatal lung
development and will be discussed in the following sections.
1.2.2.1. History and epidemiology of RDS
The first description of the clinical features and treatment of infants suffering
from RDS was published as early as 1835 by Eduard Jörg and colleagues.132 But it
took until 1903 to discover the presence of hyaline membranes in the lungs,
considered to represent aspirated amniotic fluid.117 This view changed in the early
1950s, when it was suggested that hyaline membranes resulted from tissue damage and
transudation as a secondary reaction to prematurity and foetal hypoxia.22,169 After
1954, evidence is increasing that major pulmonary function abnormalities coexist with
hyaline membrane disease.33 Pulmonary surfactant deficiency was demonstrated for
the first time in 1959 in infants who died from hyaline membrane disease.8 In the
same year, the name of the syndrome was changed from ‘idiopathic respiratory
distress syndrome’ into ‘(infant) respiratory distress syndrome’, which has been used
synonymously with hyaline membrane disease ever since.33
Before the ventilator era, the clinical course of RDS was remarkable in that death
usually occurred within the first few days after birth. As the specialty of neonatology
emerged in the 1950s and 1960s, more attention was given to supportive care of the
infants, particularly with more accurate ventilators and the survival of these infants
increased. In the late 1960s and early 1970s a further improvement of survival
occurred mainly because micro determinations of blood gases became available and
ventilators further improved.33 The introduction of continuous positive airway
pressure (CPAP) resulted in markedly reduced RDS severity and mortality from the
early 1970s. In 1973, it was demonstrated that RDS could be prevented by antenatal
corticosteroid administration and in 1980, Fujiwara and colleagues74 demonstrated the
effectiveness of artificial surfactant replacement therapy and this was followed by
many authors publishing prospective, controlled, clinical trials promoting surfactant
replacement therapy.73,119 Surfactant being administered at birth appeared to prevent
RDS and in 1993 the synergistic effects of the combined use of prenatal cortico-
steroids and surfactant replacement were demonstrated.33 
As a consequence of these improvements in perinatal care of preterm infants,
severity of RDS gradually decreased during the past decades.56 This did not seem to
affect the incidence rate in The Netherlands during past decades. (Table 1) However,
the number of preterm births as well as the survival of very preterm infants increased
at the same time.280 Since most deaths occur within the first days of life,280 RDS might
not have been registered in these infants. Both incidence rate and RDS severity are
still inversely proportional to gestational age and birth weight (Table 1). 
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Table 1. Incidence rates of RDS and CLD in preterm infants (<37 weeks gestation) according to time
period, gestational age and birth weight.
<28 weeks <30 weeks <32 weeks ≥32 weeks All
RDS
internationally 1996136 60–80% 15–30%
nationally 1983272 57%
nationally 199354 54% 45% 43% 14% 30%
nationally 200154 81% 73% 59% 19% 39%
CLD
1987163 25%/11%
1992163 41%/26%
1997163 42%/29%
1989–1999163 40–45%
nationally 199354 30% 20% 14% 0% 7%
nationally 200154 24%/8% 17%/6% 10%/4% 0% 2%
<1000 g 1000–1500 g >1500 g All
RDS
nationally 199354 49% 35% 21% 30%
nationally 200154 68% 52% 24% 39%
CLD
1967a 100% 43% 27% 28%
1989b,195 71% 14% 31%
1989-1991b,222 37%
nationally 199354 25% 8% 1% 7%
nationally 200154 19%/9% 7%/2% 0% 2%
a ‘Classic’ BPD, as described by Northway and colleagues.197
b CLD defined as supplemental oxygen requirement for 28 days after birth.
c Including infants meeting one of both definitions of CLD: supplemental oxygen requirement for 28 days after birth
and at 36 weeks post-conceptional age.
d Incidence rates of CLD for each definition separately: supplemental oxygen requirement for 28 days after birth/at 36
weeks post-conceptional age.
Besides gestational age, other factors may increase the risk of RDS development.
At any given gestational age, incidence of RDS is higher for caesarean section without
labour than for vaginal delivery.62 Also after a precipitous delivery the risk is
increased.136 When corrected for gestational age, the occurrence of RDS is
significantly increased in gestational diabetes and in insulin-dependent mothers.218
Similarly, overnourished infants who are large for gestational age without evidence of
maternal diabetes seem to be at increased risk.192 Genetic factors may also play an
important role in determining susceptibility to RDS.145 Incidence is also increased in
male sex, the second-born of twins, Caucasian race when compared to the negroid
race,33 and in situations of cold stress and asphyxia.136
Chapter 1
___________________________________________________________________
13
1.2.2.2. Clinical features
Signs of RDS indicating difficulty in breathing usually appear within minutes
after (preterm) birth. Characteristically, infants are cyanotic in room air with expiratory
grunting, tachypnoea, subcostal and intercostal retractions, nasal flaring, and duskiness
appearance.107,136 The increasing cyanosis is often relatively unresponsive to oxygen
administration.136 Respiratory rate is well above the normal range of 30 to 60 per
minute to maintain adequate alveolar ventilation at low tidal volumes due to increased
stiffness of the lung. The usually prominent expiratory grunting is caused by partial
closure of the glottis to maintain lung volume and gas exchange during exhalation.107
Breath sounds during auscultation may be normal or diminished with a harsh tubular
quality, and, on deep inspiration, fine rales may be heard, especially over the lung
bases posteriorly.136 Blood gas and acid-base values are characterized initially by
hypoxemia and later by progressive hypoxemia, hypercarbia, and variable metabolic
acidosis. Within 6–12 hours typical radiological abnormalities may develop at the chest
radiograph, which can be graded according to a system described by Giedion and
colleagues comprising of four stages. It should be noted that modern techniques of
mechanical ventilation are likely to obscure these abnormalities.81 Stage 1
abnormalities include very fine reticulo-granular pattern, normal lucency, and air
bronchograms absent or only present within the cardiac border; stage 2 abnormalities
show a generalized typical reticulo-granular pattern, slightly diminished lucency, and
air bronchograms extending the cardiac border; stage 3 includes confluent reticulo-
granular densities, marked reduction of lucency with indistinct cardiac and
diaphragmatic borders; and stage 4 represents total opacification with a total white
appearance.81 Increasingly this classification is thought to be obsolete, especially
because early mechanical ventilation is able to obscure the radiographic characteristics.
Figure 3 shows an example of the radiological appearance of RDS. 
Figure 3.
Radiological appearance of
RDS stage 3 according to
Giedion. Confluent reticulo-
granular densities can be
recognized with a marked
reduction of lucency and
indistinct cardiac and dia-
phragmatic borders.
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The natural course is characterized by progressive worsening of cyanosis and
dyspnoea. Initially, the unventilated infant requires 40 to 50 per cent oxygen after
birth for relief of central cyanosis, but develops an increasing oxygen requirement
over the subsequent 24 to 48 hours, sometimes reaching as high as 100 per cent.107
Progression and duration of RDS depends on the therapeutic measures and
complications that may arise during the course of the disease. If RDS is
uncomplicated, symptoms and signs may reach a peak within 3 days, after which
gradual improvement sets in. Improvement is often heralded by a spontaneous
diuresis and the ability to oxygenate the infant with lower inspired oxygen levels.136
The decline in oxygen requirement is relatively rapid after 72 hours and, usually,
oxygen can be discontinued after 1 week. However, complications during the course
of RDS occur frequently. Especially extremely preterm infants often require
mechanical ventilation and show a prolonged course of respiratory disease.
Complications may include air leaks, like pulmonary interstitial emphysema,
pneumothorax, pneumomediastinum, and pneumopericardium; patent ductus
arteriosus which often becomes apparent after recovery from RDS; peri- and
intraventricular haemorrhage and hypoxic-ischemic brain damage; and chronic lung
disease of prematurity (CLD).107 Death is rare on the first day of illness, usually occurs
between days 2 and 7, and is associated with alveolar air leaks (interstitial emphysema,
pneumothorax), and pulmonary or intraventricular haemorrhage. Mortality may be
delayed weeks or months if CLD develops in mechanically ventilated infants with
severe hyaline membrane disease.
1.2.2.3. Pathophysiology
Although in foetal lung homogenates of 20 weeks gestation surfactant is present
at high concentrations, it does not reach the surface of the lung until later. Between 28
and 32 weeks surfactant appears in the amniotic fluid. Mature levels of pulmonary
surfactant are usually present after 35 weeks of gestation. Surfactant synthesis depends
in part on normal pH, temperature, and perfusion. Asphyxia, hypoxemia, and
pulmonary ischaemia, particularly in association with hypovolemia, hypotension, and
cold stress, may suppress surfactant synthesis. The epithelial lining of the lung may be
injured by high oxygen concentrations and, together with the effects of respiratory
management, this may result in further reduction of surfactant.136
Due to deficiency of surfactant production, the alveolar surface tension increases
producing atelectases in presence of a highly compliant chest wall and small
respiratory units. The number of adequately ventilated alveoli is decreased and
hypoxia may develop. Decreased lung compliance, small tidal volumes, increased
physiologic dead space, increased work of breathing, and insufficient alveolar
ventilation eventually result in hypercarbia.136 The collagen and elastin matrix is
underdeveloped in preterm infants, and the pressure-volume curve for the preterm
lung will not achieve a plateau or maximal volume. Increasing inspiratory pressures
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will yield linearly increasing volumes yielding additional lung damage.129 Furthermore,
following hypercarbia, hypoxia and acidosis,83 pulmonary arterial vasoconstriction may
develop with increased right-to-left shunting through the oval foramen, arterial duct,
and within the lung itself. Because of reduced pulmonary blood flow, ischemic injury
to the surfactant producing cells and the vascular endothelial cells, effusion of
proteinaceous material, recognizable as hyaline membranes, into the alveolar spaces
occurs. Interstitial oedema may develop and, as a consequence, the compliance of the
lungs further decreases, requiring higher pressures to expand the small alveoli and
airways.136 Epithelial damage appears within 30 minutes of the onset of breathing, and
the hyaline membranes appear within 3 hours after birth. Bronchiolar lesions may
result from a combination of atelectases in terminal air spaces and disruptive
overdistention of more proximal airways.107 As a consequence of atelectasis, the
functional residual capacity (FRC), measured by nitrogen washout, can be reduced.
When measured with body plethysmography FRC may be increased, because of air-
trapping secondary to bronchiolar obstruction. Although bronchus obstruction may
exist, most of the affected bronchi may be collapsed and pulmonary resistance may
not be gravely affected in this situation.136 (See also Figure 5.) It must be emphasized
that severity of RDS has decreased substantially during the past decades and the
severe forms of RDS with massive atelectases are rare nowadays, because of improved
ventilatory care, i.e. antenatal corticosteroid treatment, more effective ways of
mechanical ventilation that are less harmful for lung tissue, and exogenous surfactant
therapy.
1.2.2.4. Prevention and treatment
In case preterm labour can no longer be postponed, administration of
dexamethasone or betamethasone to women 48 to 72 hours before delivery of
foetuses at 32 weeks or less of gestation prevents development of severe RDS and
significantly reduces the incidence, morbidity and mortality of RDS up to about 40 per
cent.37,129,134 However, in case of imminent preterm birth the required time for steroids
to become effective is often too short. Postnatally, early selective use of surfactant
administered in infants requiring assisted ventilation leads to a decreased risk of
neonatal mortality and CLD at 36 weeks gestation in comparison with a delay in such
treatment.289 Antenatal steroids may act synergistically with postnatal exogenous
surfactant therapy.136
Treatment is required in presence of an inadequate exchange of oxygen and
carbon dioxide with secondary metabolic acidosis and circulatory insufficiency. Early
supportive care to minimize acidosis, hypoxia, hypotension, and hypothermia lessen
RDS severity. Treatment requires careful and frequent monitoring of heart and
respiratory rates, arterial partial oxygen (PaO2) and carbon dioxide pressures (PaCO2),
pH, bicarbonate, electrolytes, blood glucose, haematocrit, blood pressure and
temperature.136 Warm humidified oxygen should be provided at a concentration
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sufficient to keep the oxygen saturation levels of haemoglobine (SaO2) between 90
and 95 per cent. When this cannot be achieved by supplemental oxygen alone,
continuous positive airway pressure (CPAP) by nasal prongs is indicated. This usually
produces a sharp rise in PaO2. When despite these measures, the inspiratory oxygen
fraction (FiO2) remains above 0.7, the partial arterial carbon dioxide pressure exceeds
55 mmHg, acidosis persists with pH decreasing below 7.25, or serious apnoeas persist,
mechanical ventilation is required to achieve adequate SaO2 levels and to keep the
PaCO2 between 40–45 mmHg. When peak inspiratory pressure during mechanical
ventilation (PIP) remains below 20 cmH2O while FiO2 rises above 0.6, or when PIP
exceeds 20 cmH2O while FiO2 is above 0.45 rescue therapy with exogenous surfactant
is required. Rescue treatment is usually initiated in the first 24 hours of life via the
endotracheal tube and multiple doses may be needed.136 
1.2.3. Factors affecting postnatal lung development: chronic lung disease of prematurity
(CLD)
Despite successful efforts to decrease RDS severity, like exogenous surfactant,
increased use of antenatal corticosteroids, more effective modalities of mechanical
ventilation that are less harmful for lung tissue, a more careful use of fluid intake and a
more aggressive management of a patent ductus arteriosus, the incidence CLD
remained high or may even have increased14,55 and RDS does not seem to be a
prerequisite for CLD development anymore.201
1.2.3.1. History and epidemiology
As a consequence of improved survival in preterm infants, proliferate reparative
phenomena had a chance to develop, as was described for the first time in 1962 by
Boss and colleagues.24 This was supported by the findings of Robertson and
colleagues in 1964, who found thickened alveolar walls with an increase of fibroblasts
and excess of reticulin or collagen fibres, and radiological abnormalities, like
emphysematous blebs and patchy infiltrates changing to small areas of atelectases in
these infants.219 In 1967, Northway and colleagues described the clinical, histological
and radiological features of this pulmonary disease following respiratory therapy of
RDS and they called it bronchopulmonary dysplasia (BPD).197 These infants
developed severe RDS for which they required high FiO2 and prolonged mechanical
ventilation with high positive airway pressures. However, as a consequence of
decreased RDS severity nowadays and increased survival of extremely premature
infants (i.e. 24–26 weeks gestation, birth weight <1000 grams), who are most likely to
develop CLD,55,196,203 the clinical features and definition of CLD has been changing
since then. The initial description by Northway and colleagues197 was followed by a
definition consisting of the presence of respiratory distress, abnormal chest radiograph
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and need for supplemental oxygen after 28 or 30 days of age in 1979.13,259 Since need
for supplemental oxygen may be a function of immaturity rather than intrinsic lung
pathology, Shennan and colleagues proposed a definition that better predicted
pulmonary outcome and consisted of the requirement for additional oxygen at 36
weeks corrected post-conceptional age in 1988.230 Both definitions for CLD (i.e.
oxygen requirement at 28 days of life and at 36 weeks post-conceptional age) have
remained in common use until now,143 and it has been proposed that a combination of
these definition59 more accurately describes the subsequent adverse pulmonary effects
of preterm birth, although it is not in widespread use yet.194 However, in practice, even
the term BPD is still used synonymously with CLD.201
Apart from the use of different criteria to define CLD, the reported variation in
incidence rates of CLD can be attributed to differences in patient populations and
management.55 Valuable reported data about incidence rates include information
regarding the definition used and the patient population studied. In 1989, the overall
percentage of infants with RDS developing CLD (based on oxygen requirement
beyond 28 days of age) was similar to the incidence rate of BPD in the early 1960s (31
per cent vs. 28 per cent, respectively) (Table 1), but, simultaneously, the number of
infants surviving with birth weights below 1000 grams had dramatically increased.
Since the incidence rate of CLD increased between 1987 and 1992 and subsequently
decreased between 1992 and 1997, accompanied by a significant improvement of
survival, the actual risk of CLD development may have fallen.63,163 In The
Netherlands, a small decreasing trend of the incidence rate of CLD was seen between
1993 and 2001. However, care should be taken when interpreting these data, since
registration in 1993 was not complete. 
1.2.3.2. Clinical features
‘Classic’ BPD, as described by Northway and colleagues,197 is a severe form of
chronic lung disease that traditionally occurred in infants experiencing RDS or other
lung problems after prolonged exposure to high levels of ventilator support and
oxygen.128 Since this form of chronic lung disease is uncommon nowadays, only the
clinical features of the ‘new’ CLD will be discussed. Although not necessary, CLD still
often develops in the setting of neonatal RDS, most often secondary to surfactant
deficiency and pulmonary immaturity.201 Infants who develop CLD nowadays initially
require, in contrast to the classic BPD, only low or moderate concentrations of
oxygen, mechanical ventilation with low pressures, and show a favourable response to
the administration of surfactant during the acute phase.55 The modest ventilator and
oxygen needs decrease over weeks to months128 and chest radiographs appear diffuse
hazy and dense, persisting over time and sometimes progressing into a fine lacy
parenchymal pattern with modest hyperinflation and a few large cysts (Figure 4).12,258
Maldistribution of ventilation leads to a mismatch of ventilation and perfusion
resulting in hypoxemia. Both respiratory rate and physiologic dead space are increased
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causing decreased alveolar ventilation and elevated PaCO2 values. Severity of CLD
varies considerably. Infants with minimal disease (the vast majority) show some signs
of respiratory insufficiency during exercise, e.g. tachypnoea and hypoxia when feeding,
but a large number are asymptomatic and do not require supplemental oxygen by the
time they are discharged home. Infants with more severe disease show signs of
respiratory insufficiency sufficient to require prolonged oxygen therapy beyond 36
weeks post-conceptional age. Airflow obstruction can be recognized by wheezing,
decreased exercise tolerance, insufficient respiratory reserve, deformities of the chest
wall (hyperinflation) and a depressed liver. Even in rest, these children may exhibit
tachypnoea, hypoxia, and intercostal and subcostal recession. Generally during the
first 2 years of life, a gradual improvement in pulmonary function is seen due mainly
to continuing lung growth and constant repair and remodelling. However, even those
with mild disease are prone to recurrent attacks of wheezing especially in association
with viral respiratory tract infections. Infants with moderate to severe CLD may be
wheezy even at rest.201 Most children are weaned of oxygen within a few months, but
a few may require supplemental oxygen for several years.53 Since survivors of the
‘new’ CLD did not reach adult age yet, pulmonary sequelae at this age are unknown to
date. 
1.2.3.3. Pathophysiology
CLD is a multifactorial disease. Infants who develop CLD nowadays are more
immature compared to the ‘classic’ BPD and signs of RDS are usually mild and may
even be absent.31 A predominant pathogenetic factor in CLD is the interruption of
normal lung parenchymal development during the canalicular or saccular stage of
human lung development (paragraph 1.1.1.) at preterm birth, resulting in fewer and
Figure 4.
Radiological appearance of
CLD at 1e month after birth.
Small cystic lucencies appear
in both lungs alternating with
dense areas. Lung volume is
increased, presented by the
horizontal configuration of
the ribs.
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larger alveoli. The total number of arteries may also be reduced, maintaining a normal
alveolar to arterial ratio in infants with CLD, while a marked alveolar hypoplasia may
become prominent during subsequent years.55,104 
While the ‘classic’ BPD was mainly the consequence of barotraumas and oxygen
toxicity, the ‘new’ CLD in the surfactant era results from the interaction of many
factors, including extreme prematurity, poor respiratory effort, need for prolonged
mechanical ventilation and colonization of the airways with pathogens triggering an
inflammatory cascade.14 Frequently, these infants develop sepsis and in many of them
a patent ductus arteriosus reopens.85 Hence, the persistent or recurrent pulmonary
inflammatory reaction, although less prominent compared to the ‘classic’ BPD,129 is
probably caused by intrauterine infection/inflammatory disease that continues after
birth, or by neonatal damage to the airways and airspaces due to hyperoxia,
barotrauma/volutrauma or other toxins.292 Elevated concentrations of oxygen lead to
the production of oxygen radical species and the release of chemotactic factors that
attract polymorphonuclear leukocytes to the lung. When activated, these cells release
inflammatory mediators and proteolytic enzymes. Compared to infants born at term,
preterm infants have significantly lower levels of antioxidant enzymes, such as
catalase, superoxide dismutase, and peroxidase and, consequently, are more
susceptible to oxygen toxicity. During progression to CLD leukocytes remain present
in alveolar lavages129 and anti-inflammatory cytokines such as interleukin (IL)-10 are
low when pro-inflammatory cytokines are high.130 Presence of multiple protein and
lipid mediators of inflammation in lung tissue cause a prolonged release of
proteolases. Eventually, destruction of elastin by uncontrolled elastase activity due to
an imbalance between elastase and alpha protease inhibitor induce development of
neonatal lung injury.12,194 Consequences of persistent pulmonary inflammation include
deficiencies in surfactant components (SP-A),104 interstitial and peribronchial oedema,
loss of epithelial cells and ciliae, necrotizing bronchiolitis and, eventually, fibrosis.106,201
Elevated concentrations of fibronectin in the lung, released by pulmonary alveolar
macrophages, and macrophage inflammatory protein-1 are associated with develop-
ment of pulmonary fibrosis.12 Pulmonary oedema before or during CLD development
may be exaggerated by reopening of the ductus arteriosus decreasing lung compliance
and increasing airway resistance by narrowing of the terminal airways.197 Reopening of
the ductus may also play a pathogenetic role in the development of CLD.12
At autopsy of infants with CLD, pulmonary fibrosis is less compared to the
‘classic’ BPD, but deregulated alveolarization160 or arrested airway development is
increased.125 Open lung biopsy specimens from infants of low birth weight on
ventilator support (postnatal age 2 weeks to 7 months) were reported to show a
simplified distal lung acinus, consistent lack of significant alveolarization, abnormal
capillary configuration, and an adaptive dysmorphic pattern of vascular
organization.106 Additionally, normal development of the extracellular matrix around
the smaller airways is disrupted with focal, dense and abnormal deposition of
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elastin.160 The walls of both large and small conducting airways are thickened largely as
the result of an increased smooth muscle mass. Alveolar attachments tethering the
airway are remarkably decreased in number, while their thickness is increased. This
results in a deformation of the diameter of the airways increasing airway resistance.201
Airway resistance further increases by damage and destruction of airways (airway
plugging with cellular debris), airway inflammation with peribronchial oedema and
increased mucus production, and airway wall thickening by increased airway smooth
muscle mass also exhibiting bronchospasms.80,84,106,151,201 Increased baseline airway
resistance is only partly reversible by inhaled bronchodilators and systemic
corticosteroids.201 Static compliance is decreased, but may be increased if damage to
the lung is sufficient to result in loss of elastic recoil.106 FRC may be decreased
following diffuse atelectases, but may also be increased in presence of air trapping
caused by increased dynamic airway obstruction. As a consequence of alveolar
hypoplasia, total lung capacity and lung compliance may be decreased. Infants and
children with CLD exhibit bronchial hyperresponsiveness201 due to interruption of
normal maturational changes in respiratory mechanics as a consequence of impaired
lung maturation (paragraph 1.1.3.).180 (See also Figure 5.)
1.2.3.4. Prevention and treatment
Preventive measures include limitation of potential provocative factors. As in
RDS, prematurity should be prevented whenever possible. The infant’s heart rate can
be recorded during uterus contractions, reducing the risk of neonatal asphyxia. After
birth, supplemental oxygen therapy and high inspiratory pressures during mechanical
ventilation should be avoided when possible. Current practice is to maintain SaO2
between 92 and 95 per cent instead of higher values.194 A few large ventilator breaths
during resuscitation may already induce an inflammatory cascade, compromising
potential improvement by other interventions, like surfactant therapy.14,129
Prophylactic use of nasal continuous positive airway pressure (nCPAP) may preclude
initiation of intermittent positive pressure ventilation (IPPV) and may thereby
decrease the risk of CLD development, but this was not confirmed by systematic
reviews.247 Since Kraybill and colleagues found that CLD rates were inversely related
to PaCO2 levels,139 it was thought that permissive hypercapnia may prevent
hyperventilation and, thereby, severe lung damage. However, a clear benefit in
reducing mortality, pulmonary and neurodevelopmental morbidity has not been
proven yet.284 Injury to surfactant-deficient lungs can be minimized by recruiting lung
volumes and then maintaining a higher-than-normal FRC by high-frequency
oscillatory ventilation (HFOV).72 More recently described recruitment strategies, in
which pressures are gradually increased to recruit collapsed lung units followed by
decreasing pressures to the least PEEP necessary to maintain sufficient alveolar
recruitment with or without the use of surfactant, are more promising with regard to
decreasing lung injury.217,270 
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Diuretics may immediately improve lung mechanics by diminishing pulmonary
oedema and, thereby, reducing the need for high inspiratory pressures.25 Effective
treatment of a patent ductus arteriosus reduces interstitial oedema. Because of
increased expenditure of energy probably due to increased work of breathing caloric
intake should be elevated. Growth is extremely important to overcome respiratory
problems associated with preterm birth, because airway resistance decreases (Figure 2)
and the response to bronchodilators and corticosteroids improves with somatic
growth.201 Other measures include vigilance regarding antenatal and postnatal
infections, including postnatal sepsis. Prevention of prematurity should get the highest
priority, but prolonged exposure of the foetus to pro-inflammatory cytokines may
inadvertently promote development of CLD. Therefore, strategies to identify
important antenatal cytokines related to CLD development may increase future
potential for prevention.128 Although antenatal administration of corticosteroids
improves lung maturation and decreases the incidence of RDS, repeated courses may
increase the incidence of CLD.70 
Postnatal corticosteroids facilitate extubation from the ventilator due to the anti-
inflammatory effect48 reducing airway oedema and obstruction.42 However, because of
the adverse long-term side effects,97,266 its use has been restricted dramatically during
recent years. In some centres, postnatal corticosteroids are not being administered at
all. In our centre, hydrocortisone instead of dexamethasone is used. There may be
indications that some of the adverse long-term side effects are less severe when
hydrocortisone is used.268 Alternatively, in some infants, bronchodilators help to
decrease airway resistance in CLD282 and inhaled corticosteroids may accelerate
extubation.153 
One of the innovative treatments is nitric oxide that may be efficient in the
treatment of severe hypoxemic RDS.16 As long as the randomized controlled trial
testing the hypothesis that early low-dose inhaled nitric oxide may reduce the
incidence of death or CLD in infants with severe RDS is under way, nitric oxide
therapy should be considered an experimental drug, and its use restricted to clinical
studies in this specific population.217
After discharge from hospital, managing hypoxemia with low flow domiciliary
oxygen and nutrition has improved the respiratory outcome of children with CLD.53
Nutrition has been improved with calorie and vitamin supplementation orally or,
when necessary, given via a naso-gastric tube or a percutaneous gastrostomy. Drug
therapy includes inhaled corticosteroids and, if associated with symptomatic
improvement, beta-2-agonist bronchodilators. Oral corticosteroids may be used
during respiratory exacerbations. Diuretics may be helpful when there is evidence of
right heart involvement with interstitial pulmonary oedema. Immunizations against
respiratory pathogens Haemophilus influenzae type B, Bordetella pertussis, and influenza
viruses are given at the earliest opportunity. Specific anti-respiratory syncytial virus
Perinatal lung development
___________________________________________________________________
22
(anti-RSV) immunoglobulin therapy during winter months has recently become
common practice in the European population.255
1.2.4. Factors affecting postnatal lung development: postnatal therapeutic interventions
Although life-saving, mechanical ventilation induces additional lung injury when
the lungs are inflated to volumes that exceed total lung capacity. Immature lungs are
especially susceptible to lung damage, because only 10 to 20 ml/kg of lung gas volume
is available between FRC and total lung capacity for safe ventilation of the preterm
infants without hyperinflation.129 Regional or uniform overinflation causes rupture of
the distal air spaces leading to pulmonary interstitial emphysema and leukocyte
migration (macrophages and granulocytes) into lung parenchyma inducing an
inflammatory cascade with increased permeability, and interstitial and alveolar
Figure 5. Summary of ante- and postnatal factors affecting postnatal lung
function. Rrs = respiratory system resistance; Crs = respiratory system
compliance; FRC = functional residual capacity. BR = bronchial responsiveness.
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oedema.14,129,198 As with overdistention, ventilation at low lung volumes promotes
accumulation and activation of peripheral leukocytes in the lungs, because of the
cyclic opening and closing of lung units. Mechanical ventilation seems to interfere not
only with alveolarization but also with the surfactant system, causing increased lipid
pools in tissue, while alveolar pools stayed relatively low at about 20 mmol/kg of
saturated phosphatidylcholine. Already after a few large ventilator breaths, secretion of
de novo-synthesized saturated phosphatidylcholine may be decreased and its
catabolism increased.14,129 Important preventive measures regarding mechanical
ventilation have to focus on prevention of high inspiratory pressures especially during
acute resuscitation, gradual recruitment of collapsed lung units, maintaining sufficient
alveolar recruitment and minimizing supplemental oxygen to preclude an stimulation
of the pulmonary inflammation.194 
Surfactant treatments have profound effects on static lung volumes that translate
into better lung mechanics, improved gas exchange, and a 30 to 40 per cent decrease
in mortality for preterm infants with RDS. Oxygenation is improved by increased
recruitment of new gas exchange surface as well as by increasing functional residual
capacity (FRC) due to increased stability of the lungs on deflation (Figure 5).129
Immediate effects include improved alveolar-arterial oxygen gradients, reduced
ventilator mean airway pressure,124 increased pulmonary compliance (Figure 5),45,113
and improved appearance of the chest roentgenogram.50 By stabilizing lung volume
and avoiding alveolar overdistention surfactant may mitigate the inflammatory
response in the lung. In addition, endotoxin-stimulated secretion of several pro-
inflammatory cytokines, like tumour necrosis factor, IL-1 and IL-6 by alveolar
macrophages, may be decreased after administration of surfactant.256 Hence,
surfactant treatment may decrease the granulocyte accumulation and oedema that is
partly caused by mechanical ventilation.129 Furthermore, surfactant also inhibits
neutrophil superoxide production5 and has been shown to reduce bacterial growth in
experimentally induced group-B streptococcal infection in immature rabbits.114 On the
other hand, administration of surfactant increases the risk of overdistention of some
air spaces if peak inspiratory pressures are not reduced as rapidly as lung compliance
improves.14
The rationale for the postnatal use of glucocorticoids was primarily to prevent or
treat CLD by minimizing the inflammation and injury associated with ventilation and
oxygen exposure. By suppressing a number of indicators of inflammation/injury,
postnatal glucocorticoids acutely improve lung function, facilitate extubation, but only
have modest effects on the incidence of CLD defined as supplemental oxygen need at
36 weeks.96,101,103 Unfortunately, according to experiments in rodents, the major effect
of glucocorticoids on the pre-alveolarized postnatal lung is to decrease alveolar and
vascular development.164 Furthermore, postnatal corticosteroid therapy increases the
risk of adverse long-term neurodevelopmental outcome.95,266 As a consequence of
these recent publications, the use of postnatal corticosteroid therapy has been
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dramatically restricted. The Cochrane Reviews regarding this kind of therapy
recommend to limit the use of postnatal corticosteroids to infants, who cannot be
weaned from the ventilator, and to perform further research to find out safer
treatment strategies and the effectiveness of less potent drugs.94,100,103
Diuretics diminish interstitial and peribronchial oedema, theoretically improving
lung function (Figure 5) and, consequently, decreasing ventilator conditions. Inhaled
corticosteroids will limit the ongoing inflammatory processes, reducing pulmonary
oedema and potentially decreasing bronchial responsiveness, although the relationship
between pulmonary inflammation and the subsequent development of bronchial
hyperresponsiveness is still obscure.201 Bronchodilators will reduce the reversible
component of airway narrowing, if present, directly decreasing airway resistance
(Figure 5). Stimulating somatic growth by sufficient calorie and vitamin intake will
decrease airway resistance, increase lung volume (Figures 2 and 5) and improve the
response to inhaled bronchodilators and corticosteroids although in the more severe
cases the irreversibility may be permanent.
 
 
CHAPTER 2
Respiratory function at neonatal age and
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After birth the lung starts to function as an absorptive organ in contrast to its
secretory function in utero. The primary objective of the lung is to provide the body
with oxygen (O2) and to release carbon dioxide (CO2) that is produced by metabolism
processes. This is achieved by:
1. Ventilation of the lung by environmental air.
2. Gas exchange at the alveolar surface area by diffusion of O2 from the alveolar
space into the capillary system and of CO2 from the capillary system into the
alveolar space.
To accomplish this, the respiratory system consists of active components
including (a) respiratory muscles which generate pressures required to produce airflow
between alveoli and mouth and (b) smooth muscle in the airway walls regulating
resistance to flow, and passive components including the airways, their diameter
depending on lung volume, and the gas exchange surfaces of the alveoli. All
components may be affected by age and respiratory disease. In this chapter,
respiratory function will be discussed starting with the physiological properties of the
respiratory system followed by a description of various possibilities to measure
respiratory function in infancy and early childhood. At the end of the chapter, the
tests that were used for the studies in this thesis are described in detail.
2.1. Physical properties of the respiratory system
2.1.1. Forces operating during quiet ventilation
Although, already in the second century, Galen described the mechanism of
breathing as the expansion of the thorax allowing the weight of the surrounding air to
fill the increased volume,245 it took until 1820 to complete the description of forces
involved in breathing by a description of lung elasticity.28 This was confirmed by
Donders in 1849 52 and developed further by Rohrer in 1916 208 who described the
pressure-volume relationships of the lungs and chest wall, including anatomical chest
wall, diaphragm and abdominal contents. To produce inspiratory flow, the
intrapulmonary pressure has to become subatmospheric. To achieve this, inspiratory
muscles, mainly diaphragm, produce a pressure that is more negative than the recoil
pressure of the lung tending to collapse it. Airflow is directed into the lungs according
to Boyle’s/Mariotte’s law, stating that the product of pressure and volume is constant
for an isothermal process. For an adequate expiration, relaxation of inspiratory
muscles is required. The energy stored in the lung, its elastic recoil, is sufficient to
generate expiratory flow.123 During the respiratory cycle, several pressures operate at
different locations inside the thorax that can be expressed as differences relative to
barometric pressure (PB) (Figure 1).
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At static conditions, when no flow is present, it is assumed that the pressure
measured at the airway opening (Pao) resembles alveolar pressure (PA). This pressure
can be used to assess mechanical properties of the respiratory system, which can be
separated into lung and chest wall components. The lung component or
transpulmonary pressure (Ptp) is the difference between PA and the interpleural
pressure (Ppl), which is usually measured in the oesophagus. The chest wall
component (Pcw) is the difference between Ppl and PB. Actual pressure course of
alveolar and pleural pressures during the entire respiratory cycle is presented in Figure
2.
The pressure differences can be used to estimate mechanical characteristics of the
respiratory system. Rohrer applied Newton’s laws of motion to the respiratory
system,207 being further developed by his pupil Wirz, who initiated together with his
colleague Neergard studies of lung mechanics in humans.184 Rohrer proposed three
independent forces involved in lung movement, namely, elastic recoil, resistance, and
inertance (the force required to initiate movement of the lung mass). According to the
equation of motion, the sum of these forces provides the total driving force for
breathing: 
Ptot = Pel + Pres + Pin Equation 1
where Ptot is the total pressure to move the lungs, Pel is the pressure required to
overcome lung elasticity, Pres is the pressure to overcome airway resistance, and Pin is
Figure 1. Pressures and pressure differences in the respiratory system,
while presenting the intrapulmonary situation during in- and expiration.
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the pressure needed to accelerate lung mass. In a situation of zero airflow with
complete equilibration of mouth and alveolar pressures and no muscle activity,
pressure differences only represent the elastic properties of both lungs and chest wall.
Pel is determined by the following components: 
Pel = Pel (lung) + Pel (chest wall) Equation 2
of which the elastic forces of the lung can be broken down into the surface forces of
the alveolar air-liquid interface, responsible for about 65 to 75 per cent of the lung’s
elastic recoil pressure,123 and the retractile forces of the lung tissues.171 Increased
surface tension at the air-liquid interface in alveoli due to lack of surfactant may
therefore substantially increase the pressure required to inflate the lung. This can be
explained by LaPlace’s law, in which internal pressure of a spherical structure increases
with increasing surface tension and decreasing radius.258 The physical properties of
surfactant include stabilizing the lung by decreasing surface tension relative to the
surface area of the alveolus. The larger the surface area, the greater surface tension is
allowed before alveoli tend to collapse. So, increased surface tension in a large alveolus
offsets the larger radius, making the recoil pressure equal to that in a smaller
alveolus.123 Elastance of the respiratory system (Ers) is further related to volume
Figure 2. Comparison of changes in alveolar and
interpleural pressure during the respiratory cycle. Note
that the interpleural pressure normally remains negative
throughout the respiratory cycle. By contrast, alveolar
pressure is atmospheric when there is no gas flow, that
is, at end-expiration and at end-inspiration, but becomes
negative during inspiration and positive during
expiration, thereby providing the driving force to move
air in and out of the lungs. (See also Figure 1.)
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changes, i.e. Pel depends on the volume of air present inside the lungs. Hence, Ers
resembles Pel/V.
The resistive component of the driving pressure mainly depends on diameter and
geometric configuration of bronchi through which the air is flowing. In infants,
peripheral airways may account for a significant proportion of the total resistance to
airflow, whereas in older children and adolescents, they account for a negligible
proportion of the total resistance of airflow, which is then mainly determined by the
central airways:
Pres = Pres (airways) + Pres (lung tissues) + Pres (chest wall) Equation 3
In the infant, who often breathes through the nose, an additional category due to
nasal resistance should be added.230 Furthermore, the resistance of the respiratory
system (Rrs) also depends on the physical properties of the air according to Poiseuille’s
law, in which resistance increases with increasing viscosity of air.21 Airway diameter
may vary enormously as a consequence of smooth muscle contraction. Also according
to Poiseuille’s law, Rrs is further related to the rate of volume change (flow: V’), i.e.
Pres depends on airflow into or out of the lungs. Hence, Rrs resembles Pres/V’. 
Pin is determined by the following components:
Pin = Pin (lung) + Pin (chest wall) Equation 4
The inertance of the respiratory system (Irs) is related to the rate of flow, i.e. Pin
depends on acceleration of volume flowing into or out of the lungs (V’’). Hence, Irs
resembles Pin/V’’.
After replacing these pressure differences by respiratory system elastance,
resistance and inertance Equation 1 can be rewritten into Equation 5: 
Prs = Ers·V + Rrs·V’ + Irs·V’’ Equation 5
Ers is the reciprocal of compliance (Crs), a measure of respiratory system stiffness,
and can be replaced by 1/Crs in Equation 5. In young infants, the compliance of the
chest wall is very high, at least three times as high as that of the lung, increasing to five
times as high in preterm infants.84 So, at young age, lung compliance is the major
factor determining Crs. The principal assumption when applying Equation 5 is that the
respiratory system behaves like a single unit and that its mechanical characteristics are
linear.220 Depending on a single compliance and resistance, the single-compartment
respiratory system empties according to a single time constant (τ), i.e. the time
required to expire 63 per cent of the residual air left inside the lungs. Since three time
constants are required to achieve 95 per cent lung emptying, the combination of a
relatively rapid respiratory rate (short expiratory time) and a long time constant is
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likely to result in dynamic elevation of end-expiratory lung volume and the
development of intrinsic positive end-expiratory pressure (iPEEP). The τ of the
respiratory system (τrs) can be defined as:
Τrs = Crs · Rrs Equation 6
Inertial forces are negligible during quiet tidal breathing compared to the much
greater elastic and resistive forces.170 Pressure-volume relationships of the lungs are
assumed to be linear within the tidal volume range and static hysteresis is minimal.184
Hysteresis develops in elastic systems at volumes outside the tidal volume range when
more pressure is required to move or stretch the system than is recovered on
relaxation. Consequently, the pressure-volume curve differs during inspiration and
expiration, i.e. at the same volume, Ptp is smaller during expiration than during
inspiration. 
2.1.2. Changes in normal respiratory physiology
Whereas the normal lung may act as a single-compartment model, the associated
assumptions tend to break down under conditions of increased ventilator
requirements such as exercise, disease, and infancy. At extremes of flow, for instance,
resistance becomes non-linear as airflow within the airways moves from a rather
predictable laminar flow to turbulent flow. Compliance varies non-linearly at volumes
Figure 3. Static volume-pressure curve of the lung,
chest wall, and the total respiratory system. Volume
is expressed as percentage of vital capacity. The
compliance of the lung, chest wall and the total
respiratory system are the slopes of the respective
curves at the level of the functional residual capacity.
A = chest wall;
B = lung;
C = respiratory system;
D = forced inspiration;
E = forced expiration;
F = functional residual capacity (FRC)
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above or below tidal volume (Figure 3). Furthermore, during severe respiratory
diseases inequality of ventilation and unequal distribution of resistance and
compliance may create a number of single-compartment models, arranged either in
parallel to each other or in series. Asynchronous filling and emptying of lung units can
result in an important frequency dependence, which can be attributed to continuing
gas flows within the lungs while flow at the airway opening has already stopped.
Eventually, mechanical models will become increasingly complex and difficult to
follow.233
Since lung volumes increase dramatically through infancy, childhood, and into
adolescence, the distinction between anatomical/morphological growth and functional
development varies with age. The chest wall has a major influence on the underlying
lungs, as its outward recoil is extremely low in the infant and young child, 84 but
increases with age. The equilibrium of the outward recoil pressure of the chest wall
and the inward recoil pressure of the lungs determines the static resting volume of the
lungs, i.e. elastic equilibrium volume (EEV). Because of the high compliance of the
chest wall in young infants, the respiratory system reaches this equilibrium at a
relatively lower lung volume compared to older children and adults. Infants are at risk
of airway closure at these low lung volumes, because of decreased distending
pressures across the airways. Since this may lead to progressive atelectases and
increased venous admixture, end-expiratory lung volume (functional residual capacity
(FRC); Figure 4) is dynamically elevated above EEV in young infants to overcome the
tendency of the lung to collapse by using various strategies:139,180
Figure 4. Lung volumes and capacities at different levels during respiration.
TLC = total lung capacity;  VC = vital capacity; IC = inspiratory capacity; FRC = functional
residual capacity (>elastic equilibrium volume in infants);  IRV = inspiratory reserve volume;
Vt = tidal volume;  ERV = expiratory reserve volume;  RV = residual volume.
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1. Inspiratory muscle activity slowly decreases during the first part of expiration,
causing expiratory braking.
2. Subsequent inspiration is initiated prematurely before expiration has reached
EEV.
3. Increasing airflow resistance in the upper airways by laryngeal adduction during
expiration, further increasing expiratory braking.
4. Increasing respiratory rate with insufficient expiratory time to reach EEV
regarding to what is needed with the prevailing respiratory system time constant
(see later in paragraph).
Between 6 to 12 months of age, infants abandon these strategies and expiratory flow
changes into a more relaxed pattern.35
The large central airways are supported by cartilage to resist collapse during
expiration, whereas smaller peripheral airways have no such support and rely on a
transpulmonary distending pressure together with the surface-tension-reducing
properties of surfactant, to remain patent.233 Consequently, with a highly compliant
chest wall, young infants are very susceptible to peripheral airway closure. Since the
peripheral airways are the most substantial part of total respiratory system resistance,
peripheral airway closure can have severe consequences, in which mainly basal
ventilation is reduced while perfusion is increased, resulting in a significant ventilation-
perfusion mismatch.40 The ability of young infants to cope with added respiratory load
is also reduced by the configuration of the respiratory pump. Ribs are placed
horizontally, reducing the potential for thorax expansion191 and relying more on
diaphragmatic activity to increase thoracic volume. Together with the high compliance
of the chest wall, inspiratory activity may cause an inward movement of the floppy
chest, so that up to about one third of the tidal volume is lost due to paradoxical chest
movement.182 The loss is made up by an increased work of breathing, even under
normal conditions. Furthermore, young infants have fewer type I muscle fibres and
are therefore at greater risk of developing respiratory failure due to fatigue.182 The high
compliance of both airways and chest wall increases the tendency of the airways to
collapse at low lung volumes in these infants. Airway smooth muscle is also less
contractile and less sensitive to neural and mediator control compared to the mature
subject.229
Sleep state may also affect respiratory function. In the neonatal period, three
sleep states can be recognized: active, quiet, and indeterminate (transitional) sleep.39
After 6 months of age, sleep states start to resemble those in adults with an active
(rapid eye movement) REM sleep for 25 per cent of sleeping time. In preterm infants,
REM sleep accounts for 80 per cent of sleeping time and in term infants for 50 per
cent.36 During REM sleep, diaphragmatic and postural (intercostal and abdominal)
muscle tone and laryngeal braking are diminished. As a consequence, FRC (Figure 4)
falls during REM sleep. Other circumstances in which lung volumes may be
functionally decreased are atelectases, pneumothorax and congenital myopathy.
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Structural reduction of lung volume may occur in cases of lung hypoplasia and
alveolar hypoplasia.
Finally, factors affecting O2 uptake will be discussed. Since achieving and
maintaining gas exchange is the primary function of the lung, blood gases may
complete the picture of total respiratory function. O2 uptake depends on the matching
between alveolar ventilation and pulmonary blood flow (V’/Q’ matching) and on
diffusion time, diffusion gradient, and diffusion area. It is not possible to distinguish
between different variations of V’/Q’ mismatching, for example, whether mainly
unventilated areas are well perfused, well-ventilated areas are badly perfused, or
inequalities between ventilation and perfusion exist.259 V’/Q’ matching and diffusion
area are substantially affected by lung volume. Both high and very low lung volumes
will decrease lung compliance and may impair both alveolar ventilation and effective
pulmonary blood flow. During mechanical ventilation, O2 uptake depends mainly on
mean airway pressure. The reason is unclear, but it is likely that it is related to
optimizing lung volumes and V’/Q’ matching by, for example, recruitment of
unventilated alveoli.26
Since CO2 diffuses readily from the blood into the alveoli, its elimination depends
almost exclusively on alveolar ventilation, which is the product of breathing rate and
tidal volume. If the time allowed for inspiration becomes too short and minute
ventilation will drop, CO2 retention will occur.65 If the time for expiration becomes
too short, gas trapping may result, which will manifest as CO2 retention, impaired
venous return to the heart, poor cardiac output, and thus compromized O2 uptake.27
2.2. Measuring respiratory function in infants and young children
Since the 1700s, various attempts have been made to measure lung volumes; the
water spirometer has existed for nearly 150 years.121 But it was not until the 1940s and
1950s that pulmonary function testing in adults and older children began to develop as
a science with clinical, epidemiological, and research applications.3 However, tests for
measuring lung function in infants have lagged behind. There are a number of reasons
that may explain this: (a) infants are uncooperative and therefore difficult to study, (b)
sedation is often required and the duration of test procedures is long, (c) parental
concerns exist over testing and sedation, (d) lung dynamics may change rapidly, and
(e) there may be a lack of physicians and scientists interested in this field.233 Although
there were pulmonary physiologic studies of normal neonates and new-borns with
HMD as early as the mid-1950s2 and of infants with bronchiolitis143 and cystic
fibrosis198 in the 1960s, the interest in studying the respiratory system in infants has
only increased substantially since the past 25 years. Initial tests of lung function in
infants focused predominantly on measurements of dynamic compliance, resistance,
and lung volumes.2 Initially, measurements of the former two were invasive and
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cumbersome, requiring oesophageal balloons or complicated equipment and testing
procedures. Recently, technologic advances provided tests that are less invasive and
easier to perform, such as passive deflation curves or occlusion techniques,150,180,190 the
weighed spirometry for measuring respiratory system compliance,44,236 forced
expiratory manoeuvres by chest compression techniques.234 More recently, even less
invasive tests such as the analysis of tidal breathing pattern have been devised to
assess respiratory health and disease.252 
In infant lung function testing the optimal measurement condition depends very
much on the environment. To optimize success rate, infants should be well fed, clean
and dry and placed in a standardized position. Maybe even more important are the
qualities of investigators in the field of infant lung function testing, who should be
very patient and have great attention to detail. When sedation is allowed in
combination with the respiratory function tests, the chance of obtaining reliable
repeated measurements is increased.82
Mechanical ventilation induces several limitations for respiratory function
testing.228 In ventilated infants, non-linearity of the pressure-volume relationships due
to alveolar collapse toward end-expiration, if insufficient positive end-expiratory
pressure (PEEP) is used, or overdistension of some lung units toward end-inspiration,
if peak ventilation pressures are too high, may substantially affect respiratory
function.41 Presence of the endotracheal tube will add a (non-linear) resistance to the
actual resistance of the airways or respiratory system.152,164 To reduce this effect,
routine suctioning, to clear secretions in the endotracheal tube and trachea before
respiratory function testing, is required.220 In infants, endotracheal tubes are uncuffed,
increasing the risk of air leakage between tube and trachea. Expiration into a ventilator
system with maintained PEEP will affect respiratory function results, as will tube
geometry and characteristics of the ventilator tubes connected to measuring
equipment.142 Characteristics of the inspired gas regarding composition, temperature,
relative humidity and pressure may considerably affect respiratory function
measurements, 21,47,69,92,96,97,110,212,248,250,263,269 as does variation in flow rates (Chapter 3
of this thesis).67,73 It should be noted that respiratory function testing should be
performed during adequately long periods of spontaneous breathing or continuous
mechanical ventilation. Combination of the two modes of ventilation (i.e. spontaneous
and continuous) causes havoc with analysis and interpretation of the data. One
advantage of mechanical ventilation is that airflows and pressures during breathing
can easily be recorded via the endotracheal tube; infants and young children often do
not accept a facemask that is sealed against their face. Furthermore, results are not
affected by the compliance of the upper respiratory tract.
Always note that the equipment used for respiratory function measurements will
increase total measured resistance and dead space affecting SaO2 and PaCO2 values,
spontaneous breathing pattern and FRC.220
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In the following sections, only the respiratory function techniques that were used
for the studies in this thesis are described. Considerations regarding the choice of
respiratory function measurements are described followed by a description of the
equipment required, basic principles, and advantages and disadvantages of the
techniques will be discussed. 
2.2.1. Considerations regarding the choice of respiratory function measurements
The results in this thesis are based on a study population of preterm infants who
were mechanically ventilated within 24 hours after birth. Respiratory function
measurements were performed in a period ranging from the first day after birth until
the second birthday. Considering this group of children, high demands were made
upon respiratory function testing. Since vital functions are relatively unstable in
preterm ventilated infants, even minimal disturbances can result in severe clinical
deterioration. So, measurements should preferably not disturb the patient, be non-
invasive, easy applicable and little time consuming. Furthermore, additional dead space
and resistance of the equipment should be minimal because of small lung volumes and
low muscle strength. When not sufficiently adjusted, these factors may result in
inadequate ventilation with increased PaCO2 levels and, eventually, decreased PaO2
levels. From the ethical point of view, it is no topic of discussion that infants should
remain inside the incubator and ventilator conditions should not be changed when
respiratory function tests are performed. Also, transport of the infants may
substantially disturb the patient and is therefore not preferred. 
Taking all this into consideration, we chose to use the single breath occlusion
technique (SBT) for respiratory function testing during the neonatal period of
mechanically ventilated preterm infants. This technique can be easily performed
during mechanical ventilation. It only takes a few seconds to put a pneumotachometer
with valve mechanism between endotracheal tube and ventilator tubes.
Pneumotachometers with a minimal dead space and low resistance to airflow are
commercially available. Five occluded breaths are required according to the European
Respiratory Society recommendations.80 Including the time for the FRC level to
regress to original values between separate occluded breaths, it only takes a few
minutes to complete the test. When (a) the test is scheduled after a routine suction
procedure to remove mucus that may have been accumulated inside the endotracheal
tube and (b) testing equipment is situated next to the incubator at the neonatal
intensive care unit (NICU), disturbance to the patient will be minimized. This
technique is little time consuming. In contrast to the measurement of dynamic
respiratory system mechanics instability of the chest wall may be an advantage rather
than a disadvantage, because the portion reflected by the lungs will be increased.
Compared to the multiple occlusion technique (MOT), this technique less depends on
stability of the FRC level, which may substantially vary in preterm infants. In contrast
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to tidal breathing parameters, which can be determined very easy and fast as well, the
SBT allows separation of the resistive and elastic properties of the respiratory system.
Compared to forced expiration techniques, SBT allows maintaining a PEEP, which is
highly recommended in ventilated preterm infants, and infants do not have to be
paralysed. Although body plethysmography has the advantage of assessing lung
volumes together with mechanics, it probably is too much of an effort for preterm
infants to breathe against a closed valve, losing the effect of PEEP. Furthermore,
body plethysmography requires expensive equipment, is complicated by pressure and
temperature instability, and is rather time consuming. Although lung volume
measurements by gas dilution techniques are preferred during mechanical ventilation
in preterm infants, measurement errors will be relatively large because of the small
lung volumes.
During follow-up period of our study, respiratory function measurements were
repeated at 1 year and 2 years of age. At 1 year of age, respiratory function testing can
be performed successfully after sedation by chloral hydrate. Since lung volume
assessment may add important information to respiratory system mechanics, FRC
assessment was added to the measurement of the compliance (Crs) and resistance (Rrs)
of the respiratory system, provided that the child was sleeping long enough. Since
equipment required to perform the helium dilution technique in these infants was
already available, including an appropriate gas analyser and spirometer, this method
was chosen. 
According to our experience of the measurements at 1 year of age, it seemed that
falling asleep was sometimes hard to accomplish, despite additional measures, like
scheduling the test according to personal daily sleeping patterns of the infants and
actively keeping the infants awake during the car ride to hospital. Therefore, we
decided not to repeat the same measurements at 2 years of age, because with the
children walking and playing by that time, falling asleep would even be harder and the
risk of getting hurt by losing their balance, induced by chloral hydrate, would be
increased. We chose to perform bronchial provocation tests at 2 years of age, for
which no sedation is required and which reveals information about bronchial
responsiveness, a relevant determinant of respiratory course in ventilated preterm
infants.174,181,195,222 Adequate inhalation of methacholine can be achieved if their
attention is sufficiently diverted.
2.2.2. Single breath occlusion technique (SBT) to determine passive respiratory system
mechanics at neonatal age and at 1 year of age
Passive mechanical characteristics are assessed in absence of respiratory muscle
activity and can be obtained during spontaneous breathing as well as during
mechanical ventilation. For the occlusion techniques, besides a heated
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pneumotachometer to measure airflow, a valve mechanism has to be connected
between endotracheal tube and ventilator tubes or to a facemask to perform
occlusions at the airway opening at end-expiration. In spontaneously breathing infants,
occlusions can also be performed manually at the outlet of the pneumotachometer.
This technique relies on the fact that the Hering-Breuer inflation reflex is still strong
in infants and young children. Consequently, if lung volume is held above FRC, either
by inflation or by an occlusion at the airway opening, there is stimulation of stretch
receptor activity, inhibiting subsequent inspiratory effort, resulting in prolongation of
expiration with complete relaxation of respiratory muscles.150 
Via a pneumotachometer and pressure transducer, signals of airflow, volume
(integrated from airflow) and mouth pressure can be displayed simultaneously on a
Figure 5. Single breath occlusion technique. At high inspiratory volume the airway is briefly
occluded. During this occlusion no airflow is present, mouth pressure rises and reaches a
plateau, and volume remains stable. The pressure difference (P) between baseline and
plateau is used for calculations of both Crs and Rrs. After the occluded breath is rendered
into a flow volume graph, τrs can be determined as well as flow difference (V’) and
volume difference (V). Subsequently, Crs can be calculated by V/P and Rrs by
P/V’. FRC = functional residual capacity; EEV = elastic equilibrium volume.
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computer screen. As was described by Le Souef and colleagues in 1984, 150 occlusions
are performed at high tidal volumes to elicit the Hering-Breuer reflex resulting in
respiratory muscle relaxation. As a consequence of the inward recoil pressure of lungs
and chest wall, mouth pressure rises to reach a plateau representing equilibrium
between the recoil pressures of lung and chest wall related to the amount of air
present inside the lungs. The optimal duration of occlusions has still to be
determined163 and is related to respiratory rate and degree of respiratory disease
affecting equilibration time. After occlusion is released, a passive expiration occurs
determined by the τrs. The τrs is reflected by the linear portion of the expiration part of
the flow-volume curve (Figure 5). EEV is determined by crossing of the line
representing τrs and the volume-axis. The ratio between the volume of air within the
lungs above EEV and the mouth pressure representing alveolar pressure during
occlusion reflects Crs. By extrapolating the line representing τrs towards the flow-axis
the airflow during occlusion can be determined. The ratio of mouth pressure and the
airflow during occlusion reflects Rrs.150 Since τrs resembles the product of Crs and Rrs,
Rrs can alternatively be calculated by dividing τrs by Crs.180 
If expiration occurs into the ventilator circuit, mechanical properties of this
circuit are included in these calculations. Ideally, infants should expire into the
atmospheric air; however, the loss of PEEP may have adverse clinical implications.
There is no current consensus as to the best approach in these circumstances.80
The SBT is based on a physical model relying on several assumptions. For many
respiratory function tests, the respiratory system is considered to behave like a single-
compartment model, as was already mentioned in paragraph 2.1. Consequently, both
Crs and Rrs are thought to remain constant throughout expiration within the range of
tidal breathing and the respiratory system should be described by a single τrs.
Furthermore, it is assumed that the pressure at the airway opening resembles the
elastic recoil pressure of the respiratory system. This can only be achieved when there
is complete relaxation of respiratory muscles and complete equilibration of pressures
throughout the respiratory system. Especially in neonates, brief airway occlusions do
not invariably induce a respiratory pause and, in the presence of severe airway
obstruction and rapid respiratory rates, complete equilibration of airway and alveolar
pressures may not be reached. Finally, it is assumed that all respiratory muscles remain
relaxed during the expiration following occlusion and that inertance is negligible.68 
Important advantages of the SBT include the ease and non-invasive character of
the test and the fact that it only takes a few minutes to carry out. Since enough time
for redistribution of intrapulmonary air during a period of zero airflow is provided
during airway occlusion, results are not frequency dependent. However, although
respiratory muscle activity is eliminated, lung characteristics cannot be separated from
chest wall characteristics. In some cases, no muscle relaxation can be achieved and
thus no results obtained. During mechanical ventilation, the accuracy of the results
can be substantially affected by the endotracheal tube in situ228 and air leakage
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alongside the endotracheal tube. Also inspiratory pressures affect the level within the
pressure-volume curve reflecting the degree of lung recruitment and overdistention,
directly affecting Crs.132 Additionally, in infants with upper or lower airway obstruction
there may be marked changes in resistance throughout the respiratory cycle,
invalidating the assumption regarding linearity (paragraph 2.1.1.).41 Furthermore,
factors causing severe deformations of the expiratory part of the flow-volume curve,
like laryngeal braking, expiratory muscle activity or severe airway obstruction, may
result in serious deviations of EEV. Therefore, when EEV, assessed after
extrapolation of the linear part of the expiratory flow-volume curve to the volume
axis, deviates by more than 10 per cent from FRC, where the expiratory flow-volume
curve really crosses the volume axis at end-expiration, results should be considered
unreliable. Following end-inspiratory occlusions, infants often inspire earlier than
usual on the subsequent breath, such that any rise in end-expiratory resistance due to
dynamic airway closure may be missed.
To ensure reliability of Crs and Rrs assessments by SBT, occluded breaths have to
meet certain criteria. There should be no evidence of leaks around the endotracheal
tube or facemask. Leaks in the system or around the endotracheal tube can be easily
detected as mouth pressure decreases gradually during occlusion. With gentle manual
compression of the trachea present leaks can be minimized. Persisting tube leaks
causing a decrease in occlusion pressure of 0.02 kPa or more have to be excluded
from further analysis. No drift of the volume signal is allowed. At least five tidal
breaths should be recorded before each occlusion to allow regression to original FRC
level. Passive expiration should proceed to at least 80 per cent of the volume expired
during pre-occlusion tidal breathing, because early inspiration by the infant may
invalidate analysis.68 Analyses were performed according to the European Respiratory
Society (ERS) recommendations valid during the time of the measurements.61,80
Breath analysis was considered unreliable, when no muscle relaxation was achieved.
Muscle relaxation is assumed to be present when (1) during a short occlusion period
of less than 0.5 seconds mouth pressure reaches a plateau for at least 0.1 seconds
during which pressure changes should be trivial (i.e.  with a standard deviation (SD) of
0.01 kPa or less), and (2) the expiration part of the flow volume curve is linear for at
least 50 per cent of the volume to be expired. As a criterion for linearity, a correlation
coefficient of 0.98 or more after exclusion of the final 5 per cent of the expired
volume has to be reached. However, a linear expiratory flow-volume curve does not
guarantee relaxation of respiratory muscles or the presence of a single passive time
constant, it may also represent balanced respiratory muscle activity or reciprocal
changes in compliance and resistance as lung volume decreases. We intended to use at
least five occluded breaths meeting the above-mentioned criteria to calculate a mean
value for both respiratory mechanics for each single measurement. 
Finally, a specific description of the measurement procedure and equipment that
was used during neonatal measurements and measurements at 1 year of age is
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provided. During the neonatal period mechanically ventilated preterm infants were
measured using a heated Lilly-type pneumotachometer (8410A, linear range 0–10
L/min, dead space 1.3 ml, resistance 0.96 kPa/Ls at 5 L/min; Hans Rudolph Inc.,
Kansas City, MO, USA) placed between endotracheal tube and ventilator tubes
(Figure 6). A pressure transducer (Honeywell, type 163PC01D75, Morristown, NJ,
USA) and an IBM compatible personal computer with a Pentium processor running
the software package Respiratory Analysis System Program (Version 007.17, Physio
Logic, High Clere, Great Britain) were used to record signals at a sampling rate of 125
Hz using a 12 bit analogue-to-digital converter (LabMaster DMA, Scientific Solutions,
Mentor, OH, USA). Mouth pressure and flow signals were obtained after calibration
before each single measurement. For flow calibration, a calibrated rotameter (Air 0–15
L/min, Medec, Aalst, Belgium) was used followed by a volume calibration using a
precision syringe of 50-ml containing the actual gas mixture. For pressure calibration,
a pressure transducer tester (Veri-Cal 650–900, Utah Medical Products Inc., Midvale,
UT, USA) was used. 
At 1 year of age, the SBT was performed using a heated Lilly-type pneumo-
tachometer (3500B, linear range 0–35 L/min, dead space 8.74 ml, resistance 0.32
kPa/L·s at 17.5 L/min; Hans Rudolph Inc., Kansas City, MO), attached to a facemask
(Laerdal Infant Mask No.1, Laerdal BeNelux BV, Valkenswaard, The Netherlands;
dead space 10 ml) covered with therapeutic putty (Magic Putty, medium, Oldelft
Benelux BV, Delft, The Netherlands) to prevent air leakage (Figure 7).  Infants were
Figure 6. Respiratory function testing during the neonatal period at the
neonatal intensive care unit.
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sedated with 50–100 mg/kg chloral hydrate and measurements were performed in
supine position with the head end elevated at approximately 30 degrees relative to
horizontal. Calibration procedure was performed with a precision syringe containing
100 ml of air.
2.2.3. Methacholine provocation test at 2 years of age
Provocation tests were initially applied in older children and adults, since
conventional methods included peak expiratory flow assessments (PEF)29 or spiro-
metry measures (forced expiratory volume in 1 second)140 to determine the response
to non-specific irritants. The introduction of other measures, like V’max,FRC,181 Raw,
Gaw140 and chest auscultation with or without the assessment of SaO2,9,225 made this
technique also feasible in infants and young children. The simplest method to perform
in infants and young children is probably the method described by Avital and
colleagues in 1988.9 For this technique, chest auscultation is used to determine the
threshold value of methacholine. Compared to the conventional method, chest
auscultation seems to correlate well with spirometer measures in older children.9,224,225
Figure 7. Respiratory function testing at 1 year of age. Infants were sedated while breathing
through a facemask and pneumotachometer. Occlusions were performed manually at the
opening of the pneumotachometer to atmosphere. For FRC measurements the
pneumotachometer was removed and the valve attached to the spirometer closed system was
connected to the facemask.
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Chest auscultation is performed before the periods of nebulizing are started.
Continuous SpO2 monitoring takes place by attaching a pulse oximeter to a toe of the
child. Subsequently, nebulizing is started for periods of 2 minutes starting with
isotonic saline followed by increasing concentrations of methacholine.34 After each
nebulizing period, chest auscultation is performed. If wheezing occurs during chest
auscultation or oxygen saturation falls below 90 per cent the preceding methacholine
concentration is recorded as the threshold value. Finally, salbutamol is administered to
relieve bronchial constriction. 
According to the literature, the method described by Avital and colleagues seems
to be safe, effective, easily applicable, and clinically significant in young
children.9,18,98,225 However, especially in young children, the method is time consuming
and without sedation only applicable from 2 years of age. At this age, great effort is
required to divert the attention of the child. 
Besides respiratory disease, airway responsiveness is affected by pulmonary
hyperinflation and age, and these factors should therefore be taken into consideration
when results are interpreted. Since the nebulizing techniques that are used nowadays
are similar at different ages, the concentration of inhaled methacholine may relatively
increase with decreasing ages, because dilution of the nebulizing solution of
methacholine by environmental air is less in young children compared to older
children and adults, in whom inspiratory airflow during tidal breathing will exceed the
airflow used to nebulize methacholine (6 L/min). Hence, the increased bronchial
responsiveness at younger ages may exist due partly to exposure to relatively increased
methacholine concentrations.148 Lack of standardization of the method in young
children limits clinical application. However, in studies of children of the same age,
results are less determined by interindividual differences of methacholine exposure.
Still, factors like excessive commotion and crying during the test may induce
additional bronchial constriction. There is also a large deficit of studies investigating
bronchial responsiveness in healthy children. In conclusion, the method needs further
validation before implementation in clinical practice should be encouraged in such
young children.
A specific description of the measurement procedure and equipment that was
used during measurements at 2 years of age is provided. Bronchial challenge tests were
carried out using a continuous inhalation tidal breathing method as described by
Cockroft and colleagues.34 Before the test was started, chest auscultation was
performed. Isotonic saline was administered for 2 minutes from a nebulizer (Up-draft
II nebuliser, Hudson Respiratory Care Inc., Temecula, CA), connected to a flow meter
(Endomed Air 20°C 0–17 L/min, Endomed B.V., Didam, The Netherlands)
delivering a flow rate of 6 L/min out of the hospital circuit of compressed air (Figure
8). Chest auscultation was repeated shortly after saline nebulization. If no wheeze was
heard, a serial inhalation of doubling concentrations of methacholine was started from
a concentration of 0.15 mg/ml every 5 minutes to a maximum concentration of 9.6
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mg/ml (i.e. 0.15, 0.30, 0.60, 1.20, 2.40, 4.80 and 9.60 mg/ml consecutively). Each
methacholine concentration was nebulized for 2 minutes. Shortly after each inhalation,
chest auscultation was performed by the same observer every time.
 The response to the challenge was monitored by a pulse oximeter (Nellcor N-
395, Mallinckrodt Europe B.V., ‘s-Hertogenbosch, The Netherlands) attached around
a toe. Baseline values of SpO2 were attained after a short period of stabilization. The
challenge was considered positive and terminated if an audible wheeze was present
over the chest, if SpO2 fell below 90 per cent (for at least ten seconds) or if the final
methacholine concentration of 9.6 mg/ml was reached, whatever occurred first. At
that moment, the provocative concentration of methacholine (PC) was recorded, as
was the SpO2. Children inhaled 800 µg of Salbutamol via a Babyhaler to decrease
bronchusconstriction. When children were wheezing before initiation of the test, their
parents were kindly requested to come back for the test a few days or weeks later. 
2.2.4. Pulse oximetry for monitoring during provocation tests at 2 years of age
At 2 years of age, SpO2 was monitored during methacholine provocation tests to
check for desaturations that may follow methacholine provocation. Additionally, SpO2
was used to determine the threshold value of methacholine when no wheeze was
heard by auscultation and SpO2 decreased below 90 per cent. In general, appropriate
flexible sensors should be attached around a toe or finger and, if SpO2 values are low
Figure 8. Respiratory function testing at 2 years of age. A nebulising mask is held loosely in
front of the child’s face producing nebulized methacholine for periods of  2 minutes.
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together with a low heart rate, the sensor should be repositioned until a reliable signal
is obtained. 
Although this technique was developed in 1974,7 it took another 10 years before
it was introduced in clinical practice. The technique is based on the difference in
absorption spectra of oxygenated and deoxygenated haemoglobin. Oxygenated
haemoglobin absorbs more light in the infrared band (850–1000 nm) and
deoxygenated haemoglobin absorbs more light in the red band (600–750 nm). The
oximeter probe emits light at two specific wavelengths (at 660 and 940 nm), being
transmitted through tissue (e.g. a finger or toe) and measured by a photodetector. The
ratio of the light absorbances at the two wavelengths correlates with the proportion of
oxygenated to deoxygenated haemoglobin in the tissue. To select only the pulsating
part of the tissue, which correlates with arterial O2 saturation and is characterized by
changes in the total light permitted (Figure 9), the pulse oximeter divides the
absorbances at the peaks by those at the corresponding troughs, thereby obtaining a
‘pulse-added’ absorbance that is independent of the absorbance characteristics of the
non-pulsating parts of the tissue. A major advantage of the technique is the ease of
usage, because no calibration or heating of the skin is required to immediately provide
information about arterial oxygenation. Response time is faster compared to PtcO2
monitoring, but may vary depending on the averaging time of the pulse oximeter.
Sensitivity and specificity of detecting hypoxemia and hyperoxemia differs
substantially between different brands, but is most of the time better than PtcO2
monitoring. Most manufacturers claim that 95 per cent of the measured values will be
within 4–6 per cent of the actual SaO2. Pulse oximetry depends less on peripheral
perfusion. However, improper placement and sensor type may affect the precision of
a pulse oximeter by optical shunting of ambient light. Furthermore, skin burns have
been described in situations where one brand of sensor was used with a different
brand of instrument, the sensor surface was damaged, but also without any apparent
cause.200 Since the pulsating signal is only 1–5 per cent of the total absorbance
Figure 9. Basal and
pulsatile components in
the light absorbances
measured by the pulse
oximeter.
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measured, the instrument is very sensitive to sudden changes in background signal due
to, for example, body movements. To minimize this, the light plethysmographic
waveforms should be judged simultaneously to see whether they are distorted.
Abnormal haemoglobins or dyes with abnormal absorption spectra may also affect the
accuracy of the pulse oximeter. Since pulse oximeters rely on algorithms based on in
vitro measurements of SaO2 obtained from healthy adult volunteers within a range of
70 to 100 per cent, for saturations below this range algorithms are simply extrapolated.
This procedure may lead to an underestimation of true degree of hypoxemia and has
led to recommendations that in these situations SaO2 should be determined in order to
measure the true severity of hypoxemia.200
For SpO2 monitoring during the methacholine provocation tests at 2 years of age,
a Nellcor pulse oximeter was used (Nellcor N-200 pulse oximeter, Mallinckrodt
Europe BV, ’s-Hertogenbosch, The Netherlands) with an appropriate sensor (Nellcor
I-20 oxisensor 2, Mallinckrodt Europe BV, ’s-Hertogenbosch, The Netherlands). The
sensor was attached around a toe and, when reliable SpO2 signals were being
displayed, the child’s sock was put back on. When at the provocation test SpO2 values
decreased below 90 per cent, the test was ended.
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3.1. Abstract
Objective: To assess the effects of different oxygen concentrations and flow rates
on the measurement errors of neonatal pneumotachometers in heated and unheated
situations, and to develop correction factors to correct for these effects.
Design: Prospective laboratory study.
Setting: Outpatient clinic with equipment in a standardized setting.
Subjects: Neonatal pneumotachometers.
Interventions: In standardized conditions the tested pneumotachometer was
calibrated at a flow rate of 3 L/min with 60 per cent oxygen and was set in series with
a closed spirometer system being used as a reference. Different airflow levels (1–9
L/min) and oxygen concentrations (21–100%) were infused into the closed system
with pneumotachometer and spirometer.
Measurements and Main Results: The pneumotachometers were significantly affected
by changing oxygen concentrations (p<0.01) and increasing flow rates (p<0.01)
increasing the actually measured flow rate. Correction factors, developed by multiple
regression analysis, significantly reduced the overall maximum errors of the
pneumotachometers from  -1.1–0.6 L/min to  -0.5–0.4 L/min.
Conclusions: The effects of changes in oxygen concentrations and flow rates on
neonatal pneumotachometers could be considerably decreased by the use of
correction factors as were calculated in this study. This will preclude frequent
calibration procedures with actual flow and oxygen levels during changes in
experimental settings.
3.2. Introduction
In research as well as in clinical practice, accurate measurements of respiratory
gas flow rates are important. Pneumotachometers are used in set-ups for estimating
lung volumes, respiratory system compliance and resistance. Pneumotachometers can
be based on several principles, like linear resistive pneumotachometers, turbine
flowmeters, thermal devices, ultrasonic flowmeters, polyvinylidene fluoride
piezoelectric film flowmeters, non-linear differential pressure-based transducers, linear
differential pressure devices and flow plethysmography.68 Since the dead space of
pneumotachometers has been sufficiently reduced they can be used in neonates. There
are, however, more specific conditions to be taken into account during lung function
testing in neonates, especially when they are mechanically ventilated. According to
Hagen-Poiseuille’s law, changes in physical characteristics of a respiratory gas
(composition, temperature, relative humidity, and pressure)21 directly affect pneumo-
tachometer flow measurements.47, 69, 73, 92, 96, 97, 110, 212, 248, 250, 263, 269
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pD = (8·L· η·v) / (π·r4)
Where  pD is the decrease in pressure; L the length of tube over which pressure
decrease is measured; η the viscosity of gas; v the velocity; and r the radius of tube
over which pressure decrease is measured
In addition, turbulence,279 the geometry of the tubes connecting the
pneumotachometers142 and the dimensions of the resistive element279 influence flow
recordings by pneumotachometers. In experimental settings at a neonatal intensive
care unit (NICU) water can accumulate on the resistive element of
pneumotachometers increasing resistance and causing turbulence, leading to
measurement errors. Heating of the pneumotachometer diminishes this effect. In the
NICU flow rates and oxygen concentrations are often changed leading to a varied
accuracy of flow signals. In recently developed neonatal ventilators algorithms are
incorporated to reduce the measurement error of their pneumotachometers. However,
most of them (Stephanie and Dräger among other companies) only include
corrections for body temperature and pressure saturated with H2O vapour (BTPS).
The Viasys Avea and the VIP Bird neonatal and paediatric ventilators additionally
correct for altitude (barometric pressure). However, to our best knowledge, no
correction is made for actual oxygen concentration and flow rate. We investigated the
accuracy of the two most frequently used neonatal pneumotachometers17 to measure
lung function in experimental settings. Both are based on the linear resistive principle:
a Fleisch type pneumotachometer (consisting of parallel capillary tubes)92 and a Lilly
type pneumotachometer (containing a fine wire mesh screen).212 We studied
measurement errors secondary to changing measurement conditions (e.g. flow rate,
oxygen concentration and heating of the devices). Correction factors were calculated
in order to prevent the need for frequent calibration procedures at actual flow rates
and oxygen concentrations. 
3.3. Material and methods
A Lilly pneumotachometer (8410A, Hans Rudolph Inc., Kansas City, MO; linear
range 0–10 L/min) and a Fleisch pneumotachometer (No. 00, General Medical Corp.,
Erie, PA; linear range 0–9 L/min) were tested. Pressure differences across the resistive
element of both pneumotachometers were measured with a differential pressure
transducer (type 163PC01D75, Honeywell, Morristown, NJ). Air and oxygen from the
hospital circuit were mixed with an oxygen-air mixer (961 Siemens-Elema, Siemens,
The Hague, The Netherlands) and flow rates were roughly set by a rotameter (Air 0–
15 L/min, Medec, Aalst, Belgium) (Figure 1).
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The oxygen concentration (at 30 cm before the pneumotachometer) as well as the
temperature (at 80 cm after the pneumotachometer) inside the system were recorded
by an oxygen meter (Teledyne TED 60T, Teledyne Brown Engineering, Huntsville,
Alabama) and a thermometer (Fluke 51 K/J thermometer, Fluke Nederland B.V.,
Eindhoven, The Netherlands), respectively. A 10-litre-rolling-seal spirometer
(Masterscreen-FRC Jaeger complete system, Erich Jaeger GmbH, Hoechberg,
Germany) was used as a gold standard for volume against time. Connections between
different parts of the equipment were formed by ribbed rubber tubes with an inner
diameter of 2 cm and an outer diameter of 2.9 cm before and after the
pneumotachometer, and the standard ribbed tubes belonging to the spirometer with
an inner diameter of 3.0 cm and an outer diameter of 3.2 cm connected the former
tubes from the point of temperature assessment to the spirometer. Flow signals from
the pneumotachometers were processed by computer using the software package
RASP (Respiratory Analysis System Program, Physio Logic, High Clere, Great
Britain).
We calibrated the pneumotachometer system at an oxygen concentration of 60
per cent to keep the maximum error, expected to be caused by the most extreme
oxygen concentrations, as small as possible. Flow calibration was performed at zero
flow and at a maximum of 3 L/min according to the spirometer. Since flow rates
measured by the spirometer can only be determined afterwards all measured values
were multiplied with a new calibration factor determined afterwards at 3 L/min and
60 per cent oxygen. This calibration procedure was performed for each measurement
session separately.
At the start of the measurements an oxygen concentration of 21 per cent and a
steady flow rate of about 1 L/min (according to the spirometer) was used. We
repeated the same procedure at an oxygen concentration of 21 per cent and a steady
flow rate of 2 L/min, followed by 3, 4, 6 and 9 L/min. Afterwards we tested the other
oxygen concentrations of 30, 40, 50, 60, 70, 80, 90 and 100 per cent at the same steady
Figure 1. Schematic view of the experimental setting during the measurements.
*oxygen-air mixer; #oxygen concentration meter; ¶thermometer; +RASP,
Respiratory Analysis System Program.
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flow rates. We repeated half the session, i.e. the same measurement procedures in the
opposite order at 100, 80, 60, 40 and 21 per cent oxygen every time at 1, 3, 6 and 9
L/min. 
The complete procedure was performed for each pneumotachometer, i.e. the
Lilly and the Fleisch pneumotachometer heated as well as unheated. Recordings
during every measurement were continued until the spirometer with a volume of 10 L.
was completely filled, except at a flow rate of 1 L/min a maximum total volume of 6
L. mean was achieved. No lower volumes were accepted to prevent measurement
errors due to a potential inaccuracy of the spirometer. Before and after each
measurement procedure calibration settings were checked with a precision syringe of
50 ml independently from the spirometer.
When this check revealed an error of more than 2.5 per cent the whole
measurement procedure was repeated. Paired-samples t-tests were performed to
estimate significant differences of the measurement errors between calibration level
and the lowest and highest oxygen concentrations and flow rates. Bonferroni
correction for multiple comparisons was performed. 
Multiple regression analyses were used to derive correction equations for each
pneumotachometer. We used a stepwise forward regression technique with the
reference flow (i.e. the flow recorded by the spirometer) as the dependent variable.
The flow measured by the pneumotachometer, its product term with the oxygen
concentration and its square were included as independent variables. Variables were
added on the basis of statistical significance (p<0.05) or when they substantially
improved the fit of the model, according to the distribution of the residuals left. To
enable comparison between pneumotachometers data were presented as relative
measurement errors calculated from the regression equations. This means that the
differences between the flow rates measured by the pneumotachometer and the
calculated spirometer flow rates (dependent variable in regression equation) after
entering the pneumotachometer flows in the equations were presented. These
differences were divided by the spirometer values and expressed as percentages. Since
variances explained by the regression equations were very high (R2>0.99) no
important deviation from the real measured data was to be expected. To test the
improvement due to the use of the correction factors following from the regression
equations Bland&Altman plots20 were used in which the differences between
spirometer and pneumotachometer were plotted against the mean of their flow rates.
The paired samples t-test was again used to estimate any significant improvements due
to the use of these correction factors. 
Polynomials of different pneumotachometer flow errors relative to spirometer
flow were calculated with the multiple regression equations using arbitrary oxygen
concentrations and flow rates. The Statistical Product and Service Solutions 10.0
(SPSS Inc, Chicago, IL, USA) for Windows was used for the statistical calculations.
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3.4. Results
The temperature measured inside the closed circuit at 80 cm after the
pneumotachometer did not change by more than 1.3°C (ranges for each experiment,
21.9–23.2; 20.2–21.1; 21.1–21.7; 20.3–21.4) for the unheated pneumotachometers and
not more than 2.4°C (ranges for each experiment, 20.7–23.1; 20.6–21.7; 22.1–23.1;
21.3–23.1) for the heated pneumotachometers within each experiment. Changes of
barometric pressure and humidity during the measurement procedures were not
present or very small reaching maximum values of 0.2 kPa and 4 per cent,
respectively. 
Figure 2. Trends of relative measurement errors of the pneumotachometers (PNT)
at the calibrated flow rate (3 L/min) at different oxygen concentrations.
Figure 3. Trends of relative measurement errors of the pneumotachometers (PNT) at
the calibrated oxygen concentration (60%) at different flow rates.
PNT flow rate l / min
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Considerable effects of oxygen concentration, shown in Figure 2, were
underlined by the relative error being significantly different at 21 and 100 per cent
oxygen (at 3 L/min) compared to calibration level (60 per cent oxygen at 3 L/min) in
all pneumotachometers (p<0.02). All pneumotachometers showed a comparable
increase of the relative measurement error at rising oxygen concentrations, the most
prominent for the unheated Lilly pneumotachometer. However, differences between
pneumotachometers were small. Compared to calibration level (3 L/min at 60 per
cent oxygen) the measurement errors were significantly different at 1 L/min and 9
L/min at 60 per cent oxygen in all pneumotachometers (p<0.02) (Figure 3). An
increasing measurement error became apparent in all pneumotachometers above
calibration flow rate. The relative measurement error also increased at lower flow
rates. Again differences between pneumotachometers were relatively small.
Multiple regression analyses yielded correction equations for each pneumo-
tachometer (Table 1). With these regression equations a corrected flow could be
calculated from the measured flow at different levels of oxygen concentration and
Table 1. Multiple regression equations for each separate pneumotachometer.
Pneumotachometer Regression Equation r2
Heated Fleisch FlowRa = 1.10·FlowMb– 0.0013·FlowM·O2% - 0.086·(FlowM)2 >.99
Unheated Fleisch FlowR  = 1.10·FlowM – 0.0009·FlowM·O2% - 0.015·(FlowM)2 >.99
Heated Lilly FlowR  = 1.11·FlowM – 0.0013·FlowM·O2% - 0.011·(FlowM)2 >.99
Unheated Lilly FlowR  = 1.14·FlowM – 0.0013·FlowM·O2% - 0.014·(FlowM)2 >.99
aFlowREAL = spirometer flow (L/min); bFlowMEASURED = pneumotachometer flow (L/min).
Table 2. Mean differences, limits of agreement and maximum error ranges in L/min
according to Bland & Altman analysis20 of the differences between the pneumotachometers
and the spirometer.
Pneumotachometer Mean Limits of Agreement Maximum Error Range
difference min max (difference)
Before correction
Heated Fleisch -0.18 -0.83, 0.46 -1.09,   0.40   (1.5)
Unheated Fleisch -0.20 -1.02, 0.62 -1.26,   0.51   (1.8)
Heated Lilly -0.36 -1.33, 0.61 -1.08,   0.17   (1.3)
Unheated Lilly -0.13 -1.01, 0.74 -1.28,   0.58   (1.9)
After correction
Heated Fleisch -0.01 -0.26, 0.24 -0.28,   0.35   (0.6)
Unheated Fleisch -0.01 -0.34, 0.31 -0.29,   0.39   (0.7)
Heated Lilly -0.04 -0.32, 0.24 -0.51,   0.37   (0.9)
Unheated Lilly -0.02 -0.28, 0.24 -0.46,   0.37   (0.8)
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flow rate. As illustrated in Table 2, correction of the measured values with
pneumotachometers resulted in a significant decrease of the measurement errors
(p<0.03) in all pneumotachometers. Before correction a mean measurement error
varied between -0.13 and -0.36 L/min depending on the pneumotachometer tested.
After correction this was significantly reduced to -0.01 and -0.04 L/min. Limits of
agreement, corresponding with two standard deviations of the differences between
pneumotachometer and spirometer, even exceeded 1 L/min in some cases, while
these limits remained below 0.40 L/min after correction. Maximal error ranges
showed a comparable pattern. To avoid the use of these complex correction equations
in practice we calculated polynomials to estimate the relative measurement errors at
arbitrary oxygen concentrations and flow rates (Figure 4). 
The heated Fleisch pneumotachometer showed the most dispersed polynomials
in horizontal direction indicating that the relative measurement error did not increase
as fast at rising flow levels as it did in the heated and unheated Lilly
pneumotachometers and the unheated Fleisch pneumotachometer. The heated Fleisch
curve in Figure 3 also seemed to be the flattest. Judging the dispersion of the curves in
Figure 4 in vertical direction the increase of the measurement errors based upon a rise
Figure 4. Relative measurement errors of the pneumotachometers relative to the reference flow
rate of the spirometer plotted as polynomials according to oxygen concentration and flow rate.
Underestimation of flow rates by the pneumotachometer is indicated as a negative relative
error and overestimation of flow rates as a positive relative error.
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in oxygen concentration was most obvious in the unheated Lilly pneumotachometer
and least obvious in the unheated Fleisch pneumotachometer. This was also
demonstrated in Figure 2. 
3.5. Discussion
Both the Fleisch and Lilly pneumotachometers were significantly affected by
increasing oxygen concentrations from 21 to 100 per cent and increasing flow rates
from 1 to 9 L/min increasing the actually measured flow rate in the heated as well as
in the unheated situation. Multiple regression analysis yielded correction factors to
correct for these effects resulting in a significantly improved accuracy of the flow
measurements in almost all pneumotachometers. This means that after a calibration at
0 and 3 L/min and 60 per cent oxygen and correction for the influences of oxygen
and flow rate reliable flow measurements can be achieved in the appropriate flow
range and at all oxygen concentrations with these neonatal pneumotachometers.
Although linear resistance pneumotachometers are supposed to be used heated to
avoid water accumulation, we tested them unheated as well. In practice sometimes
unheated probes are used. Therefore, it would be interesting to correct for
measurement errors caused by differences in heating assuming that no detectable
water accumulation had occurred in the unheated situation. Our results confirmed
that when heated pneumotachometers were used the error caused by flow rates, but
not by oxygen concentrations, was less compared to when they were tested unheated.
However, the actual gas temperature measured behind the heated pneumotachometer
was also flow dependent. At lower flow rates the gas had more time to warm up
compared to higher flow rates. Hence, the temperature difference that we measured
between low (1 L/min) and high (9 L/min) flow rates was 10°C for the heated Fleisch
pneumotachometer (40.0 to 29.9°C). For the heated Lilly pneumotachometer the
maximum temperature difference was 5°C (30–24.9°C). Maximal temperature
differences of 10°C and 5°C cause maximal viscosity changes of 2.6 per cent and 1.3
per cent, respectively.17 Temperature decreased at higher flow rates. So, levelling
temperatures at all flows implies that the temperature at high flow rates should
increase or the temperature at low flows should decrease. Increasing the temperature
at high flows will increase gas viscosity and, thereby, the measurement error. The
other possibility, decreasing temperature at low flow rates, results in the negative flow
error to be increased. In both cases the slope of the lines of both heated
pneumotachometers will rise approximating the ones of the unheated pneumo-
tachometers. 
Environmental changes during our experiments, like changes in temperature,
barometric pressure and humidity outside the closed circuit, were negligible because
changes were minimal and because calibration procedures were performed before
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each measurement procedure. The maximum changes in humidity would have caused
a decrease in viscosity of 0.1 per cent. Barometric pressure changes would only give a
measurable effect on viscosity when exceeding 500 kPa,69 which it did not during our
measurements. Because before each single measurement calibration was performed
the effect caused by a slightly different connection of the tubes to the pneumo-
tachometers could be ignored. Furthermore, changes in temperature inside the
spirometer during heating of the pneumotachometers could be neglected. After being
heated by the pneumotachometer to temperatures above 25°C, air cools down to
room temperature by the time it reached the spirometer, which was 160 cm further in
the circuit. The maximum temperature 23.2°C measured at 80 cm behind the
pneumotachometer, where the thermometer was located, proved that the air
equilibrated quickly to room temperature (22°C). When, for example at a NICU, the
oxygen concentration in inspiratory air is increased, the viscosity of this gas mixture
increases and thereby causes the pneumotachometers to overestimate flow rates.97
This effect was confirmed by our results presenting a progressive measurement error
at increasing oxygen concentrations. Because differences between pneumo-
tachometers were relatively small and because they were not considered as the
purpose of this study, a thorough discussion concerning the potential causes did not
seem appropriate.
In equipment based on differential pressure, like pneumotachometers, turbulence
can cause a considerable error, thereby overestimating flow rates. Frey et al.73
indicated that the physical properties of most pneumotachometers usually cause a
non-linear relationship between the applied and measured signals. According to Yeh
et al.269 flow-conductance characteristics of differential pressure pneumotachometers
are non-linear. Finucane et al.67 observed a non-linearity in screen pneumotacho-
meters as well as in Fleisch type pneumotachometers. Our data showed that flow
errors in all pneumotachometers increased considerably when flow rates were
progressively higher than calibration flow rate. Pneumotachometers underestimated at
flow rates lower than calibration flow of 3 L/min.
Although constant in the absolute way, this small error increased relatively at
lower flow rates. Noise in the recorded signals probably caused the most important
part of this measurement error. Although the used pneumotachometers should be
linear within the flow range measured, non-linearity of the pneumotachometers within
this range was, to our opinion, the most plausible explanation for the error pattern
that was found. Differences between pneumotachometers were again relatively small
and were therefore not considered for discussion. 
The correction factors, following the multiple regression equations for each
heated and unheated pneumotachometer separately, reduced the measurement errors
significantly in all pneumotachometers. Maximal error ranges were reduced by more
than 50 per cent in most pneumotachometers. Peak flow rates in preterm neonates
might exceed 6 L/min in some cases. If we assume that flow rates in preterm infants
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varied between 0 and 6 L/min, according to our results, a measurement error of ±9
per cent could be expected when no correction was performed (±5 per cent because
of the oxygen effect plus ±4 per cent caused by the flow rate effect). After correction
for oxygen and flow effects a residual effect of ±2 per cent caused by variance in
oxygen concentration and flow rate could be expected within a flow range of 0–6
L/min. The pneumotachometers we tested are predominantly used in research
settings to measure lung function (compliance, resistance, forced expiratory flow rates,
etc.) in preterm infants. The role of lung function testing in improving ventilator
adjustments, and diagnosis and prognosis of respiratory morbidity in neonates has
been investigated increasingly during recent years. Consequently, lung function
measures like respiratory resistance, which is highly flow dependent, will become more
accurate after correction. Some mechanical ventilators use comparable
pneumotachometers. When the same pneumotachometers are used as described
above the built-in corrections for BTPS might be extended with corrections for
oxygen concentrations and flow rates based on our results. Integral application of the
regression equations will be necessary for a reliable correction during conditions of
changing flow.
Correction factors were based upon measurements with dry gases at 22°C, which
were sufficiently constant during our measurement procedures. Because of their
opposite effects on the viscosity of a gas a simultaneous increase of humidity and
temperature from dry air in the hospital circuit during calibration procedures (relative
humidity approximating 0 per cent at 22°C) to a humidified and warmed environment
(relative humidity 95 per cent at 37°C) will result in a measurement error of
approximately 2.9 per cent (4.1 per cent caused by the increase of temperature and -
1.2 per cent caused by the increased humidity).17 This implicates that besides
corrections for the effects of oxygen concentrations and flow rates humidity and
temperature effects should be corrected for when flow measurements are performed
at the NICU. 
3.6. Conclusions
Our data showed that measurement errors in pneumotachometers were
significantly affected by both flow rate and oxygen concentration. Therefore, it is
necessary to calibrate with the actual oxygen concentrations and flow rates before
starting a measurement in clinical or experimental settings. However, frequent
calibration procedures during changes in gas composition in the clinical setting is
often not practical, e.g. in case of increasing oxygen need in the neonate. For this
reason we calculated regression equations to correct flow readings during changing
conditions, which significantly reduced the measurement errors. 
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This means that after a calibration at 0 and 3 L/min and 60 per cent oxygen
reliable flow measurements can be achieved in the appropriate flow range and at all
oxygen concentrations with the described neonatal pneumotachometers. In practice
quick corrections can be performed using polynomials as shown in Figure 4. Further
investigation is needed to extend the applicability of the correction factors in
humidified and warmed conditions.
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4.1. Abstract
To evaluate scoring systems for chest radiographs, we determined the
interobserver agreement and relation with lung function during the first week of life in
ventilated preterm infants. Three independent observers examined chest radiographs
by applying radiological scores according to Lischka, Yuksel, Greenough, Toce, and
Giedion at postnatal days 2 and 7. Kappa-statistics were used to assess interobserver
agreement. By means of regression analysis mean scores and individual radiological
scores of three observers were studied in relation to ventilation and oxygenation
indices, and respiratory system resistance and compliance. Forty-eight radiographs
were evaluated at day 2, and 17 at day 7. All scoring systems showed kappa values
equal or lower than 0.5. Regression analysis revealed no significant associations
between radiological scores and ventilator requirements or respiratory mechanics. We
conclude that in ventilated preterm infants radiological scoring systems showed poor
interobserver agreement and that they were not related to current respiratory function.
4.2. Introduction
Several radiological scoring systems have been developed to describe chest
radiographs in relation to pulmonary disease and respiratory course in preterm
neonates. Yuksel et al.,277 Greenough et al.95 and Toce et al.242 developed scores to
predict the respiratory outcome of preterm infants. Scores of Lischka et al.154 and
Giedion et al.86 were developed to indicate the severity of respiratory distress
syndrome (RDS). The scores are mainly based on characteristics like lung volume, air
bronchograms, reticulogranular pattern, and the presence of cysts that may point to
RDS (Figure 1) or a beginning chronic lung disease of the newborn (CLD; Figure 2). 
At the neonatal intensive care unit (NICU), chest radiography is regularly used to
check for pulmonary problems. In the multidisciplinary NICU setting these
radiographs are often judged by more than one physician, e.g. a neonatologist,
radiologist or pulmonologist. Good interobserver agreement is a prerequisite for
applying scoring systems in general practice and as an outcome parameter in clinical
studies. 
In older children, for example with cystic fibrosis, a good correlation has been
observed between radiological scores and lung function.169, 203 Such associations have
been studied only scarcely in ventilated preterm infants.154 
In order to evaluate the clinical value of chest radiographs in preterm ventilated
infants, we studied the interobserver agreement of radiological scoring systems and
whether these scoring systems related to functional markers of the respiratory
condition at that time. 
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4.3. Patients and methods
This study was part of a large longitudinal study investigating lung function in
ventilated preterm infants. Infants of less than 37 weeks gestation born between July
1999 and August 2000 at the NICU of the University Medical Centre Utrecht, The
Netherlands, or admitted to this centre within 24 hours after birth, were recruited. For
inclusion, mechanical ventilation had to be started within 24 hours after birth. Infants
with congenital anomalies, like multiple external dysmorphias, skeleton abnormalities,
and hernia diaphragmatica were excluded from the study. Lung function tests were
Figure 1. Chest radiograph of boy at day 2 of life. Birth weight: 1575 g. Gestational age: 33 wk
+ 5 d. Surfactant was administered once at 6 hours after birth. Current ventilator
requirements: synchronized intermittent mandatory ventilation with a peak inspiratory
pressure of 17 cm H2O, a positive end expiratory pressure of 5 cm H2O, a frequency of
40/min, and no supplemental oxygen.
Scores of three observers: 
Lischka scores: 4 – 9 – 4; mean±S.D.: 5.7±2.9
Yuksel scores: 4 – 4 – 4; mean±S.D.: 4.0±0.0
Greenough scores: 2 – 2 – 2; mean±S.D.: 2.0±0.0
Toce scores: 2 – 2 – 3; mean±S.D.: 2.3±0.6
Giedion scores: 0 – 1 – 0; mean±S.D.: 0.3±0.6
Chapter 4
___________________________________________________________________
65
performed at days 2 (24–48 hours) and 7. Only infants, in whom digital chest
radiographs of day 2 (24–48 hours) or day 7±1 were clinically indicated, were selected
for further analysis. The study was approved by the Medical Ethics Review
Committee of our centre and parental informed consent was obtained.
Mechanical ventilation was started as a consequence of respiratory distress, when,
despite supplemental oxygen or continuous positive airway pressure, the inspiratory
oxygen fraction (FiO2) remained above 0.7, the partial arterial carbon dioxide pressure
(PaCO2) exceeded 55 mm Hg, acidosis persisted with pH decreasing below 7.25, or
when serious apnoeas existed. Ventilator setting was adjusted to keep the arterial
Figure 2. Chest radiograph of boy at day 6 of life. Birth weight: 1060 g. Gestational age: 28 wk
+ 4 d. Surfactant was administered twice during the first days of life. Current ventilator
requirements: synchronized intermittent mandatory ventilation with a peak inspiratory
pressure of 16 cm H2O, a positive end expiratory pressure of 5 cm H2O, a frequency of
40/min, and an inspired oxygen fraction of 0.27.
Scores of three observers: 
Lischka scores: 10 –  9 – 10; mean±S.D.:  9.7±0.6
Yuksel scores: 10 – 15 – 11; mean±S.D.: 12.0±2.7
Greenough scores:   6 –  8 – 6; mean±S.D.:  6.7±1.2
Toce scores:   7 –  7 – 5; mean±S.D.:  6.3±1.2
Giedion scores:   1 – 4 – 3; mean±S.D.: 2.7±1.5
Neonatal chest radiograph scores
___________________________________________________________________
66
oxygen saturation of haemoglobin between 90–95% and the PaCO2 between 40–45
mm Hg. For mechanical ventilation, one of the following infant respirators was used:
Stephanie (Stephan, Gackenbach, Germany), Bear BP2001 (Bear, Palm Springs, CA,
USA), and Bourns BP200 (Bourns, Inc., Riverside, CA, USA). When the PIP
exceeded 25 cmH2O, conventional ventilation was switched to high frequency
oscillatory ventilation (HFOV). 
Table 1. Characteristics of radiological scores
Radiological scores Characteristics
Lischka154 Pattern (few streaks to completely reticulogranular: score 1, 2, 3)
Size of specific pattern (single area to >two third of lungs: score 1, 2, 3)
Density of pattern (<liver to homogeneous to liver: score 1, 2, 3)
Air distribution (normal to extra-alveolar presence of air: score 1, 2, 3)
Yuksel277 Quality of X-ray (bad or good: score 0, 1)
Intubated or not (score 0, 1)
Lung volume
  (configuration diaphragm/ribs: normal, de-, increased: score 0, 1, 2)
Number of posterior ribs (<14, 14–16, >16: score 0, 1, 2)
Opacification (not present, perihilar/regional, complete: score 0, 1, 2, 3)
Air bronchogram(s) present in outer third of lungs or not (score 0, 1)
Interstitial changes (none to present in four zones: score 0, 1, 2, 3, 4)
Emphysematic changes (none to bullae present: score 0, 1, 2)
Cystic changes (none to multiple: score 0, 1, 2)
Size of cysts (not present to >one third of lungs: score 0, 1, 2)
Greenough95 Number of posterior ribs (<14, 14–16, >16: score 0, 1, 2)
Interstitial changes (none to present in four zones: score 0, 1, 2, 3, 4)
Cystic changes (none to multiple: score 0, 1, 2)
Toce242 Number of posterior and anterior ribs right sided 
   (<14, 14–16, >16: score 0, 1, 2)
Heart figure size (normal to enlarged: score 0, 1, 2)
Interstitial changes (none to considerable: score 0, 1, 2)
Emphysematic changes (none to bullae present: score 0, 1, 2)
Subjective judgement (mild to seriously abnormal: score 0, 1, 2)
Giedion86 (0) No signs of pulmonary disease
(1) Reticulogranular pattern
(2) Reticulogranular pattern and air bronchogram
(3) Reticulogranular pattern, air bronchogram and indistinct heart outline
(4) Totally white appearance
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Digital chest radiographs were obtained at maximal inspiratory level in supine
position. Five radiological scores for preterm neonates were used: Lischka,154
Yuksel,277 Greenough,95 Toce242 and Giedion86 (Table 1). Two paediatric
pulmonologists (B.A. and K.v.d.E.) and one paediatric radiologist (E.B.)
independently evaluated the images with the use of the five scoring systems. They
were unaware of the infants’ clinical condition. 
With each radiograph, the oxygenation index (= (mean airway pressure * FiO2) /
PaO2), a measure for diffusion capacity of the lungs, and the ventilation index (=
(ventilator frequency * peak inspiratory pressure * PaCO2) / 1000),197 a measure for
alveolar ventilation, were determined. High indices imply poor pulmonary gas
exchange. Time of assessment was equal to the time at which respiratory function
measurements were performed. 
Measurements of passive respiratory system resistance (Rrs) and compliance (Crs)
were performed at days 2 and 7 of life. Since measurements were only performed in
intubated infants, fewer infants participated at day 7 because they did not longer
require mechanical ventilation. Rrs and Crs were assessed according to the single breath
occlusion technique (SBT) described by Le Souef.68,150 A heated Lilly-type pneumo-
tachometer (8410A, linear range 0–10 L/min, dead space 1.3 ml, resistance 0.96
kPa/Ls at 5 L/min; Hans Rudolph Inc., Kansas City, MO, USA) was placed between
endotracheal tube and ventilator tubes. A pressure transducer (Honeywell, type
163PC01D75, Morristown, NJ, USA) and an IBM compatible personal computer with
a Pentium processor running the software package Respiratory Analysis System
Program (Version 007.17, Physio Logic, High Clere, UK) were used to record signals
at a sampling rate of 125 Hz using a 12 bit analogue-to-digital converter (LabMaster
DMA, Scientific Solutions, Mentor, OH, USA). Mouth pressure and flow signals were
obtained after calibration before each single measurement. For flow calibration, a
calibrated rotameter (air 0–15 L/min, Medec, Aalst, Belgium) was used followed by a
volume calibration using a precision syringe of 50 ml containing the actual gas
mixture. For pressure calibration, a pressure transducer tester (Veri-Cal 650–900, UT
Medical Products Inc., Midvale, UT, USA) was used. Leaks in the system or around
the endotracheal tube were easily detected as mouth pressure decreased gradually
during occlusion. With gentle manual compression of the trachea present leaks were
minimized. Persisting tube leaks causing a decrease in occlusion pressure of 0.02 kPa
or more were excluded from further analysis.45,220 During occlusion, activity of
inspiratory muscles is inhibited via stimulation of the airway receptors inducing the
Hering-Breuer reflex. Breath analysis was considered unreliable, when no muscle
relaxation was achieved. Muscle relaxation was assumed to be present when (1) during
a short occlusion period of less than 0.5 second mouth pressure did reach a plateau
for at least 0.1 seconds with a standard deviation (SD) of 0.01 kPa or less, and (2) the
expiration part of the flow volume curve was linear for at least 50 per cent of the
volume to be expired. As a criterion for linearity, a correlation coefficient of 0.98 or
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more after exclusion of the final 5 per cent of the expired volume had to be reached.
At least five occluded breaths meeting these criteria were used to calculate a mean
value for both respiratory mechanics in each single measurement. These criteria
complied with the European Respiratory Society (ERS) recommendations.80 No
correction was made for endotracheal tube resistance.164
4.3.1. Statistics
Kappa-statistics were calculated to assess the chance-corrected proportional
agreement between observers.6 For each possible pair of observers (three in total) a
kappa was calculated. Subsequently, the obtained kappas were averaged for each score
at days 2 and 7 separately. Kappa values lower than 0.5 represent poor agreement.6 To
assess whether interobserver variability affected our results individual as well as mean
scores of the three observers were studied in relation to clinical and lung function
variables. Using regression analyses, associations between radiological scores as
independent variables and the oxygenation and ventilation indices, Rrs and Crs as
dependent variables were studied. The oxygenation index and Rrs were transformed by
taking the natural logarithm, because of their deviation from the normal distribution.
Data were analysed for days 2 and 7 separately.
4.4. Results
Fifty-one infants were initially included in the study. In three of them respiratory
function measurements were unreliable according to ERS criteria. Hence, at the
second day of life, results of 48 infants were evaluated. In 17 of 51 infants both chest
radiographs and respiratory function results were available at day 7. Fourteen of these
17 patients had been included for evaluation at day 2. Patient characteristics are
presented in Table 2.
Radiological scoring systems were categorized before kappas were calculated.
Kappa-statistics could not be calculated when constants were present or when
complete categories were not scored by one or two observers. The Yuksel score was
categorized into four categories: 0–5/6–10/11–15/16–20. At day 2, the mean kappa
of the three pairs of observers was 0.48 and at day 7 this was 0.11. The Greenough
score was categorized into three categories: 0–2/3–5/6–8. The mean kappa of the
Greenough score was 0.18 at day 2 and 0.20 at day 7. The Toce score was categorized
into three categories: 0–2/3–6/7–10 and its mean kappa was 0.20 at day 2 and 0.50 at
day 7. The Lischka score was categorized into three categories: 4–6/7–9/10–12 and
its mean kappa was 0.01 at day 2, and 0.14 at day 7. Finally, the Giedion score was
categorized into three categories: 0/1–2/3–4 and its mean kappa was -0.04 at day 2
and 0.26 at day 7.
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Table 2. Patient characteristics. 
Clinical characteristics
Baseline (n=51)
Gestational age (weeks) 29.3   (25.3–35.9)
Birth weight (grams)
      Birth weight below 1500 grams
1300 (590–2710)
44 (68%)
Sex (male) 30 (60%)
Antenatal steroid administration 33 (65%)
Outcome (n=51)
Surfactant administration (any time) a
At day 1
At day 2
Later
37 (73%)
30 (81%)
5 (14%)
2 (5%)
Duration of mechanical ventilation (days) 16  (2–58)
Postnatal systemic corticosteroids (any time) 18 (35%)
Mortality 3 (6%)
Day 2 characteristics (n=48)
Oxygenation index b 0.08 (0.02–0.28)
Ventilation index c 38.2 (8.3–71.8)
Respiratory system compliance (ml/kPa per kg birth weight) 3.8 (0.7–8.3)
Respiratory system resistance (kPa/Ls) 19.3 (7.9–46.5)
Day 7 characteristics (n=17)
Oxygenation index b 0.04 (0.01–0.11)
Ventilation index c 27.9 (0.0–68.0)
Respiratory system compliance (ml/kPa per kg birth weight) 5.6 (2.1–8.6)
Respiratory system resistance (kPa/Ls) 15.6 (6.4–28.8)
Data presented as mean (range) or number (percentage).
a Criteria for surfactant administration are explained in the Methods section. 
b Oxygenation index = (mean airway pressure * inspired oxygen fraction) / pO2.  
c Ventilation index = (ventilator frequency * peak inspiratory pressure * pCO2) / 1000. One infant
receiving continuous positive airway pressure was indexed 0 concerning the ventilation index.
No statistically significant associations were found between the mean
radiological scores of the three observers and any of the respiratory function measures
neither at day 2 (Figure 3) nor at day 7. With respect to individual radiological scores,
only two statistically significant associations were found: (1) between respiratory
system resistance and the Toce score by one observer at day 7 (β per radiological score
unit = 0.126; 95% confidence interval (CI), 0.017 to 0.234; p=0.027), and (2) between
oxygenation index and Lischka score by another observer at day 2 (β per radiological
score unit = 0.049; 95% CI, 0.003 to 0.096; p=0.037). Besides these two exceptions,
results concerning individual radiological scores as well as mean scores at day 7 were
similar to the results of the mean scores at day 2, presented in Figure 3.
Neonatal chest radiograph scores
___________________________________________________________________
70
4.5. Discussion
Radiological scoring systems used to evaluate neonatal chest radiographs showed
poor interobserver agreement. Furthermore, none of the studied radiological scoring
systems was associated with respiratory function. Although in earlier studies
radiological scoring systems were developed and evaluated, this is the first study to
evaluate associations between several of these scoring systems and respiratory
function measures during the first week of life in ventilated preterm infants.
The poor interobserver agreement is of clinical importance. Our data show that
experienced physicians remarkably differ in their interpretations of radiological
findings. This argues the importance of the presence of actual chest radiographs
during clinical discussions, since individual physicians cannot judge chest radiographs
from oral or written reports of a colleague. Our findings also question the value of
Figure 3. Results of regression analysis exploring the associations between the mean
radiological scores of three observers (independent variables) and respiratory function
variables (dependent variables) assessed at the second day of life. Regression coefficients (β)
are presented with their 95% confidence intervals. Results concerning individual radiological
scores and scores at day seven were similar to these results.
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using scoring systems as an endpoint in clinical studies. Interobserver variability may
be decreased in computer-assisted analysis of chest radiographs in preterm infants.50 
We were not able to find any relationship between radiological scores and lung
function parameters. Beside the lack of inter-observer agreement this may be due to
several other factors. Firstly, radiographs may accentuate different aspects of
respiratory pathology compared to respiratory function. Clear radiological
abnormalities, like singular cysts, may only have trivial effects on respiratory condition.
On the contrary, radiologically invisible abnormalities, like bronchospasms, may have
major effects on current respiratory condition. Factors affecting the radiological lung
appearance as well as extrapulmonary factors affecting ventilation or oxygenation
indices, like cardiovascular shock or improper placement of the arterial catheter, may
cause a poor match between radiological findings and ventilator requirements.
A second reason for the lack of agreement between lung function and chest
radiograph scores may be that the used scoring systems were not developed for
children at this age. The Yuksel score, partly based on aspects related to persistent
pulmonary problems, like haziness and cystic abnormalities, was originally developed
to be used at 1 month of age. The Greenough score should be used at 28 days of age
and consisted of similar radiological items, including interstitial abnormalities and lung
volume. Toce’s score was meant to be applied at 21 days of age to assess the severity
of CLD. Yuksel et al. stated that their score was also applicable at day 7 of life 276 and
because Greenough and Toce scores were very similar, we decided to include these
scoring systems as well. Furthermore, after unravelling the Yuksel, Greenough and
Toce scores, it appeared that they consisted partly of radiological aspects that may
already be seen from the second day of life, like interstitial abnormalities and in- or
decreased lung volume.
Furthermore, ventilator conditions may directly affect the radiological lung
appearance, obscuring potential associations between radiological and functional
factors as well.86 Additionally, limitations of the neonatal respiratory function
measurements,150 especially in intubated preterm infants, may obscure potential
relationships as well.228 However, by using strict criteria recommended by the ERS,
validity of neonatal respiratory function results was acceptable. Although endotracheal
tube resistance is known to substantially affect neonatal Rrs values, we decided not to
correct for endotracheal tube resistance. Previous studies showed that correction does
not guarantee a better approximation of Rrs.152,164
In contrast to our findings, Lischka and colleagues described significant
associations between their score and Crs within 24 hours after birth.154 Others
described correlations between Giedion scores and parameters of lung function43,124,
However, these studies were performed before exogenous surfactant therapy had
been widely introduced. Many infants in our study did receive exogenous surfactant at
the first day of life, which is known to affect both radiological and functional aspects,
decreasing RDS severity32 and increasing Crs directly.45 
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In conclusion, radiological scoring systems used to evaluate neonatal chest
radiographs showed poor interobserver agreement in ventilated preterm infants and
were not associated with functional parameters of respiratory condition. The use of
these scoring systems as an indicator of the current respiratory condition during the
first week of life is not justified.  
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5.1. Abstract
Aim: To predict prolonged mechanical ventilation (10 days) and need of
postnatal steroid therapy in preterm ventilated infants early after birth in an attempt to
select high-risk infants in order to improve implementation of practical preventive
measures and increase research possibilities. 
Methods: Preterm infants of <37 weeks gestation, mechanically ventilated from
day 1, were recruited. Chest radiographs and lung function tests performed at day 2
were evaluated together with demographic information by logistic regression analysis
and receiver-operating characteristic (ROC) curves. 
Results: In 48 preterm infants prolonged mechanical ventilation was reliably
predicted by radiological signs of haziness and hyperinflation, and the respiratory
system resistance. Gestational age, haziness and respiratory system resistance
accurately predicted postnatal need of steroid therapy. Both prediction models had
areas under the ROC curves of >0.80 after dichotomization of independent variables.
Convenient scores based on regression coefficients roughly indicated infants to three
different risk levels for each outcome. 
Conclusion: Preterm infants at high risk of prolonged mechanical ventilation and
postnatal need of steroid therapy could be selected at 48 hours after birth using
prediction models based upon clinical, radiological and lung mechanical information.
Identifying preterm infants at risk of separate aspects of respiratory outcome may
have important advantages in serving separate goals.
5.2. Introduction
The introduction of prenatal corticosteroids and postnatal exogenous surfactant
treatment in perinatal care, probably have played a major role in the observed trend of
decreasing severity of respiratory distress syndrome (RDS) during the past decades.32
Nevertheless, the risk of developing chronic lung disease of the neonate (CLD) has
remained high and may even have increased.58 The risk to develop acute respiratory
morbidity decreases with increasing gestational age, although RDS may develop until
37 weeks post-conceptional age up to even 5 per cent of the infants born after this
age.138 
Since pathophysiologic processes causing chronic lung disease (CLD) in these
infants may start as early as in utero,211,272 early intervention101 may be one of the most
effective ways to prevent pulmonary morbidity. During the first 24 hours after birth,
signs of a wet lung may obscure underlying pulmonary pathology. At the second day
of life signs of RDS generally become more apparent. Preventive measures, like
minimizing ventilator conditions268 or early corticosteroid administration, probably
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give most benefit when applied as early as possible. Hence, the ideal timing to predict
clinical respiratory course in these infants may be between 24 and 48 hours of life.
Most infants with RDS are being ventilated for less than 1 week, since clinical
deterioration generally reaches a peak around the third day of life.138 Hence, ventilator
dependency of 10 days would reliably select those infants with ongoing pulmonary
problems. On the other hand, infants in need of late steroid therapy are most
interesting subjects to investigate the effect of early steroid therapy in lower doses or
with less potent steroid drugs, as has been implicated by the Cochrane Review.101
We intended to construct two prediction models to select high-risk infants for
prolonged mechanical ventilation (≥10 days) and postnatal systemic steroid treatment
in ventilated preterm infants. To include as many infants at risk as possible, all
preterm infants with respiratory distress requiring mechanical ventilation within 24
hours after birth born after a gestational age of <37 weeks were studied.
5.3. Materials and methods
5.3.1. Patients
This study was part of a large longitudinal study investigating respiratory function
in ventilated preterm infants. Infants of less than 37 weeks gestation born between 28
July 1999 and 31 August 2000 at the University Medical Centre Utrecht, The
Netherlands, or admitted to this centre within 24 hours after birth, were recruited into
the study. For inclusion, mechanical ventilation had to be started within 24 hours after
birth (i.e. day 1). Infants with congenital anomalies were excluded from the study. For
the longitudinal study, respiratory function tests were performed at days 1 (0–24
hours), 2, 3, 7 and just before extubation. Only infants, in whom digital chest
radiographs of day 2 (24–48 hours) were clinically indicated, were selected for further
analysis. The study was approved by the Medical Ethics Review Committee of the
University Medical Centre Utrecht and informed parental consent was obtained for
each infant.
Infants were intubated when, despite measures of supplemental oxygen and/or
nasal continuous positive airway pressure (CPAP), an oxygen supply of >70 per cent
remained necessary, partial pressure of arterial carbon dioxide (PaCO2) was >55 mm
Hg or arterial pH was <7.25. The inner diameter of the endotracheal tubes varied
from 2.5 mm to 3.0 mm with a total length between 11.0 and 18.0 cm. The ventilators
that were used were: Stephanie (Stephan, Gackenbach, Germany), Bear BP2001 (Bear,
Palm Springs, CA, USA), and Bourns BP200 (Bourns, Inc., Riverside, CA, USA). At
the discretion of the attending neonatologist, who was not involved in the study,
ventilator conditions were adjusted to keep the arterial oxygen saturation of
haemoglobin (SaO2) between 90–95 per cent and PaCO2 at 40–45 mm Hg. When
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radiological signs of RDS86 were present while being mechanically ventilated,
exogenous surfactant (natural bovine surfactant: Alvofact®, Boehringer, Ingelheim,
Germany) was administered at a dose of 50 mg/kg according to the following limits
of positive inspiratory pressure (PIP) and the inspiratory fraction of oxygen (FiO2): a
PIP <20 cmH2O with a FiO2 >0.60 and a PIP 20 cmH2O with a FiO2 >0.45. When
the PIP exceeded 25-cmH2O conventional ventilation was switched to high frequency
oscillatory ventilation (HFOV). In case of (1) a postnatal age of >7–14 days, (2)
ventilator dependency with an increased inspired oxygen fraction of >0.30, (3)
radiological signs of CLD (including stage I abnormalities) described by Northway et
al.188, and (4) no potential to decrease ventilator conditions for 72 hours, systemic
hydrocortisone therapy (Solu-Cortef®, Pharmacia & Upjohn, Pharmacia Corporation,
NJ, USA) was started. Hydrocortisone therapy was initiated at the discretion of the
attending neonatologist, who was not involved in the study. This occurred most often
in the second week of life with 5 mg/kg per day in four divided doses. The amount
per dose as well as the number of doses decreased slowly at intervals of 5 days
reaching a total of 22 days of therapy. In the absence of respiratory improvement,
steroid treatment was either prolonged or repeated. 
5.3.2. Predictors
We studied the predictive value of seven, early available, variables to predict
prolonged ventilator need (10 days) and need of postnatal steroid treatment. These
variables referred to clinical, radiological and lung function aspects, of which the latter
two were assessed between 24 and 48 hours after birth. Clinical variables included
gestational age (GA), prenatal steroid administration to stimulate lung maturation and
premature rupture of the membranes (PROM). Radiological variables included the
presence of haziness (increased density: 0 = no haziness; 1 = regionally localized or
around hilus; 2 = regionally and around hilus; 3 = total haziness) and the number of
posterior ribs bilaterally (0 = less than 14 ribs; 1 = between 14 to 16 ribs; 2 = more
than 16 ribs) as a measure of hyperinflation. Digital chest radiographs were obtained
at maximal inspiration in infants in supine position. These chest radiographs were
scored independently by a paediatric pulmonologist and a paediatric radiologist, both
unaware of the clinical course of the infants. The mean score of both physicians was
calculated for each variable, since this corresponded with current clinical practice at
most NICUs, where chest radiographs are judged by at least two physicians, a
neonatologist and a radiologist. Lung function variables included respiratory system
compliance (Crs) and resistance (Rrs).
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5.3.3. Pulmonary Function Tests
Rrs and Crs were assessed between 24 and 48 hours of life according to the single
breath occlusion technique (SBT) described by Le Souef.68,150 Sometimes
measurements could not be performed, because of clinical instability of the patient or
unavailability of qualified personnel. In case infants received HFOV, a switch to
SIMV was required when the clinical condition allowed this. A heated Lilly-type
pneumotachometer (8410A, linear range 0–10 L/min, dead space 1.3 ml, resistance
0.94 kPa/Ls at 5 L/min; Hans Rudolph Inc., Kansas City, MO, USA) was placed
between endotracheal tube and ventilator tubes. A pressure transducer (Honeywell,
type 163PC01D75, Morristown, NJ, USA) and an IBM compatible personal computer
with a Pentium processor running the software package Respiratory Analysis System
Program (Version 007.17, Physio Logic, High Clere, Great Britain) were used to
record signals at a sampling rate of 125 Hz using a 12 bit analogue-to-digital converter
(LabMaster DMA, Scientific Solutions, Mentor, OH, USA). Mouth pressure and flow
signals were obtained after calibration before each single measurement. For flow
calibration, a calibrated rotameter (Air 0-15 L/min, Medec, Aalst, Belgium) was used
followed by a volume calibration using a precision syringe of 50-ml containing the
actual gas mixture. For pressure calibration, a pressure transducer tester (Veri-Cal 650-
900, Utah Medical Products Inc., Midvale, UT, USA) was used. Leaks in the system or
around the endotracheal tube were easily detected as mouth pressure decreased
gradually during occlusion. With gentle manual compression of the trachea present
leaks were minimized. Measurements with persisting tube leaks causing a decrease in
occlusion pressure of 0.02 kPa or more were excluded from further analysis.45,220
During occlusion, activity of inspiratory muscles is inhibited via stimulation of the
airway receptors inducing the Hering-Breuer reflex. Analyses were performed
according to the European Respiratory Society (ERS) recommendations valid during
the time of the measurements.61,80 Breath analysis was considered unreliable, when no
muscle relaxation was achieved. Muscle relaxation was assumed to be present when
(1) during a short occlusion period of less than 0.5 seconds mouth pressure did reach
a plateau for at least 0.1 seconds during which pressure changes showed a standard
deviation (SD) of 0.01 kPa or less, and (2) the expiration part of the flow volume
curve was linear for at least 50 per cent of the volume to be expired. As a criterion for
linearity, a correlation coefficient of 0.98 or more after exclusion of the final 5 per
cent of the expired volume had to be reached. At least five occluded breaths meeting
these criteria were used to calculate a mean value for both respiratory mechanics at the
second day of life.
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Table 1. Patient characteristics (n=48).
Absolute number/mean 
(%/range)
Baseline:
Gestational age (wk)
<28 15 (31)
28–29 16 (33)
30–31 9 (19)
32–34 7 (15)
35–36 1 (2)
Birth weight (g)
500–999 16 (33)
1000–1499 16 (33)
1500–1999 14 (29)
2000–2499 2 (4)
Sex (male) 28 (58)
1-minute Apgar score 4.8 (0–9)
5-minute Apgar score 7.7 (3–10)
Umbilical cord pH 7.19 (6.89–7.39)
Maximum RDS classificationa 3 (1–4)
Surfactant administration before 24 hours 28 (58)
Surfactant administration between 24–48  hours 5 (10)
PDA (diagnosed before 48 hours)b 13 (27)
HFOV at day 2c 17 (35)
Duration of mechanical ventilation (days) 16 (2–58)
Mortality 3 (6)
Potential predictors
PROMd 8 (17)
Prenatal corticosteroid administration 31 (65)
Mean haziness score at radiographe 1.1 (0–3)
Mean lung volume score at radiographf 1.7 (1–2)
Crs/kg (ml/kPa)g 3.8 (0.7–8.3)
Rrs/kg (kPa/Las)h 18.5 (4.6–62.4)
Outcome:
Prolonged mechanical ventilation (10 days) 27 (56)
Postnatal systemic steroid therapy (any time) 17 (35)
a Maximum score during the admission period according to the radiological Giedion gradation of
respiratory distress syndrome (0 = no abnormalities and 4 = total white appearance).86
b Patent ductus arteriosus established by ultrasound performed by a paediatric cardiologist.
c High frequency oscillatory ventilation.
d Premature rupture of membranes (24 hours before delivery.e  Mean haziness score of two physicians
according to 4 stages: 0 = no haziness; 1 = regionally localized or around hilus; 2 = regionally and around
hilus; 3 = total haziness.
f Mean lung volume score of two physicians according to the number of posterior ribs visible at the chest
radiograph in 3 categories: 0 = less than 14 ribs; 1 = 14 to 16 ribs; 2 = more than 16 ribs.
g Compliance of the respiratory system per kilogram birth weight according to the single breath occlusion
technique.68
h Resistance of the respiratory system per kilogram birth weight according to the single breath occlusion
technique.
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Table 2. Univariate associations between a priori selected variables and outcome variables. 
Independents (cut-off values) OR (95% CI)a
Prolonged
 ventilation
Need of
steroid therapy
Gestational age (<30/30 wk) 31.3 (5.6–175.1) 17.1 (2.0–144.8)
Prenatal corticosteroids (yes/no) 0.6 (0.2–1.9) 0.3 (0.1–1.1)
PROMb (yes/no) 1.4 (0.3–6.5) 3.9 (0.8–18.9)
Haziness (0–3 stages: 0/1)c 10.4 (1.1–94.8) 3.8 (0.4–34.9)
Lung volume (0–2 stages: 0–1/2)d 4.9 (1.1–21.8) 7.6 (0.9–65.8)
Crs/kg (ml/kPa) (4/>4)e 2.1 (0.6–7.3) 2.1 (0.5–7.8)
Rrs/kg (kPa/Las) (<15/15)f 5.7 (1.6–20.0) –
Rrs/kg (kPa/Las) (<20/20) – 9.6 (2.3–40.2)
a Odds ratio with 95% confidence interval.
b Premature rupture of membranes 24 hours before delivery.
c Mean haziness score of two physicians according to 4 stages: 0 = no haziness; 1 = regionally localized or
around hilus; 2 = regionally and around hilus; 3 = total haziness.
d Mean lung volume score of two physicians according to the number of back ribs visible at the chest
radiograph in 3 categories: 0 = less than 14 ribs; 1 = 14 to 16 ribs; 2 = more than 16 ribs.
e Compliance of respiratory system per kg birth weight according to the single breath occlusion
technique.68
f Resistance of respiratory system per kg birth weight according to the single breath occlusion
technique.68
5.3.4. Statistical analyses
A priori selection of potential predictors was based on clinical and physiological
plausibility. After univariate analysis, the predictors were entered into multivariable
logistic regression models as independent variables to assess their independent value
in predicting prolonged ventilator need (≥10 days) or need of postnatal steroid
treatment. A combination of backward and forward stepwise independent selection
was used. Final models consisted of independents with p-values less than 0.157
(Akaike's information criterion111), as was suggested by Steyerberg et al.226 for stepwise
selection of independents in small data sets. Finally, selection variables were
dichotomized.
Regression coefficients and corresponding odds ratios of both prediction models
were presented after correction for overestimation according to the heuristic shrinkage
method described by van Houwelingen and le Cessie.254 Subsequently, by calculating
the area under the receiver operating characteristic curves (AUC)104 the overall
discriminatory capacity of each model was obtained. AUC-values range from 0.5 (no
discriminatory capacity) to 1.0 (perfect discrimination). The Hosmer and Lemeshow
test was performed to test the ‘goodness-of-fit’ of each model. 
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Table 3. Characteristics of dichotomous shrinked prediction models for each outcome variable.
Independent Regression coefficients OR (95% CI)a Score
Prolonged mechanical ventilation (10 days):
Constant -4.0
Rrs/kg (15 kPa/L·s)b 1.6 6.7 (1.5–30.3) 1
No. of ribs (>16)c 1.9 9.7 (1.6–58.0) 1
Haziness (present)d 2.2 13.8 (1.2–161.6) 1.5
Need of postnatal steroid therapy:
Constant -2.8
Haziness (present) 0.5 1.9 (0.1–27.3) 1
Rrs/kg (20 kPa/L·s) 1.3 4.7 (1.0–21.6) 2.5
Gestational age (<30 weeks) 1.7 7.7 (0.8–76.4) 3.5
a Odds ratio with 95% confidence interval.
b Resistance of respiratory system per kg birth weight according to the single-breath occlusion tech-
nique.68
c Mean lung volume score of two physicians according to the number of back ribs visible at the chest
radiograph in 3 categories: 0 = less than 14 ribs; 1 = 14 to 16 ribs; 2 = more than 16 ribs. 
d Mean haziness score of two physicians according to 4 stages: 0 = no haziness; 1 = regionally localized
or around hilus; 2 = regionally and around hilus; 3 = total haziness.
To facilitate practical implementation, risk scores were developed and evaluated.
Points were assigned to all predictors by dividing each coefficient by the smallest in
the model and rounding it to halves. Total scores for individual infants were calculated
by adding up the separate points for each predictor present. Subsequently, an
observed risk of the outcome was obtained for the total score categories. 
Our data were analysed with the Statistical Product and Service Solutions 10.0 for
Windows (SPSS Inc, Chicago, IL, USA).
5.4. Results
Eighty-eight infants were initially included for the large longitudinal study. In 51
of 88 infants, chest radiographs of day 2 were available, but in three of them
respiratory function measurements were unreliable according to ERS criteria. Hence,
48 premature infants were enrolled in the study. Patient characteristics are
summarized in Table 1, showing wide ranges of GA, birth weight, 1- and 5-minute
Apgar scores, umbilical cord pH and RDS classification. Twenty-eight infants received
exogenous surfactant before 24 hours of age, i.e. before assessment of radiological or
lung mechanical variables. Five infants received surfactant between 24 and 48 hours
and relation to assessment of radiological or lung mechanical variables could not be
detected. Three infants died while being mechanically ventilated. In one of them there
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was a discrepancy between the actual duration of mechanical ventilation and its severe
respiratory condition, which was the reason it died. Therefore, it was allocated to the
prolonged ventilation group, which eventually included infants who were mechanically
ventilated for ≥10 days or died because of respiratory insufficiency.
Results of univariate regression analysis are presented in Table 2. Following
multivariate regression analysis, three out of seven a priori selected potential
predictors were actually included in each logistic regression model (Table 3). The
radiological items, haziness and number of posterior ribs bilaterally, significantly
contributed to the prediction model for prolonged mechanical ventilation. GA and
haziness were included in the prediction model for postnatal steroid therapy. Rrs
expressed per kilogram birth weight (Rrs/kg) was additionally selected for both
prediction models. With these models, the individual probability of outcome can be
calculated for each patient fulfilling the inclusion criteria as follows: 1/1+e-LP where
LP (linear predictor) is the sum of the constant and the regression coefficients for
each variable present. For instance, the probability of prolonged mechanical
ventilation of an infant with haziness on its chest radiograph, 14 posterior ribs visible,
and a Rrs/kg of 16 kPa/Ls per kg is 1/1+e-(-4.0+2.2+1.6), i.e. 45 per cent. Overall dis-
criminatory capacity of each model was illustrated with ROC curves (Figures 1 and 2).
The AUC was 0.82 for each outcome, representing a good discriminatory capacity
Figure 1 (left). ROC curve of the prediction model to predict prolonged mechanical ventilation
(10 days) in preterm infants.
Figure 2 (right). ROC curve of the prediction model to predict postnatal steroid need in preterm
infants.
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according to Weinstein et al.264 The Hosmer and Lemeshow test was not significant in
neither model, indicating good fit.
Risk scores were perhaps more convenient but less precise. Points for each
variable present were added up and, subsequently, the corresponding probability could
be read from Table 4. Individual scores to predict prolonged mechanical ventilation
and need of steroid treatment ranged from 0 to 3.5 and from 0 to 7.0 for the patients
in our study, respectively, and were strongly related to the observed outcome
probability, illustrated in Table 4. Using the same example as described earlier, the
sum of the points would be 3.5, i.e. >2.5, indicating a probability of approximately 84
per cent. Compared to the former calculation, resulting in a probability of 45 per cent,
the probability based on the calculated risk score was much higher. 
 
5.5. Discussion
In this study, reliable prediction models were constructed to select high-risk
preterm infants for (1) prolonged mechanical ventilation (10 days) and (2) need of
systemic postnatal steroid therapy. Radiological haziness and hyperinflation, and
respiratory system resistance were important predictors in the ventilation model.
Gestational age, radiological haziness and respiratory system resistance were important
in the steroid model. 
Table 4. Relative number of infants with positive outcome for each score to predict prolonged
mechanical ventilation (10 days) and need of postnatal steroid therapy.
Total score Probability of positive
outcome
(%)
Number of infants with positive outcome
/ number of infants in score category
Prolonged mechanical ventilation (10 days):
<2.5 9.1 1/11
2.5 55.6 10/18
>2.5 84.2 16/19
Total 56.3 27/48
Need of steroid therapy:
<4.5 5.6 1/18
4.5 37.5 6/16
>4.5 71.4 10/14
Total 35.4 17/48
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Both models can have relevant implications for clinical practice as well as for
scientific research. Early reliable selection of high-risk infants of prolonged
mechanical ventilation and postnatal corticosteroid therapy help to have one’s
priorities in clinical practice and to limit exposition to potentially adverse effects of
new treatment strategies, when studying early administration of alternative anti-
inflammatory drugs. Although indications for postnatal steroid therapy might differ
substantially between countries and medical centres, our steroid model can be widely
used, when the indications for postnatal steroid administration, described in the
methods section of this manuscript, are used as the outcome measures. 
Our results were confirmed by other authors, who found decreased GA to
predict adverse respiratory outcome.210,256,270 In contrast to these findings, acute lung
inflammation is often less severe in extremely immature infants. One might think that
in these infants long-term respiratory morbidity would be less severe as well.
However, while RDS severity decreased during past decades accompanied by an
increased survival of more immature infants, the incidence of CLD did not.58,125
Radiological risk scores were seldom studied this early after birth.19,87,154 Chest
radiographs later in respiratory course have the advantage of showing more
radiological signs of advanced lung disease and may, therefore, become more sensitive
in predicting respiratory outcome. Substantial interobserver variability of chest
radiographs213 usually reduces their value in prediction models.270 In order to decrease
interobserver variability two dichotomous radiological items were chosen which were
easy to interpret. 
Radiological appearance is also known to be affected by differences in ventilator
modes. HFOV-conditions are usually determined by the inflation degree on chest
radiographs (guidelines used at our NICU consisted of an inflation degree 8 to 8.5 ribs
unilaterally during HFOV) and a constantly present high MAP during HFOV might
decrease pulmonary oedema, and, thereby, haziness at the radiograph. In our study
population, no significant differences were found between infants being
conventionally ventilated and those ventilated by HFOV (77 per cent of the infants in
both groups showed hyperinflation according to the criteria in Table 2 (p=0.94); 81
per cent of the conventionally ventilated infants showed haziness vs. 94 per cent of
the infants receiving HFOV (p=0.21); data not shown). Administration of exogenous
surfactant might affect radiological lung appearance as well. However, we found no
such effect in our study population. Of the infants receiving surfactant within 24
hours after birth (28), 50 per cent had some degree of haziness at the chest radiograph
and 50 per cent showed hyperinflation. 
Lung mechanical characteristics have been studied before as potential predictors
of the respiratory condition in preterm ventilated infants, but results are inconsistent.
19,46,70,89,137,160,256 Increased respiratory system resistance may both contribute to
development of lung damage and be a manifestation of CLD itself. Airway damage
secondary to endotracheal intubation, positive pressure, and/or high oxygen
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concentrations may cause increased respiratory system resistance, as may increased
pulmonary blood flow or left heart failure secondary to a patent ductus arteriosus
(PDA) causing peribronchial oedema.89 However, we did not find a significant
difference in PDA prevalence (confirmed by ultrasound performed by a paediatric
cardiologist) between infants with high and infants with low Rrs (29% vs. 27%,
respectively; p=0.88, when using a cut-off value of 20 kPa/L·s; and 33% vs. 19%,
respectively; p=0.27, when using a cut-off value of 15 kPa/L·s). 
Although Crs decreases in the presence of respiratory disease in preterm infants,
we did not find this variable to be an important predictor of clinical respiratory
course. Previous studies performed before the surfactant era were also
inconsistent.19,46,62,70,89,91,137 219,256 Although administration of exogenous surfactant is
known to immediately affect Crs,45 we did not find significant differences in surfactant
administration between infants with high and infants with lower Crs values (data not
shown). 
There are some remarks concerning the study design. The statistical power of the
study was limited as a consequence of the small study population. Therefore, the
number of a priori selected predictors was limited, increasing the risk of missing
valuable predictors, for example, ventilator conditions, which have been studied as
potential predictors of respiratory course before.91,137,214,256,270 Since in small data sets
regression coefficients tend to overestimate, we used the heuristic shrinkage method
to correct for this effect. However, external prospective validation in a comparable
group of infants is still recommended before widespread use of the prediction models
can be encouraged. Although in the majority of studies a pre-selection of infants was
made based on GA <30 or <32 weeks or birth weights of <1500 or <1000
grams19,95,210,214,270 in order to optimize sensitivity of the models, we preferred to enroll
all preterm infants of <37 weeks gestation, as did Toce et al.242 and Lischka et al.,154 to
include different pathologic aspects in both extremely immature infants and less
premature infants. Switching ventilator conditions from HFOV to SIMV to make
lung function testing possible might have caused a selection bias, excluding most
severely ill patients not capable to undergo this switch without problems, or a
measurement bias when reactive bronchospasms occurred after this switch. Since in
only one infant of our study this switch was needed, we assumed this effect to be
trivial. 
Both prolonged mechanical ventilation and need for postnatal steroid therapy are
known to be strongly associated with CLD development. However, the main
advantage of our models is the possibility to make separate selections. Early selection
of high-risk infants for prolonged mechanical ventilation may have important
consequences for clinical practice in having one’s priorities concerning preventive
strategies. Early selection of infants at risk of late steroid therapy may increase
research possibilities for new treatment strategies by decreasing the risk of
unnecessary exposure. The Cochrane Review101 about early postnatal steroid therapy
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(<96 hours after birth) implicated an urgent need of further studies investigating
different doses and schedules of steroid treatment, effects of inhaled steroids and
potentially safer steroids.
In summary, reliable prediction of prolonged mechanical ventilation (10 days)
and need of postnatal steroid therapy in preterm infants can be performed before 48
hours after birth with clinical, radiological and lung mechanical variables. Prospective
external validation of these prediction models is recommended before widespread
application can be encouraged. Eventually, early selection will increase the potential to
improve preventive strategies as well as further research concerning new interventions
in preterm ventilated infants.
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6.1. Abstract  
Because severity of acute respiratory distress (RDS) has been decreasing,
aetiology of long-term respiratory problems may have changed in preterm infants. We
investigated the causal relationships between early neonatal respiratory resistance (Rrs)
and compliance (Crs) and development of respiratory morbidity and lung function
abnormalities during the first year of life in ventilated preterm infants.
In 70 infants of less than 37 weeks gestation, mechanically ventilated within 24
hours after birth, Rrs and Crs were assessed daily during the first 3 days of life and
medians were calculated subsequently (Rrs,neo and Crs,neo). Rrs and Crs were reassessed 1
year later in 57 of 70 infants (Rrs,1year and Crs,1year). 
After correction for endotracheal tube size, increased Rrs,neo was significantly
related to respiratory morbidity during the first year of life (odds ratio, 1.20; 95%
confidence interval (CI), 1.04 to 1.38; p=0.013), increased Rrs,1year (multiplicative β per
kPa/L·s, 1.017; 95% CI, 1.000 to 1.034; p=0.045), and decreased Crs,1year (multi-
plicative  per kPa/L·s = 0.986; 95% CI, 0.974 to 0.998; p=0.023). Associations were
not adversely affected by degree of prematurity, neonatal disease and treatment. Crs,neo
did not show any significant associations. 
In the current surfactant era, increased Rrs,neo, and not Crs,neo, was associated with
poor respiratory outcome during the first year of life in preterm ventilated infants.
Neonatal disease and treatment seemed to be of minor importance compared to
inborn properties of the respiratory system. 
6.2. Introduction
The introduction of prenatal corticosteroids and postnatal exogenous surfactant
treatment in perinatal care, probably have played a major role in the observed trend of
decreasing severity of respiratory distress syndrome (RDS) during the past decades.32
Nevertheless, the risk of developing chronic lung disease of the neonate (CLD) has
remained high and may even have increased.58 
Respiratory system resistance (Rrs) and compliance (Crs) have been extensively
studied in preterm infants. Results relating these parameters to respiratory outcome
are conflicting, particularly with regard to the development of CLD.19,70,89,91,137,160,219,256
Moreover, most of these studies were performed before the use of prenatal
corticosteroids and the introduction of exogenous surfactant therapy. As a
consequence of these recent developments in perinatal care, the survival of more
immature infants has increased. Acute respiratory disease is often less severe and
respiratory outcome seems to be mainly determined by an arrest of lung development
in these infants.125 Antenatal corticosteroid treatment may also cause impaired
postnatal lung growth.108,247 So, contemporary associations between early postnatal Rrs
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and Crs and long-term respiratory outcome may have changed compared to the pre-
surfactant era. 
The purpose of this study was to investigate whether neonatal respiratory
mechanics play a role in the aetiology of respiratory morbidity and lung function
abnormalities during infancy in preterm ventilated infants and whether other relevant
neonatal factors, like degree of prematurity, ventilator conditions, respiratory disease
severity and therapeutic measures, affected these relationships. 
6.3. Subjects and methods
Preterm infants of less than 37 weeks of gestation, who were admitted to our
neonatal intensive care unit between 28 July 1999 and 31 August 2000 and who were
mechanically ventilated within 24 hours after birth, were studied prospectively. Infants
with congenital anomalies were excluded from the study. The study was approved by
the Medical Ethics Review Committee of our centre and parental informed consent
was obtained.
Mechanical ventilation was started as a consequence of respiratory distress, when,
despite supplemental oxygen and/or continuous positive airway pressure, the
inspiratory oxygen fraction (FiO2) remained above 0.7, the partial arterial carbon
dioxide pressure exceeded 55 mm Hg, acidosis persisted with pH decreasing below
7.25, or when serious apnoeas existed. Ventilator setting was adjusted to keep the
arterial oxygen saturation of haemoglobin between 90–95 per cent and the partial
arterial carbon dioxide pressure between 40–45 mm Hg. For mechanical ventilation,
one of the following infant respirators was used: Stephanie (Stephan, Gackenbach,
Germany), Bear BP2001 (Bear, Palm Springs, CA, USA), and Bourns BP200 (Bourns,
Inc., Riverside, CA, USA). 
RDS was diagnosed when clinical symptoms of tachypnoea (>60/min),
retractions, expiratory grunting and cyanosis were present in combination with
radiological signs described by Giedion.86 Exogenous surfactant (natural bovine
surfactant: Alvofact, Boehringer, Ingelheim, Germany) was administered at a dose of
50 mg/kg using the following limits of peak inspiratory pressure (PIP) and FiO2: PIP
<20 cmH2O and FiO2 >0.6, or PIP 20 cmH2O and FiO2 >0.45. When PIP exceeded
25 cmH2O, conventional ventilation was switched to high frequency oscillatory
ventilation (HFOV). 
Measurements of passive respiratory system mechanics were performed daily
during the first 3 days of life in intubated infants. No extra sedation of the infants was
required. Sometimes measurements could not be performed, because of clinical
instability of the patient, unavailability of qualified personnel, i.e. two of the
contributing authors (Y.S. and P.d.W.), or because patients were extubated before the
actual time of measurement. To optimize the total number of measurement results,
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the median passive respiratory system resistance (Rrs,neo) and compliance (Crs,neo) of the
first 3 days of life were calculated. Rrs and Crs were assessed according to the single
breath occlusion technique (SBT) described by Le Souef.68,150 A heated Lilly-type
pneumotachometer (8410A, linear range 0–10 L/min, dead space 1.3 ml, resistance
0.94 kPa/Ls at 5 L/min; Hans Rudolph Inc., Kansas City, MO, USA) was placed
between endotracheal tube and ventilator tubes. A pressure transducer (Honeywell,
type 163PC01D75, Morristown, NJ, USA) and an IBM compatible personal computer
with a Pentium processor running the software package Respiratory Analysis System
Program (Version 007.17, Physio Logic, High Clere, Great Britain) were used to
record signals at a sampling rate of 125 Hz using a 12 bit analogue-to-digital converter
(LabMaster DMA, Scientific Solutions, Mentor, OH, USA). Mouth pressure and flow
signals were obtained after calibration before each single measurement. For flow
calibration, a calibrated rotameter (Air 0-15 L/min, Medec, Aalst, Belgium) was used
followed by a volume calibration using a precision syringe of 50-ml containing the
actual gas mixture. For pressure calibration, a pressure transducer tester (Veri-Cal 650-
900, Utah Medical Products Inc., Midvale, UT, USA) was used. Leaks in the system or
around the endotracheal tube were easily detected as mouth pressure decreased
gradually during occlusion. With gentle manual compression of the trachea present
leaks were minimized. Measurements with persisting tube leaks causing a decrease in
occlusion pressure of 0.02 kPa or more were excluded from further analysis. 45, 220
During occlusion, activity of inspiratory muscles is inhibited via stimulation of the
airway receptors inducing the Hering-Breuer reflex. Analyses were performed
according to the actual European Respiratory Society (ERS)61 Breath analysis was
considered unreliable, when no muscle relaxation was achieved. Muscle relaxation was
assumed to be present when (1) during a short occlusion period of less than 0.5
seconds mouth pressure did reach a plateau for at least 0.1 seconds during which
pressure changes showed a standard deviation (SD) of 0.01 kPa or less, and (2) the
expiration part of the flow volume curve was linear for at least 50 per cent of the
volume to be expired. As a criterion for linearity, a correlation coefficient of 0.98 or
more after exclusion of the final 5 per cent of the expired volume had to be reached.
At least five occluded breaths meeting these criteria were used to calculate a mean
value for both respiratory mechanics for each single measurement. 
At the age of one, Rrs,1year and Crs,1year were determined during spontaneous
breathing using the same technique (SBT). At this age, infants were sedated with 50–
100-mg/kg chloral hydrate and measurements were performed in supine position with
the head end elevated at approximately 30 degrees relative to horizontal. A heated
Lilly-type pneumotachometer (3500B, linear range 0–35 L/min, dead space 8.74 ml,
resistance 0.32 kPa/Ls at 17.5 L/min; Hans Rudolph Inc., Kansas City, MO, USA)
was attached to a facemask (Laerdal Infant Mask No.1, Laerdal BeNelux BV, Valkens-
waard, The Netherlands; dead space 10 ml) covered with therapeutic putty (Magic
Putty, medium, Oldelft Benelux BV, Delft, The Netherlands) to prevent air leakage.
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To evaluate internal validity of the tests, the intrasubject variability of both Rrs
and Crs in mechanically ventilated infants was studied.228 Coefficients of variance of
Rrs and Crs were determined within subjects within each occasion and within subjects
between up to three occasions that were used to calculate median Rrs and Crs of the
first 3 days of life.
Clinical data, i.e. gestational age, birth weight, severity of RDS according to
Giedion,86 duration of mechanical ventilation, mean PIP during ventilation, number of
days requiring a FiO2 of  more than 0.4, and oxygen dependency at 36 weeks
gestational age, was derived from clinical charts. To achieve an indication of
respiratory morbidity after hospital discharge, data about inhaled corticosteroid or
bronchodilator therapy and hospital readmission for respiratory problems were
obtained via questionnaires completed by the parents at the end of the first year. The
questions in these questionnaires were similar to the key questions in the
questionnaire used by Kuehni et al.144 in children between 0 and 5 years of age.
Questions included (translated from Dutch): 
 During the past 12 months, has your child taken medicine for wheezing or
coughing?
 If so, which medication was taken?
 During the past 12 months, has your child been admitted to hospital for
respiratory problems?
If inhaled corticosteroids or bronchodilators were used, or rehospitalization occurred
during the first year of life respiratory morbidity was judged as present.
6.3.1. Data analysis
Characteristics of the patients who were lost to follow-up were compared to the
characteristics of the patients who returned for follow-up measurements by
independent Student’s t-tests, when data were normally distributed and variances were
equal. Otherwise, Mann-Whitney U-tests were used. For comparison of frequencies of
dichotomous variables between groups, Chi-square analyses were performed. 
As a first evaluation of data, associations between early neonatal clinical and
functional data (as independent variables) and respiratory morbidity, Rrs,1year, and
Crs,1year (as dependent variables) were studied by univariate regression analyses. Since
endotracheal tube size substantially affects Rrs measurements during mechanical
ventilation,152,164 Rrs,neo was subsequently corrected for this effect by including tube
diameter in all regression models. In these cases, we will refer to Rrs,neoC. Respiratory
morbidity during the first year of life was expressed dichotomously (1 for present and
0 for absent) and logistic regression analyses were used regarding this outcome
measure. Rrs,1year and Crs,1year were transformed by taking the natural logarithm, because
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of their deviation from the normal distribution. Since results of regression analyses are
presented after back transformation, regression coefficients and their 95% confidence
intervals (CI) should be interpreted as multiplicative instead of additive.
Subsequently, aetiological models were constructed and their independency from
potentially confounding factors was studied (i.e. clinical data, such as gestational age,
birth weight, severity of RDS according to Giedion,86 duration of mechanical
ventilation, mean PIP during ventilation, number of days requiring a FiO2 of  more
than 0.4, and oxygen dependency at 36 weeks gestational age). Only factors affecting
the initial regression coefficients of the respiratory mechanics by more than 10 per
cent were included in the models and discussed subsequently.
Our data were analysed with the Statistical Product and Service Solutions 10.0 for
Windows (SPSS Inc, Chicago, IL, USA). For all analyses, a p-value of <0.05 was
considered statistically significant.
6.4. Results
Initially, 88 infants were randomly recruited. Eleven infants died during the
neonatal period leaving 77 infants for follow-up at the age of one. Six infants died of
respiratory insufficiency, four due to neurological problems and one due to circulatory
problems. Rrs,neo and Crs,neo results in seven infants were considered unreliable
according to the ERS criteria and, therefore, excluded from further analysis.
Eventually, data in 70 infants were analysed. Patient characteristics of this group are
listed in Table 1.
Information about respiratory morbidity during the first year of life was complete
for 66/70 (94%) infants. In 57/70 (81%) infants, respiratory function measurements
were performed at the age of one. Parents of 10 infants decided not to return for
follow-up respiratory function measurements for various personal reasons, in two
cases no reason was given, and one infant was tested 3 months late and therefore
excluded for further analysis. The 13/70 (19%) infants, in whom follow-up data were
missing, did not substantially differ from the 57/70 (81%) infants, in whom these data
were available, with respect to gestational age (median (range), 29.9 (26.6–33.7) vs.
29.4 (25.3–36.3) weeks, respectively; p=0.794), birth weight (1536 (875–1860) vs. 1240
(630–3020) g; p=0.572), sex (54% vs. 56% male; p=0.881), maximum PIP (23 (14–40)
vs. 22 (15–35) cmH2O; p=0.387), Giedion score  (3 (0–4) vs. 3 (0–4); p=0.268), and
oxygen dependency at 36 weeks post-conceptional age (0% vs. 7%; p=0.325).
However, groups did differ with respect to duration of mechanical ventilation (5 (1–
15) vs. 11 (1–67) days; p=0.014) and number of days requiring FiO2 of >0.4 (0 (0–1)
vs. 1 (0–48) days; p=0.008). Rrs,neo and Crs,neo were comparable between both groups
(14.9 (9.8–22.1) vs. 15.3 (8.8–30.4) kPa/L·s; p=0.381, and 5.9 (3.6–12.1) vs. 5.2 (2.3–
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22.2) ml/kPa; p=0.962, respectively), as was the occurrence of respiratory morbidity,
i.e. inhalation therapy or hospital readmission, during the first year of life (50% vs.
41%; p=0.557). 
Table 1.  Patient characteristics.
Median (range) /
Number (%)
Neonatal period (n=70)
Gestational age (weeks) 29.5 (25.3–36.3)
Birth weight (grams) 1277 (630–3020)
Sex (male) 39 (56%)
Prenatal exposure to tobacco smoke 16 (23%)
Prenatal corticosteroids administration (≥24 h antenatally) 45 (64%)
Radiological RDS severitya 3 (0–4)
Duration of mechanical ventilation (days) 9 (1–67)
Maximum peak inspiratory pressure (cm H2O) 22 (14–40)
Number of days with FiO2 >0.4 1 (0–48)
Surfactant administration 46 (66%)
      Hour of life of surfactant instillation 9 (1–52)
Diagnosis of a patent ductus arteriosus (PDA)b 27 (39%)
Day of PDA diagnosis 2 (1–9)
Size of endotracheal tube (internal diameter):
2.5 mm 35 (50%)
3.0 mm 32 (46%)
3.5 mm 2 (3%)
Switched from 2.5 to 3.0 mm at second day of life 1 (1%)
Rrs,neo (kPa/L·s) 15.1 (8.8–30.4)
Crs,neo (ml/kPa) 5.4 (2.3–22.2)
Oxygen dependency at 36 weeks 4 (6%)
Postnatal corticosteroid administration 23 (33%)
Outcome during the first year of life
Inhalation therapy with bronchodilators and/or steroids   (n=66) 27 (41%)
Rehospitalization for respiratory problems 9 (14%)
Respiratory morbidityc 28 (42%)
Rrs,1year (kPa/L·s) (n=57) 4.6 (2.7–8.3)
Crs,1year  (ml/kPa) 99.2 (59.6–169.3)
Age at follow-up measurement corrected for gestation (days) 303 (270–437)
Weight at follow-up measurement (kg) 8.8 (6.6–12.0)
Height at follow-up measurement (cm) 72.3 (65.0–80.0)
aRadiological score for severity of respiratory distress syndrome according to Giedion (0–4).86
bPatent ductus arteriosus, diagnosed by ultrasound performed by a paediatric cardiologist. 
cInhaled corticosteroids or bronchodilator therapy, or hospital readmission due to respiratory problems.
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6.4.1. Respiratory function measurements during mechanical ventilation
In the initial study population of 70 infants, 55 assessments of Crs were obtained
at day 1, 48 at day 2, and 45 at day 3. Since in a few of these occasions non-linear
expiratory flow patterns precluded reliable Rrs assessment, 53 Rrs assessments were
obtained at day 1, 45 at day 2 and 44 at day 3. The median number of occluded
breaths (range), on which results of each single measurement were based on, was 6 (3–
12). In nine measurements the amount of five occluded breaths was not reached and
results were based on four reliable occluded breaths in five measurements and three
reliable occluded breaths in four measurements. Of all neonatal respiratory function
measurements, the median CV (range) within subjects within measurements of Crs was
7.7 (1.5–38.7) and of Rrs was 6.4 (1.8–51.3). CV values within subjects between
measurements of the first 3 days of life were calculated in 68 per cent of the Crs
measurements and in 64 per cent of the Rrs measurements where respiratory function
measures were based on more than one measurement. The median CV (range)
between Crs measurements was 24.9 (0.8 to 60.0) and between Rrs measurements 15.6
(4.2 to 62.1). The median CV (range) between Rrs measurements was 15.6 (4.2–62.1)
and between Crs measurements 24.9 (0.8–60.0).
6.4.2. Relationships between early postnatal factors and respiratory outcome during infancy
Univariate regression analyses revealed no significant associations between early
neonatal clinical data (gestational age, birth weight, radiological RDS severity
according to Giedion, duration of mechanical ventilation, maximal PIP, number of
days requiring a FiO2 of more than 0.4, and oxygen dependency at 36 weeks
gestational age) and respiratory morbidity during the first year of life and Rrs,1year. We
did find, however, significant associations between gestational age, birth weight, and
duration of mechanical ventilation and Crs,1year (Table 2). 
Increased Rrs,neoC was associated with respiratory morbidity during the first year
of life (odds ratio (OR), 1.20; 95% confidence interval (CI), 1.04 to 1.38; p=0.013).
The association between the actually measured values of Rrs,neo and respiratory
morbidity is presented in Figure 1. Although independent of gestational age, birth
weight, radiological RDS severity according to Giedion,86 duration of mechanical
ventilation, number of days requiring a FiO2 of more than 0.4, and oxygen
dependency at 36 weeks gestational age, the association between Rrs,neoC and
respiratory morbidity was affected by the maximal PIP used during mechanical
ventilation. After including maximal PIP as independent factor into the regression
model, the initial relation between Rrs,neoC and respiratory morbidity became stronger
and more significant (odds ratio, 1.23; 95% CI, 1.05 to 1.43; p=0.009), but maximal
PIP itself was not associated with respiratory morbidity (odds ratio, 0.90; 95% CI, 0.78
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to 1.04; p=0.149). Secondly, increased Rrs,neoC was related to increased Rrs,1year
(multiplicative β per kPa/L·s, 1.017; 95% CI, 1.000 to 1.034; p=0.045) and this
association was independent of all potentially confounding factors. Thirdly, Rrs,neoC
was negatively associated with Crs,1year (multiplicative β per kPa/L·s = 0.986; 95% CI,
0.974 to 0.998; p=0.023). Of all potential confounding factors, the number of days
requiring a FiO2 of more than 0.4 substantially affected this association. After
including this variable into the regression model, the initial association between Rrs,neoC
and Crs,1year became more significant (multiplicative β per kPa/L·s = 0.984; 95% CI,
0.972 to 0.995; p=0.007) and the number of days requiring a FiO2 of more than 0.4
itself was negatively associated with Crs,1year (multiplicative β per day = 0.992; 95% CI,
0.986 to 0.999; p=0.019). 
Crs,neo was positively associated with Crs,1year (multiplicative β per ml/kPa, 1.015;
95% CI, 1.000 to 1.030; p=0.049). However, after correction for birth weight this
association lost statistical significance (multiplicative β per ml/kPa, 1.001; 95% CI,
0.984 to 1.018; p=0.885) and birth weight itself was significantly associated with
Crs,1year (multiplicative β per kg, 1.181; 95% CI, 1.052 to 1.310; p=0.007). Crs,neo was
neither associated with Rrs,1year (multiplicative β per ml/kPa, 0.998; 95% CI, 0.990 to
1.007; p=0.653) nor with respiratory morbidity (OR, 0.96; 95% CI, 0.84 to 1.09;
p=0.495).
Table 2. Results of univariate regression analyses with Crs,1year as a dependent variable.
Early postnatal factor                                        (n=70)
Multipli-
cative β
per unit
f
95%
confidence
interval of β
p-value
Gestational age (weeks) 1.035 1.013–1.057 0.002
Birth weight (grams) 1.0002 1.000–1.000 0.001
Radiological RDS severitya 1.005 0.954–1.055 0.851
Duration of mechanical ventilation (days) 0.996 0.992–0.999 0.018
Maximum peak inspiratory pressure (cm H2O) 0.995 0.979–1.011 0.510
Number of days with FiO2 >0.4 0.993 0.986–1.000 0.062
Oxygen dependency at 36 weeks post-conceptional age 1.229 0.991–1.466 0.059
Rrs,neoC (kPa/L·s) 0.986 0.974–0.998 0.023
Crs,neo (ml/kPa) 1.015 1.000–1.030 0.049
aRadiological score for severity of respiratory distress syndrome according to Giedion (0–4).86
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6.5. Discussion
We found that, in the current surfactant era, early neonatal Rrs (Rrs,neoC), and not
Crs (Crs,neo), was associated with respiratory outcome during infancy. Increased Rrs,neoC
was associated with respiratory morbidity during the first year of life, increased Rrs
(Rrs,1year) and decreased Crs (Crs,1year) at 1 year of age. These causal relationships were
not affected by factors indicating degree of prematurity and neonatal disease. The
relationship between Rrs,neoC and respiratory morbidity was strengthened by inclusion
of maximal PIP required during mechanical ventilation in the neonatal period into the
regression model. The relationship between Rrs,neoC and Crs,1year was strengthened by
the number of days requiring a FiO2 of more than 0.4. Early postnatal Crs,neo was not
associated with respiratory outcome during the first year of life. Degree of prematurity
and duration of mechanical ventilation were also associated with Crs,1year.
Rrs,neoC was the most consistent factor related to respiratory outcome during the
first year of life in ventilated preterm infants. Rrs represents the sum of the resistive
properties of chest wall, airways and, especially in immature infants, the lung
parenchyma199 Acute respiratory disease in preterm infants is dominated by
parenchymal changes, like surfactant deficiency, alveolar hyaline membrane
deposition, interstitial oedema, and pulmonary interstitial emphysema. Because
treatment facilities for acute respiratory disease have improved dramatically, early
postnatal Rrs increasingly reflects inborn properties of the respiratory system,68
Figure 1. Mean proportions of infants with respiratory morbidity (i.e. inhaled corticosteroid or
bronchodilator therapy, or rehospitalization) during the first year of life for two categories of
Rrs,neo. Error bars indicate 95% confidence intervals of the mean.
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depending on gestational age, intra-uterine lung development, and familial
predisposition. It has been suggested before that both interruption of antenatal lung
development by preterm birth58,125 and intra-uterine growth retardation59 are
important indicators of respiratory outcome in preterm infants. In a study of very low
birth weight infants, Chan et al.30 found that conductance (the reciprocal of resistance)
in the first year of life was not associated with neonatal oxygen score and duration of
mechanical ventilation. Lui et al.,160 who found that Rrs, measured during the first
week of life in 46 infants with birth weights of <1000 g, was related to respiratory
outcome, while Crs was not. They also found that Rrs was a better predictor of CLD
development than RDS and surfactant use. These findings support our findings and
argue that inborn properties of the respiratory system more strongly affect respiratory
outcome than acute neonatal lung injury by RDS or ventilator conditions.
Both gestational age and birth weight, as markers of intra-uterine body growth,
did not affect the relationships between Rrs,neoC and respiratory outcome. Intra-uterine
lung growth may be completely incorporated by Rrs,neoC, and may therefore not be a
real confounder. We found that inspiratory pressures during mechanical ventilation
(maximal PIP) and duration of supplemental oxygen exposure did affect the
relationships between Rrs,neoC and respiratory morbidity, and Rrs,neoC and Crs,1year,
respectively. Hence, correction for these factors seems important to reveal more pure
aetiological relationships. 
Since the compliance of the chest wall is very high in preterm infants,84 Crs,neo is
predominantly affected by changing conditions of lung tissue. In severe RDS,
surfactant deficiency together with alveolar deposition of hyaline membranes and
interstitial oedema are known to decrease Crs.43 As a consequence of decreased RDS
severity,32 neonatal Crs is less deteriorated and therefore not related to long-term
respiratory outcome. In preterm infants developing CLD, Baraldi et al.15 showed that,
instead of Rrs, Crs was strongly associated with forced expiratory flow (V’max,FRC) at the
age of 2. However, Crs was measured between 10 and 20 days of life. By that time,
CLD usually shows serious progress, causing Crs to decrease. Alternatively, the
increased variability of early neonatal Crs measurements make this a less sensitive tool
in relation to respiratory outcome. The poor relationship between Crs,neo and
respiratory outcome in this study may well have been influenced by the use of
surfactant. In 66 per cent of the infants in our study population, exogenous surfactant
was instilled at a median age of 9 hours. Surfactant is known to immediately improve
Crs values,45 and to decrease RDS severity.32 Postnatal corticosteroid administration
did not show any confounding effect. Assessment of passive respiratory mechanics
using the SBT according to Le Souef et al.150 is simple and can be easily performed in
intubated preterm infants with minimal disturbance to the patient. We are well aware
of the limitations of this technique, especially in intubated preterm infants.228 By using
strict criteria recommended by the ERS, neonatal respiratory function results can be
considered reliable. CV values of Rrs and Crs within subjects within measurements
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were acceptable, indicated by low median CV values. CV values of Rrs and Crs within
subjects between the daily measurements during the first 3 days of life were larger,
especially for Crs assessments. This indicates that Rrs and Crs may change considerably
during the first days of life. 
More studies are needed to explore which factors contribute to intra-uterine lung
development, postnatal lung function and respiratory outcome in the current
surfactant era. We intend to follow our study population into childhood to explore
future respiratory development in relation to early respiratory system mechanics.
To conclude, we found important causal relationships between early postnatal Rrs
(but not Crs) and respiratory outcome during the first year of life in preterm ventilated
infants. Relationships were not adversely affected by measures reflecting degree of
prematurity, neonatal disease, and ventilator conditions. This indicates that inborn
properties of the respiratory system have become increasingly important in relation to
respiratory outcome instead of neonatal disease and treatment conditions.
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7.1. Abstract 
Background: In preterm ventilated infants, irreversible damage to the airway
mucosa in the neonatal period might be related to the development of bronchial
hyperresponsiveness (BHR) in subsequent years. 
Aims: To evaluate whether neonatal indicators of long-term respiratory morbidity,
respiratory system compliance (Crs) and resistance (Rrs), were causally related to
bronchial responsiveness at the age of two and whether these relationships were
affected by other factors. 
Study design: Mean neonatal Crs and Rrs of the first 3 days of life were assessed
using the single breath occlusion technique. Bronchial challenge tests were performed
at 2 years of age. When wheezing occurred during chest auscultation or oxygen
saturation decreased below 90 per cent, the provocative concentration of
methacholine was recorded. 
Subjects: Forty-five preterm infants of <37 weeks gestation, being mechanically
ventilated within 24 hours after birth. 
Results: Decreased neonatal Crs was related to BHR (β per ml/kPa, 0.061; 95%
confidence interval, 0.019 to 0.103; p=0.006). Correction was required for radiological
gradation of respiratory distress syndrome, the maximal peak inspiratory pressure
required during mechanical ventilation and postnatal corticosteroid therapy. Neonatal
Rrs, gestational age and birth weight were not related to subsequent BHR
development. 
Conclusion: In ventilated preterm infants, decreased neonatal Crs was related to the
development of BHR at the age of two. 
7.2. Introduction
In preterm infants with chronic lung disease (CLD), bronchial hyper-
responsiveness (BHR) in childhood is common.174,181,195,223 Also without development
of CLD, bronchial responsiveness may be increased in preterm infants at school
age.78,94,195 Irreversible damage to the airway mucosa due to inflammation and
mechanical ventilation in the neonatal period is thought to cause BHR development in
subsequent years.174 Data on BHR in infancy are scarce, as conventional methods
required spirometry.
Alternatively, chest auscultation with pulse oximetry is easy to perform in young
infants and seems to reveal valid results during bronchial challenge testing in older
children.9,224 In preterm infants, neonatal respiratory system compliance (Crs) and
resistance (Rrs) are indicative of long-term respiratory morbidity,30,85,151,153,179,193 which
may reflect BHR during childhood.174,181,195,223 More information about causal factors
of BHR development is needed to elucidate the pathological process of BHR
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development in preterm infants. The purpose of this study was to investigate whether
neonatal respiratory mechanics play a role in the aetiology of bronchial responsiveness
in subsequent years in preterm ventilated infants and whether other relevant neonatal
factors, like degree of prematurity, ventilator conditions, respiratory disease severity
and therapeutic measures affected this relationship. To determine the clinical
importance of BHR, we also investigated whether bronchial responsiveness was
related to recent respiratory morbidity. 
7.3. Material and methods
7.3.1. Subjects
Preterm infants of less than 37 weeks of gestation, who were admitted to our
neonatal intensive care unit (NICU) between 28 July 1999 and 31 August 2000 and
who were mechanically ventilated within 24 hours after birth, were studied
prospectively. Infants with congenital anomalies were excluded from the study. The
study was approved by the Medical Ethics Review Committee of our centre and
parental informed consent was obtained.
Mechanical ventilation was started as a consequence of respiratory distress, when,
despite supplemental oxygen and/or continuous positive airway pressure, the
inspiratory oxygen fraction (FiO2) remained above 0.7, the partial arterial carbon
dioxide pressure exceeded 55 mm Hg, acidosis persisted with pH decreasing below
7.25, or when serious apnoeas existed. Ventilator settings were adjusted to keep the
arterial oxygen saturation of haemoglobin (SaO2) between 90–95% and the partial
arterial carbon dioxide pressure between 40–45 mm Hg. For mechanical ventilation,
one of the following infant respirators was used: Stephanie (Stephan, Gackenbach,
Germany), Bear BP2001 (Bear, Palm Springs, CA, USA), and Bourns BP200 (Bourns,
Inc., Riverside, CA, USA). Respiratory function measurements were performed at
neonatal age and bronchial challenge tests at the age of two. Additional information
about respiratory morbidity within this period was collected from clinical charts
during the neonatal period and questionnaires being completed by the parents at the
end of the second year for the period after hospital discharge.
7.3.2. Respiratory function tests
We intended to perform measurements of passive respiratory system mechanics
on each day during the first 3 days of life. Sometimes measurements could not be
performed, because of clinical instability of the patient or unavailability of qualified
personnel (i.e. two of the authors, Y.S. and J.P.d.W.). To optimize the total number of
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measurement results, mean Crs and Rrs of the first 3 days of life were calculated. Crs
and Rrs were assessed according to the single breath occlusion technique (SBT)
described by Le Souef et al.68,150 A heated Lilly-type pneumotachometer (8410A, linear
range 0–10 L/min, dead space 1.3 ml, resistance 0.94 kPa/Ls at 5 L/min; Hans
Rudolph Inc., Kansas City, MO, USA) was placed between endotracheal tube and
ventilator tubes. A pressure transducer (Honeywell, type 163PC01D75, Morristown,
NJ, USA) and an IBM compatible personal computer with a Pentium processor
running the software package Respiratory Analysis System Program (Version 007.17,
Physio Logic, High Clere, Great Britain) were used to record signals at a sampling rate
of 125 Hz using a 12 bit analogue-to-digital converter (LabMaster DMA, Scientific
Solutions, Mentor, OH, USA). Mouth pressure and flow signals were obtained after
calibration before each single measurement. For flow calibration, a calibrated
rotameter (air 0–15 L/min, Medec, Aalst, Belgium) was used followed by a volume
calibration using a precision syringe of 50 ml containing the actual gas mixture. For
pressure calibration, a pressure transducer tester (Veri-Cal 650-900, Utah Medical
Products Inc., Midvale, Utah) was used. Leaks in the system or around the
endotracheal tube were easily detected as mouth pressure decreased gradually during
occlusion. With gentle manual compression of the trachea present leaks were
minimized. Occluded breaths with tube leaks causing a decrease in occlusion pressure
of 0.02 kPa or more were excluded from further analysis.45,220 During occlusion,
activity of inspiratory muscles is inhibited via stimulation of the airway receptors
inducing the Hering-Breuer reflex. Breath analysis was considered unreliable, when no
muscle relaxation was achieved. Muscle relaxation was assumed to be present when
(1) during a short occlusion period of less than 0.5 second mouth pressure did reach a
plateau for at least 0.1 seconds and pressure changes during this period showed a
standard deviation (SD) of 0.01 kPa or less, and (2) the expiration part of the flow
volume curve was linear for at least 50 per cent of the volume to be expired. As a
criterion for linearity, a correlation coefficient of 0.98 or more had to be achieved after
exclusion of the final 5 per cent of the expired volume. We intended to use at least
five occluded breaths meeting these criteria for calculation of a mean value for both
respiratory system mechanics for each single measurement. These criteria complied
with the European Respiratory Society recommendations.80 We are well aware of the
limitations of these respiratory function measurements in intubated preterm infants.230
To evaluate internal validity of the tests, the intrasubject variabilities of Rrs and Crs
were studied by evaluating their coefficients of variance (CV) within each single
measurement of all measurements meeting the European Respiratory Society
recommendations. CV values within subjects between the measurements of the first 3
days were also assessed.
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7.3.3. Bronchial challenge tests
Bronchial challenge tests were carried out by one of the authors (Y.S.) at 2 years
of age using a continuous inhalation tidal breathing method as described by Cockroft
et al.34 Before the test was started, chest auscultation was performed. Isotonic saline
was administered for 2 minutes from a nebulizer (Up-draft II nebulizer, Hudson
Respiratory Care Inc., Temecula, CA), connected to a flow meter (Endomed Air 20°C
0–17 L/min, Endomed B.V., Didam, The Netherlands) delivering a flow rate of 6
L/min out of the hospital circuit of compressed air into the nebulizer. Chest
auscultation was repeated shortly after saline nebulization. If no wheeze was heard, a
serial inhalation of doubling concentrations of methacholine was started from a
concentration of 0.15 mg/ml every 5 minutes to a maximum concentration of 9.6
mg/ml (i.e. 0.15, 0.30, 0.60, 1.20, 2.40, 4.80 and 9.60 mg/ml consecutively). Each
methacholine concentration was nebulized for 2 minutes. Shortly after each inhalation,
chest auscultation was performed by the same observer every time.
The response to the challenge was monitored by a pulse oximeter (Nellcor N-
395, Mallinckrodt Europe B.V., ‘s-Hertogenbosch, The Netherlands) attached around
a toe. Baseline values of SpO2 were attained after a short period of stabilization. The
challenge was considered positive and terminated if an audible wheeze was present
over the chest, if SpO2 fell below 90 per cent (for at least ten seconds) or if the final
methacholine concentration of 9.6 mg/ml was reached, whatever occurred first. At
that moment, the provocative concentration of methacholine (PC) was recorded, as
was the SpO2. Children inhaled 800 µg of Salbutamol via a Babyhaler to decrease
bronchusconstriction. When children were wheezing before initiation of the test, their
parents were kindly requested to come back for the test a few days or weeks later. 
7.3.4. Data analysis
PCs were expressed as the number of doubling concentrations of methacholine
and were transformed by taking the square root to accomplish a normal distribution.
Relevant clinical neonatal factors were studied univariately in relation to PC, including
gestational age, birth weight, maximal radiological gradation for respiratory distress
syndrome (RDS) according to Giedion,86 duration of mechanical ventilation, number
of days with a FiO2 of >0.4, maximal peak inspiratory pressure (PIP) required during
ventilation, postnatal corticosteroid therapy, CLD development (oxygen dependency
at 36 weeks postconceptional age), and Crs and Rrs. 
Secondly, causal relationships based on a priori assumptions were investigated
between neonatal mechanics and PC by linear regression analyses with PC as the
dependent variable and Crs and Rrs as alternate independent variables. Thirdly, we
studied whether these relationships were affected by potentially confounding factors: 
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gestational age, birth weight, maximal radiological RDS grade according to Giedion,86
duration of mechanical ventilation, maximal PIP required during ventilation, number
of days requiring a FiO2 of >0.4, postnatal steroid therapy, CLD (oxygen dependency
at 36 weeks post-conceptional age), familial history of asthma or atopy, and use of
inhaled corticosteroids, number of colds, smoking by one or more household
members, and the presence of pets within the household for at least 1 year. These
factors were included separately into the initial regression models. Any factors
affecting the regression coefficients of either Crs or Rrs by more than 10% were
considered important and were included in the models. 
To study the clinical relevance of PC in our study population, we investigated
whether PC was associated with occurrence of respiratory symptoms of coughing or
wheezing of any duration and inhalation therapy, e.g. bronchodilators or cortico-
steroids, during the second year of life by logistic regression analyses. To compare PC
values in our study with the values described in previous studies in which individual
data were presented of children of similar ages, independent Students’ t-tests were
used. Statistical significance was defined as a p-value of less than 0.05.
7.4. Results
Eighty-eight infants were recruited. Eleven of them died during the neonatal
period at the NICU, leaving 77 for follow-up. Six infants died of respiratory insuffi-
ciency, four due to neurological problems and one due to circulatory problems. In
seven of 77 infants, neonatal Crs and Rrs assessments did not meet the criteria recom-
mended by the European Respiratory Society. In 45 (64%) of the 70 infants left,
bronchial responsiveness was assessed at the age of two. Parents of 18 infants did not
return for the bronchial challenge tests for various personal reasons or because they
did not want to expose their children to the tests. In two additional cases, no reason
was given. Four children did visit the hospital, but did not complete the challenge
tests, and one child was tested 4 months late. The results of these children were
excluded for further analysis. No clinically important differences existed between the
original group of 70 patients and the group of 45 patients who were included for
further analysis (Table 1). Information about occurrence of respiratory symptoms and
use of inhalation medication during the second year of life was complete in 44 of 45
(98%) infants. 
In the majority of cases (77%), bronchial challenge tests were terminated in the
presence of at least an audible wheeze during chest auscultation. In 13% of cases this
was accompanied by a decrease of SpO2 below 90 per cent. In 18% of cases, tests
were terminated by a decrease of SpO2 below 90 per cent without an audible wheeze.
In one child, the maximum concentration of 9.6 mg/ml was reached and in another
case the test was terminated after reaching the fourth doubling concentration of
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methacholine without any wheeze or SpO2 decrease, because the child did not longer
accept the nebulizing mask near its face. SpO2 during the provocation tests did not
descend below 80 per cent (Table 1).
According to univariate analyses, PC was significantly associated with maximal
radiological RDS gradation according to Giedion86 and neonatal Crs (Table 2). No
associations were found between PC and gestational age, birth weight, maximal peak
Table 1. Patient characteristics in 70 infants who were initially available for follow-up compared
to 45 infants with actual bronchial challenge test results.
n = 70
Mean (range)/
number (%)
n = 45
Mean (range)/
number (%)
p-value
(Student’s
t-test/chi-
square)
Gestational age (weeks) 29.7 (25.3–36.3) 29.4 (25.3–36.3) 0.51
Birth weight (grams) 1361 (630–3020) 1314 (630–3460) 0.34
Sex (male) 39 (56%) 22 (49%) 0.34
Maternal smoking during pregnancy 16 (23%) 9 (20%) 0.72
Maximal RDS gradationa 2,5 (0–4) 2,5 (0–4) 0.99
Mechanical ventilation (days) 14 (1–67) 17 (1–67) 0.43
Maximal peak inspiratory pressure (cmH2O) 22 (14–40) 22 (15–35) 0.68
Days with FiO2 > 0.40 3 (0–48) 3 (0–37) 0.99
Postnatal corticosteroid therapy 23 (33%) 17 (38%) 0.59
Chronic lung diseaseb 4 (5.7%) 2 (4.4%) 0.77
Neonatal Crsc (ml/kPa) 6.4 (2.3–22.2) 5.7 (2.3–16.7) 0.50
Neonatal Rrsd (kPa/L·s) 16.0 (8.8–31.0) 16.8 (9.3–31.0) 0.50
Familial history of asthma 18 (27%) 10 (22%) 0.67
Familial history of atopy 30 (46%) 17 (41%) 0.74
Coughing/wheezing in 2nd year 47 (70%) 31 (71%) 0.83
Inhalation therapy (any) in 2nd year 32 (48%) 21 (48%) 0.81
Inhalation corticosteroids in 2nd year 12 (17%) 7 (16%) 0.82
Number of colds until 2nd year 13 (0–62) 16 (0–62) 0.53
Daily smoking by household members 7 (11%) 7 (17%) 0.64
Presence of pets (1 year) 27 (44%) 17 (42%) 0.83
PC of methacholinee – 2.8 (0–7) –
SpO2 before start of provocation test (%) – 99 (95–100) –
Lowest SpO2 during provocation test (%) – 91 (81–98) –
a The maximal gradation of respiratory distress syndrome according to Giedion et al.86
b Chronic lung disease defined as supplemental oxygen requirement at 36 weeks postconceptional age.
c Mean respiratory system compliance of the first 3 days of life using the single breath occlusion technique.150
d Mean respiratory system resistance of the first 3 days of life using the single breath occlusion technique.150
e Provocative concentration of methacholine inducing audible wheeze or a fall of oxygen saturation below 90%
expressed as number of doubling concentrations.
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inspiratory pressure, duration of mechanical ventilation, number of days with FiO2 of
>0.4, postnatal corticosteroid therapy, and CLD development. Neonatal Rrs was
inversely related to PC, but not significantly. Correction for endotracheal tube size by
adding this variable in the regression model did not change this (β per kPa/L·s, -0.021;
95% confidence interval (CI), -0.051 to 0.009; p=0.170).
Since decreased neonatal Crs was significantly associated with decreased PC at the
Table 2. Results of univariate regression analyses studying associations between neonatal factors
and bronchial responsiveness at 2 years of age (dependent variable)
Independent variable β per unit of independent 95% confidence interval p-value
Gestational age (weeks) 0.038 -0.020 – 0.096 0.193
Birth weight (grams) 0.0002 0.000 – 0.001 0.147
Maximal RDS gradationa -0.141 -0.259 – -0.024 0.020
Maximal PIPb (cmH2O) 0.025 -0.009 – 0.059 0.144
Mechanical ventilation (days) -0.005 -0.013 – 0.003 0.247
Days with FiO2 >0.40 0.008 -0.015 – 0.032 0.466
Postnatal corticosteroid therapy -0.020 -0.327 – 0.287 0.895
CLDc -0.240 -0.958 – 0.479 0.505
Neonatal Crsd (ml/kPa) 0.061 0.019 – 0.103 0.006
Neonatal Rrse (kPa/L·s) -0.021 -0.048 – 0.005 0.111
a The maximal gradation of respiratory distress syndrome according to Giedion et al.86
b The maximal peak inspiratory pressure required during ventilation.
c Chronic lung disease defined as supplemental oxygen requirement at 36 weeks postconceptional age.
d Mean respiratory system compliance of the first 3 days of life using the single breath occlusion technique.150
e Mean respiratory system resistance of the first 3 days of life using the single breath occlusion technique.150
Mean Crs of the first three days of life (ml/kPa)
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Figure 1. The association
between neonatal Crs and the
provocative concentration
(PC) of methacholine at the
age of two after correction for
RDS gradation, maximal PIP
during mechanical ventilation
and postnatal corticosteroid
therapy (β per ml/kPa, 0.083;
95% confidence interval, 0.026
to 0.140; p=0.006). R2 = 0.18.
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age of two, we further analyzed this association. RDS gradation substantially affected
this association (β per ml/kPa, 0.047; 95% CI, -0.009 to 0.103; p=0.098). After
including maximal PIP into the model, neonatal Crs became more strongly related to
bronchial responsiveness (β per ml/kPa, 0.077; 95% CI, 0.036 to 0.118; p=0.000). A
similar effect was seen after including postnatal corticosteroid administration (β per
ml/kPa, 0.076; 95% CI, 0.030 to 0.122; p=0.002). Figure 1 represents the most
accurate form of the association between neonatal Crs and PC, i.e. after correction for
RDS gradation, maximal PIP and postnatal steroid therapy (partial plot). Due to this
correction, Crs values in Figure 1 do not represent the initial measured values and may
even be negative.
Presence of respiratory symptoms of wheezing and coughing during the second
year of life was significantly related to decreased PC at the age of 2 (odds ratio (OR),
0.05; 95% CI, 0.01 to 0.34; p=0.003). The association between the use of inhaled
bronchodilators and/or steroids during the second year of life and decreased PC was
borderline significant (OR, 0.27; 95% CI, 0.07 to 1.03; p=0.054) (Figure 2). 
In the initial study population of 70 infants, 55 assessments of Crs were obtained
at day 1, 48 at day 2, and 45 at day 3. Since in a few of these occasions non-linear
expiratory flow patterns precluded reliable Rrs assessment, 53 Rrs assessments were
obtained at day 1, 45 at day 2 and 44 at day 3. The median number of occluded
breaths (range), on which results of each single measurement were based on, was 6 (3–
12). In nine measurements the amount of five occluded breaths was not reached and
results were based on four reliable occluded breaths in five measurements and three
reliable occluded breaths in four measurements. Of all neonatal respiratory function
measurements, the median CV (range) within subjects within measurements of Crs was
7.7 (1.5–38.7) and of Rrs was 6.4 (1.8–51.3). CV values within subjects between
Figure 2. Mean provoc-ative
concentration (PC) of
methacholine causing an
audible wheeze or a fall of
oxygen saturation below 90
per cent for infants with
and without periods of
respiratory symptoms and
for infants who did and did
not use inhalation
medication during the
second year of life. Error
bars indicate the 95%
confidence interval.
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measurements of the first 3 days of life were calculated in 68 per cent of the Crs
measurements and in 64 per cent of the Rrs measurements where respiratory function
measures were based on more than one measurement. The median CV (range)
between Crs measurements was 24.9 (0.8 to 60.0) and between Rrs measurements 15.6
(4.2 to 62.1).
7.5. Discussion
Decreased neonatal Crs was significantly related to increased bronchial
responsiveness at 2 years of age in preterm ventilated infants. Additional correction
was required since RDS gradation, maximal PIP required during mechanical
ventilation and postnatal corticosteroid therapy substantially affected this relationship.
Bronchial challenge tests revealed clinically relevant results at the age of two, since
bronchial responsiveness was increased in children with respiratory morbidity during
the second year of life. 
To our best knowledge, this is the first longitudinal study of preterm ventilated
infants showing significant associations between neonatal respiratory function and
bronchial responsiveness at the age of two. Without assessing neonatal respiratory
function, other studies showed that childhood bronchial responsiveness was increased
in preterm infants with and without CLD.78,94,174,181,195,223 In our study, only four per
cent of the infants developed CLD. Hence, prematurity per se may be related to
Figure 3. Provocative concen-trations of
methacholine (PC) found in various
studies using a similar protocol for
bronchial challenge testing. Values are
presented in a boxplot, in which each
box represents 50 per cent of the cases
(from 25th to 75th centile) and medians
are marked by a horizontal line. The
whiskers represent highest and lowest
values within a range of 1.5 interquartile
distance from the boxes. Values outside
these ranges are marked as outliers.
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subsequent BHR development, which has been suggested before.195 Although
impaired parenchymal development of the lung has been associated with CLD
nowadays,57 it is predominantly caused by interruption of lung development at
preterm birth and probably reflects mainly the degree of prematurity.115
Pulmonary immaturity after preterm birth is characterized by surfactant
deficiency causing RDS with alveolar deposition of hyaline membranes and interstitial
oedema.66 With increasing RDS severity Crs decreases.53,112 Decreased neonatal Crs
might therefore point to a higher degree of pulmonary immaturity with an increased
risk to develop BHR in subsequent years. During the infantile period, bronchial
responsiveness decreases with age.178 Contractile forces of the airway smooth muscle,
geometry of the airways, and impedance against which the airway smooth muscle
must contract (cartilage and elastic recoil of the lung) change with age and affect
airway reactivity.178 Additionally, forces of interdependence between pulmonary
airways and parenchyma increase with age, limiting airway narrowing,239 and the
number of cholinergic muscarinic receptors and their affinity for muscarinic agonists
decrease with age while airway acetylcholinesterase activity increases.175 Hence,
increased bronchial responsiveness after preterm birth may indicate that normal
maturational changes in respiratory mechanics were, at least partly, absent.178
However, there is still some debate about whether bronchial responsiveness really
decreases with age.280 Bronchial responsiveness may also be increased in infants with
small airways, because narrowing of the airway lumen will be greater for the same
degree of airway smooth muscle shortening. Although we found that increased
neonatal Rrs was associated with BHR, this was not statistically significant. Neonatal
Rrs was undoubtedly affected by endotracheal tube resistance. However, correction for
tube size did not improve the association. 
After correction for radiological RDS gradation, neonatal Crs became less strongly
associated with bronchial responsiveness. This suggests that radiological RDS
gradation and Crs contain independent, complementary information related to BHR
development. Mechanical ventilation might cause irreversible damage to the airway
mucosa in the neonatal period increasing the risk of BHR development.174
Independently of pulmonary disease, however, the level of end-inspiratory pressures
within the pressure-volume curve during mechanical ventilation reflects the degree of
lung recruitment and overdistention, and immediately affects Crs.132 This may explain
why the association between Crs and bronchial responsiveness was strengthened after
correction for PIP. Infants with decreased neonatal Crs are at increased risk of
receiving postnatal corticosteroid therapy as a consequence of increased pulmonary
disease severity. In our study, neonatal Crs became more strongly associated with
bronchial responsiveness after correction for postnatal corticosteroid therapy.
Postnatal corticosteroid therapy may inhibit subsequent development of BHR by
reducing initial lung damage. Dik et al.49 demonstrated that dexamethasone causes a
downregulation of inflammation in preterm infants at risk of CLD development.
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However, they also found that fibroblast proliferation was not reduced after
dexamethasone administration and probably will remain increased in most of these
infants. By counteracting bronchusconstriction, fibrosis could be an additional
explanation for reduced BHR development.
In international literature, there is a substantial deficit of studies investigating
bronchial responsiveness in healthy children. According to the results in 20 healthy
young children studied by Guirau et al.,98 bronchial responsiveness was increased (i.e.
PC <5 mg/ml methacholine) in 44 of 45 (98%) children in our study (Figure 3). Avital
et al.9 studied 75 children at a mean age of 4.6 years (1 to 8 years) with clinical
bronchial asthma, recurrent pneumonia, or chronic cough. Most of their children were
older and SpO2 was not a criterion for challenge test termination. Both factors might
explain their higher PC values. PC values in our study were also significantly lower
compared to the results of Yong et al.274, who performed 72 bronchial provocation
tests in 39 recurrently wheezing children at the same age using a similar protocol.
Compared to the results of these studies bronchial responsiveness was substantially
increased in our study population. 
Assessment of passive respiratory mechanics according to Le Souef et al.150 is
simple and can be easily performed in intubated preterm infants with minimal
disturbance to the patient. We are well aware of the limitations of this technique,
especially in intubated preterm infants.230 By using strict criteria recommended by the
ERS, neonatal respiratory function results were reliable. CV values of Rrs and Crs
within subjects within measurements were acceptable, indicated by low median CV
values. CV values of Crs and Rrs within subjects between the daily measurements
during the first 3 days of life were larger, especially for Crs assessments, indicating that
Crs may change considerably during the first days of life in ventilated preterm infants. 
Avital et al.9 showed that clinical grading of asthma was significantly related to
degree of bronchial responsiveness. According to Guirau et al.98 bronchial responsive-
ness was significantly increased in wheezing babies under 2 years of age compared to
healthy controls. This was supported by our findings. There may be, however, some
concern about the safety and applicability of the method we used to assess bronchial
responsiveness in young children.282 Our results were similar to the results described
by Springer et al.,226 who found that termination of the bronchial provocation test was
accompanied by at least the presence of audible wheeze in 81 per cent of young
children with asthma (mean age 4.3 years), compared to 77 per cent in our study, and
no severe desaturations were noted. In other studies was shown that occurrence of
lung sounds agreed well with a 20 per cent fall in forced expiratory volume in one
second during bronchial challenge tests in older children.9,224 Also, interobserver
variability was highly acceptable with complete agreement between three observers in
80 per cent of cases.9 As was concluded by Springer et al.,282 we think that the method
that we used to assess bronchial responsiveness is safe, effective, easily applicable and
clinically significant. However, further standardization and validation of bronchial
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challenge tests is required in both healthy and non-healthy children at different ages,
but especially in young children.
One important limitation of this study is the low statistical power, because of the
relatively small study population. However, infants studied during follow-up
measurements at 2 years of age were representative of the initial group of recruited
infants. Our results give, therefore, a first impression of determinants of bronchial
responsiveness during lung maturation in preterm infants, but need further
confirmation by larger studies.
In summary, in preterm ventilated infants, decreased neonatal Crs was related to
BHR at the age of two. BHR might reflect the absence of normal maturational
changes during lung development as a consequence of early interruption of lung
development at an immature stage at preterm birth. 
CHAPTER 8
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8.1. Abstract
Due to recent developments in perinatal care, the incidence of severe acute
respiratory disease in preterm infants has decreased during the past 10 to 20 years.
This may have important consequences for the respiratory course during the early
years after birth. We explored tracking of respiratory function during the first week
and first 2 years after birth in ventilated preterm infants.
Preterm infants of less than 37 weeks gestation with the requirement of
mechanical ventilation within the first 24 hours after birth were recruited. Serial
respiratory function tests were performed at days 1, 2, 3 and 7, and at 1 year and 2
years of age. Respiratory system resistance and compliance were assessed during the
neonatal period and at 1 year of age by applying the Single Breath Occlusion
Technique. At 2 years of age, bronchial responsiveness was assessed by performing
methacholine challenge tests.
In 80 infants, tests were performed during the neonatal period. Fifty-seven
infants were tested at 1 year of age and 45 infants at 2 years of age. During the first
week of life, a general deterioration of both Rrs and Crs was noticed during the first 3
days of life followed by a gradual improvement towards the end of the first week.
During the first year of life, deterioration of both measures improved and
interindividual differences decreased considerably. Tracking of Rrs during this period
was more obvious than tracking of Crs. Finally, bronchial responsiveness at 2 years of
age was most consistently associated with Crs course during the first year of life.
Courses of neonatal Rrs and Crs during the first week of life reflected
characteristic pulmonary pathology in ventilated preterm infants During the first year
of life, Rrs showed better tracking than Crs, although it was only partially present.
Interindividual differences tended to decline for both measures and an overall
improvement was seen. 
8.2. Introduction
In the past, neonatal and childhood respiratory function have been studied
extensively in relation to preterm birth78,94,179,193,243, CLD development15,19,70,85,89,91,137,
160,193,219,256, and neonatal therapeutic interventions.94,151,196,275 Only one of these studies
consequently performed serial respiratory function measurements in 24 infants, who
developed CLD, during the first 2 years of life commencing in the neonatal period.15
It would therefore be interesting to summarize the results of chapters 6 and 7 of this
thesis and show the complete course of respiratory function from the neonatal period
until 2 years of age. Therefore, respiratory function results of ventilated preterm
infants are presented that were performed at days 1, 2, 3 and 7, and at 1 year and 2
years of age. Rrs and Crs were assessed during the neonatal period and at 1 year of age
Course of respiratory function in early life
___________________________________________________________________
118
by using the Single Breath Occlusion Technique described by Le Souef et al.150 At 2
years of age, bronchial responsiveness was assessed by applying methacholine
provocation tests described by Cockroft et al.34 We investigated whether respiratory
function course corresponded with expected pulmonary pathology during the first
week of life in preterm ventilated infants. Additionally, tracking of respiratory function
during the first 2 years of life was explored.
8.3. Methods
For the description of the subjects and respiratory function measurements, the
reader is referred to Chapters 6 and 7 of this thesis. 
8.3.1. Data analysis
Courses of Rrs and Crs during the first week of life were presented for the whole
study population as mean z-scores and their standard deviations (SD) of Rrs and Crs at
days 1, 2, 3 and 7. Z-score calculations were based on reference values of healthy,
non-intubated preterm infants described by Gappa et al.81 As a conse-quence of
missing values due mainly to extubation before measurements were performed, the
number of infants declined during this period. Results of Rrs were presented with and
without correction for tube resistance, which was estimated in vitro at a flow rate of
50 ml/s. 
Secondly, tracking of Rrs and Crs during the first year of life was presented by
mean z-scores and their 95% confidence intervals (CI) for each tertile of the study
population. Z-score calculations were based on reference values of healthy term
infants under 2 years of age described by Gutkowski et al.99 Tertiles were based on the
median Rrs or Crs value of the first 3 days of life, tertile 1 consisted of the lowest
values and tertile 3 of the highest values measured. Finally, first-year tracking of Rrs
and Crs was studied in relation to bronchial responsiveness at 2 years of age. Means
with 95% CIs were presented for the same tertiles. 
In case results were normally distributed and variances within tertiles were equal
for each tertile (according to Levene’s test of homogeneity of variance), differences
between tertiles were analysed by ANOVA analyses of variance, followed by a
Bonferroni correction for multiple comparisons. If results were not normally
distributed or Levene’s test was significant, Kruskal-Wallis analyses were performed
and, if significant, Mann-Whitney U-tests were executed subsequently to elucidate
which tertiles significantly differed from each other. For comparison of patient
characteristics also Chi-square tests were used when investigating differences of
frequency of occurrence.
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8.4. Results
8.4.1. Subjects
Initially, 88 infants were recruited (Figure 1). Since during the first 3 days the
results of 8 (9%) infants were considered not reliable according to the
recommendations of the European Respiratory Society (ERS), 80 infants were
included for further analyses. 10/80 (13%) infants died during the neonatal period, six
infants died of respiratory insufficiency, three due to neurological problems and one
due to circulatory problems. Parents of 11 infants decided not to return for follow-up
measurements for various personal reasons, in one additional case no reason was
given, and one infant was tested 3 months late and therefore excluded for further
analysis. Parents of 19 infants did not return for the bronchial challenge tests for
various personal reasons or because they did not want to expose their children to this
kind of tests. In two additional cases, no reason was given. Three children did not
complete the challenge tests, and one child was tested 4 months late and therefore
excluded for further analysis. Patient characteristics for all groups of children are
presented in Table 1.
Figure 1. Patient selection and dropouts.
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Table 1. Patient characteristics of different selections of infants based on availability of respi-
ratory function measurements during the neonatal period (n=80), at 1 year of age (n=57), and
at 2 years of age (n=45). Data are presented as medians (range) or as numbers (percentage).
Selection of infants: n=80 n=57 n=45
Gestational age (weeks) 29.0 (24.6–36.3) 29.4 (25.3–36.3) 29.4 (25.3–36.3)
Birth weight (grams) 1220 (590–3020) 1240 (630–3020) 1210 (630–2700)
Sex (male) 44 (55%) 32 (56%) 21 (47%)
Prenatal exposure to tobacco smoke 19 (24%) 14 (25%) 9 (20%)
Prenatal corticosteroids administration
(≥24 h antenatally) 52 (65%) 40 (70%) 31 (69%)
Radiological RDS severitya 3 (0–4) 3 (0–4) 3 (0–4)
Duration of mechanical ventilation 
(days) 9 (1–67) 11 (1–67) 9 (1–67)
Maximum peak inspiratory pressure 
(cm H2O) 22 (14–40) 22 (15–35) 22 (15–35)
Number of days with FiO2 >0.4 1 (0–48) 1 (0–48) 1 (0–37)
Surfactant administration 54 (68%) 37 (65%) 28 (62%)
Hour of life of surfactant instillation 9 (1–52) 10 (1–52) 12 (1–52)
Diagnosis of a patent ductus arteriosus
(PDA)b 30 (38%) 24 (42%) 19 (42%)
Day of PDA diagnosis 2 (1–9) 2 (1–9) 2 (1–9)
Size of endotracheal tube 
(internal diameter)
2.5 mm 43 (54%) 28 (50%) 25 (56%)
3.0 mm 33 (41%) 26 (46%) 19 (42%)
3.5 mm 2 (3%) 2 (4%) 1 (2%)
Switched from 2.5 to 3.0 mm during first
3 days of life 2 (3%) 1 (2%) 0
Rrsneo (kPa/L·s) 15.3 (8.8–30.4) 15.3 (8.8–30.4) 15.4 (8.8–30.4)
Crsneo (ml/kPa) 5.0 (2.3–22.2) 5.2 (2.3–22.2) 5.0 (2.3–17.3)
Mortality 10 (13%) – –
Oxygen dependency at 36 weeks 4 (6%) 4 (7%) 2 (4%)
Postnatal corticosteroid administration 29 (36%) 23 (40%) 17 (38%)
Rrs1year (kPa/L·s) – 4.6 (2.7–8.3) 4.6 (2.7–8.1)
Crs1year  (ml/kPa) – 99.2 (59.6–169.3) 98.7 (59.6–165.0)
Weight at 1 year of age (kg) – 8.8 (6.6–12.0) 8.6 (6.6–11.0)
Height at 1 year of age (cm) – 72 (65–80) 72 (65–79)
Provocative concentration of
methacholine (mg/ml) – – 0.60 (0–9.60)
Provocative concentration of
methacholine 
(number of doubling concentrations) – – 3 (0–7)
Weight at 2 years of age (kg) – – 11.5 (8.9–13.5)
Height at 2 years of age (cm) – – 86 (77–92)
a According to Giedion et al.86
b Confirmed by ultrasound by a paediatric cardiologist.
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8.4.2. Neonatal respiratory function
Results regarding the first week of life are presented as z-scores in Figures 2 and 3
for Rrs and Crs, respectively. Rrs results were presented both with and without
correction for tube size. Of the results with tube correction, a few results were
missing, because of wrong assessment of the length of the endotracheal tube. The
results for the whole group of infants were substantially less deteriorated after tube
correction compared to the results without tube correction. However, interindividual
A.
Without correction for
tube size.
B.
With correction for tube
size.
Figure 2. Rrs course during the first week of life. Results are presented as means of the
z-scores according to the results of Gappa et al. in healthy preterm infants.81 Error
bars indicate 95% confidence intervals of the means.
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differences were relatively similar. During the first week of life, a deterioration of both
Rrs and Crs was seen within the first 3 days of life followed by an improvement
towards day 7. 
Table 2. Patient characteristics of each Rrs tertile without tube correction (mean (95%
confidence interval of mean)/number (percentage))
Tertile 1 Tertile 2 Tertile 3
Gestational age (weeks) 31.0 (29.9–32.2)*** 29.5 (28.5–30.6) 28.5 (27.6–29.4)*
Birth weight (g) 1615 (1390–1840)*** 1340 (1112–1568) 1131 (985–1277)*
Body weight at 1 yr (kg) 9.6 (9.1–10.0)*** 8.7 (8.0–9.4) 8.4 (7.9–8.9)*
Body weight at 2 yrs (kg) 11.8 (11.2–12.3) 11.0 (10.4–11.6) 11.2 (10.6–11.8)
Antenatal corticosteroid
therapy 14 (61%) 16 (67%) 15 (65%)
Maternal smoking 6 (26%) 6 (25%) 4 (17%)
RDS gradation 2.1 (1.5–2.7) 2.7 (2.2–3.2) 2.7 (2.1–3.2)
CLD 3 (13%) 1 (4%) –
PDA 10 (44%) 5 (21%) 12 (52%)
Mechanical ventilation (days) 11.8 (4.2–19.4)*** 12.3 (7.4–17.2) 19.1 (12.3–25.9)*
Supplemental oxygen (days) 15.3 (5.1–25.4) 17.8 (8.9–26.8) 20.5 (14.2–26.8)
Maximal peak inspiratory
pressure (cmH2O)
21.4 (19.9–22.9) 22.7 (20.5–24.8) 23.3 (21.0–25.5)
Surfactant therapy 13 (57%) 14 (58%) 19 (83%)
Postnatal corticosteroid 5 (22%) 9 (38%) 9 (39%)
*p<0.05 compared to tertile 1.
***p<0.05 compared to tertile 3.
Figure 3. Crs course during
the first week of life. Results
are presented as means of
the z-scores according to
the results of Gappa et al. in
healthy preterm infants.81
Error bars indicate 95%
confidence intervals of the
means.
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Table 3. Patient characteristics of each Crs tertile (mean (95% confidence interval of mean)/
number (percentage))
Tertile 1 Tertile 2 Tertile 3
Gestational age (wk) 30.3 (29.0–31.6)*** 29.1 (28.1–30.1)*** 29.7 (28.7–30.7)#
Birth weight (g) 1587 (1351–1822)*** 1192 (1032–1351)*** 1314 (1085–1543)
Body weight at 1 yr (kg) 9.2 (8.6–9.8) 8.6 (8.1–9.1) 8.8 (8.1–9.5)
Body weight at 2 yrs (kg) 11.6 (11.0–12.1) 11.1 (10.4–11.7)*** 11.4 (10.7–12.0)**
Antenatal corticosteroid
therapy 13 (57%)# 15 (63%)* 17 (74%)*
Maternal smoking 6 (26%) 4 (17%) 6 (26%)
RDS 3.3 (3.0–3.6)*** 2.5 (2.1–3.0)*** 1.6 (1.0–2.2) #
CLD 3 (13%) – 1 (4%)
PDA 13 (57%)# 12 (50%)* 2 (9%)*
Mechanical ventilation
(days) 13.2 (8.3–18.2)*** 20.2 (12.2–28.3) 9.4 (4.0–14.9)*
Supplemental oxygen
(days) 21.8 (10.9–32.6) # 20.3 (12.9–27.7)* 11.3 (4.8–17.9)*
Maximal peak inspiratory
pressure (cmH2O) 24.3 (22.1–26.4) 22.8 (21.7–23.8)*** 20.3 (18.0–22.6)**
Surfactant therapy 22 (96%)*** 18 (75%)*** 6 (26%)#
Postnatal corticosteroid 10 (44%)*** 8 (33%)*** 5 (22%)#
*p<0.05 compared to tertile 1; **p<0.05 compared to tertile 2.
***p<0.05 compared to tertile 3; #p<0.05 compared to all other tertiles.
8.4.3. Respiratory function during infancy
The study population was divided in three tertiles according to the median Rrs or
Crs of the first 3 days of life. Patient characteristics of each tertile are presented in
Tables 2 and 3. Main differences between Rrs tertiles concerned factors indicating
degree of prematurity, like gestational age and birth weight. Although these factors
were also different between Crs tertiles, factors indicating respiratory disease severity,
therapeutic interventions and complications showed also significant differences
regarding Crs tertiles.
In Figure 4 is shown that tracking of Rrs was present during the first year of life,
although two of the three tertiles were not distinguishable. Tracking of Crs was not
obvious during this period (Figure 5). The present neonatal deterioration of both Rrs
and Crs decreased during the first year of life, although this was not so obvious for the
first Rrs tertile. Neonatal tertiles were significantly different, but these intertertile
differences declined considerably during the first year of life. The rank order of the
tertiles concerning bronchial responsiveness at 2 years of age, however, was
inconsistent with respect to Rrs tertiles. In relation to Crs, bronchial responsiveness
increased more consequently with decreasing Crs values.
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Figure 4. Rrs course during the first year of life combined with bronchial responsiveness at 2
years of age. Results are presented as means of tertiles of the study population based on median
Rrs values during the first 3 days of life (bars in different gray scales). Error bars indicate 95%
confidence intervals of the means. *Significantly different from other tertiles at the same day
according to the Mann-Whitney U- test.
Figure 5. Crs course during the first year of life combined with bronchial responsiveness at 2
years of age. Results are presented as means of tertiles of the study population based on
median Crs values during the first 3 days of life (bars in different gray scales). Error bars
indicate 95% confidence intervals of the means. *Significantly different from other tertiles at
the same day according to the Mann-Whitney U-test.
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8.5. Discussion
In this study of ventilated preterm infants, course of respiratory function was
studied during the first 2 years of life. During the first week of life, a general
deterioration of both Rrs and Crs was noticed during the first 3 days of life followed by
a gradual improvement towards the end of the first week. During the first year of life,
deterioration of both measures improved and intertertile differences decreased
considerably. Tracking of Rrs during this period was more obvious than tracking of
Crs. Finally, bronchial responsiveness at 2 years of age was most consistently
associated with Crs course during the first year of life.
To our best knowledge, this study is unique with respect to its concept of serial
respiratory function assessments during the first 2 years of life in a group of ventilated
preterm infants in the current surfactant era. Not only preterm infants developing
CLD, but all preterm infants, in whom mechanical ventilation was initiated, were
considered at risk of long-term respiratory morbidity. During the first week of life,
respiratory function course showed a recognizable pattern and, during the early years
after birth, a certain degree of tracking of respiratory function was present.
Courses of both Rrs and Crs during the first week of life can be attributed to the
course of pulmonary disease that is commonly seen in ventilated preterm infants.
Respiratory condition often deteriorates during the first few days of life as a
consequence of alveolar surfactant depletion and development of RDS. After
symptoms and signs of RDS have reached a peak within 3 days,138 the respiratory
condition normally shows a gradual improvement. When complications do not occur,
infants are often extubated within the first week of life. Since, in this study, respiratory
function measurements were only performed in intubated infants, a selection bias is
likely, leading to a potential underestimation of respiratory function at mainly day 7.
Nevertheless, respiratory function showed a general improvement at day 7 compared
to the first 3 days of life. Among those still intubated at day 7 are infants recovering
from RDS, who will be extubated within the next few days, as well as infants
developing CLD, who will remain intubated for a prolonged period. Irrespective of
pulmonary pathology, preterm infants may also remain intubated as a consequence of
immature breathing control mechanisms resulting in severe apnoeas. 
Crs results during the first week of life were decreased compared to previous
findings in extremely preterm infants.136 In extremely preterm infants, RDS is often
less severe58,129 and the chest wall more compliant.84 Interestingly, compared to
findings in infants of 10 and 20 days old with established CLD,15  neonatal Crs results
in our study were similar, but Rrs results were decreased. Hence, progression to
chronic lung disease probably mainly affects Rrs by increased pulmonary oedema,
increased smooth muscle mass, airway plugging with cellular debris, and increased
mucus production.85,188 
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The improvement of both Rrs and Crs in these infants during the first year of life
can be attributed to excessive lung growth and to the continuous process of repair and
remodelling,192 especially in infants with CLD. Extensive alveolarization and thinning
of the alveolo-capillary membrane are the main factors increasing Crs, despite a
considerable decrease of thoracic wall compliance. Since airway branching is normally
complete at approximately the 16th week of gestation,202 Rrs decreases by enlargement
of the existing airways, changes of airway wall characteristics72 and structural changes
in lung parenchyma.199
Although previous findings showed increased Rrs values between 10 to 20 days of
life compared to neonatal values in our study, results at 2 years of age were similar,15
suggesting that long-term consequences of CLD may resemble long-term
consequences in preterm infants without CLD. A potential confounding factor is
postnatal administration of corticosteroids. Besides the effects of lung growth,
intertertile Crs differences at 2 year of age may be decreased by limited development of
lung damage in the lowest Crs tertile due to administration of postnatal corticosteroids.
Several recent studies described a deterioration of airway function during the first year
of life in preterm infants developing CLD117 and those without neonatal respiratory
disease.119 Since in these studies maximal expiratory flow at functional residual
capacity (V’maxFRC) was studied, mainly representing characteristics of small
intrathoracic airways, results were not comparable to the Rrs data of our study, which
mainly represented characteristics of the large central airways72 and lung parenchyma.
199 In our study, all Rrs tertiles showed improvement of the z-scores during the first
year of life, probably mainly because of structural changes of lung parenchyma.199
Bronchial responsiveness increased most consistently with increasing Crs values.
Neonatal Crs predominantly depends on parenchymal lung characteristics. The most
important factors affecting lung parenchyma early after preterm birth are the
development of RDS and degree of surfactant deficiency. The association between
neonatal Crs and RDS severity was confirmed by our finding that several factors
related to RDS severity, like radiological RDS gradation, exogenous surfactant
therapy, and maximal PIP were significantly different between neonatal Crs tertiles.
Hence, BHR development is probably associated with RDS severity and subsequent
therapeutic measures.
Despite an initial recruitment of 88 ventilated preterm infants, only 57 and 45
infants were re-evaluated at 1 year and 2 years of age, respectively, because of neonatal
mortality, unreliability of neonatal respiratory function assessments and refusal of
parents to participate in follow-up measurements. The power of the study was
therefore limited. However, infants studied during follow-up measurements at 1 year
and 2 years of age were representative of the initial group of recruited infants.
Unfortunately, Rrs and Crs measurements were not repeated at 2 years of age, because
sedation with chloral hydrate is increasingly unsuccessful at this age. Nevertheless,
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performing methacholine provocation test while awake added relevant information
regarding the respiratory course in these children.
In conclusion, courses of neonatal Rrs and Crs reflected characteristic pulmonary
pathology in ventilated preterm infants during the first week of life. An initial
deterioration, caused by surfactant depletion and RDS development, is followed by a
gradual improvement as infants recover from RDS. During the first year of life Rrs
showed better tracking than Crs, although it was only partially present. Interindividual
differences tended to decline for both measures and an overall improvement was seen. 
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9.1. Introduction
The principle scope of the prospective cohort study described in this thesis was
to investigate respiratory function during the neonatal period and early years after
birth in ventilated preterm infants. Since the implementation of mechanical ventilation
in the 1950s, survival of preterm infants has increased substantially and, as a
consequence, physicians were confronted with unknown morbidity related to organ
immaturity in a new patient population. Due to subsequent improvements in neonatal
care, respiratory morbidity has changed considerably since then. The results of the
studies described in this thesis will expand our knowledge on currently important
clinical and mechanical determinants of early respiratory course in ventilated preterm
infants.
9.2. Limitations of respiratory function in mechanically ventilated
preterm infants
Possibilities for respiratory function assessments are limited in mechanically
ventilated preterm infants. (Chapter 2) This is due mainly to the impaired physical
condition of ventilated preterm infants and the specific environment at the neonatal
intensive care unit. Because of clinical instability due to immaturity, small events may
cause serious deterioration of the physical condition in these infants and measures to
limit the number of moments of patient disturbance are thus of extreme importance.
Therefore, respiratory function testing for research purposes should preferably be
scheduled immediately after routine nursery care. Furthermore, equipment for
respiratory function tests have to meet strict criteria with respect to dead space and
resistance in order to minimise extra effort in breathing. 
Besides limitations proceeding from the impaired physical condition of ventilated
preterm infants, respiratory functions tests are limited by the specific environmental
conditions. In intubated infants, the endotracheal tube is known to considerably
increase the total resistance measured.152 Since in vitro assessments of endotracheal
tube resistance do not correspond well with in vivo situations,152,164 correction of
respiratory system resistance was not standard practice in the studies of this thesis.
During mechanical ventilation, non-linearity of the pressure-volume relationships due
to alveolar collapse toward end-expiration or overdistention of some lung units
toward end-inspiration may affect actual respiratory function. Expiration into a
ventilator system with maintained positive end-expiratory pressure (PEEP) will also
affect respiratory function results, but loss of PEEP will often have unwanted adverse
clinical implications in these vulnerable infants. Another important issue is the effect
of the physical properties of ventilator gases on flow measurements by pneumo-
tachometers, as was shown with respect to oxygen concentration in Chapter 3.
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Previous studies have demonstrated the effect of relative humidity, temperature, and
pressure of gases on flow measurements21,47,69,74,92,96,97,110,212,248,250,263,269, but also of
ventilator tubing characteristics and geometry.142 Effects are minimized when during
calibration procedures environmental conditions correspond with measurement
conditions or adequate correction is performed afterwards. Mechanical ventilators also
depend on flow measurements by a pneumotachometer. Although in recently
developed neonatal ventilators, algorithms are incorporated that correct for body
temperature and pressure saturated with water vapour (BTPS), no correction is
included for actual oxygen concentration and flow rate. In this thesis, correction
factors for these effects were provided under specified calibration conditions. Other
limitations for respiratory function testing in preterm ventilated infants include the
inability to co-operate, dependence on incubator and ventilator, and the inability of
transporting the patient from the neonatal intensive care unit to the department of
paediatric pulmonology, where specialised equipment is available.
9.3. Importance of respiratory function in neonatal respiratory course 
in ventilated preterm infants
In clinical practice, several measures are used to indicate the actual respiratory
condition in ventilated preterm infants. Chest radiographs are among others, like
bloodgas analysis, pulse oximetry, ventilator conditions, and continuous monitoring of
breathing movements, commonly used for this purpose. Although they can be easily
applied without disturbance of the patient, interobserver agreement is known to be
poor.213 In order to improve this, several scoring systems have been developed, in
which specifically described radiographic aspects have to be scored according to a
rank order of severity. Scores of different aspects can be summarized to calculate total
scores, which have been found to associate with severity of respiratory distress
syndrome (RDS)86,154 and clinical respiratory outcome.95, 242, 277 Despite these attempts
to improve interobserver agreement, results in Chapter 4 indicate a poor
interobserver agreement of the radiological scoring systems when applied during the
first week of life in ventilated preterm infants. Although some of the scoring systems
were not meant to be applied this early, this did not seem to be the most important
cause, since other scoring systems, which were actually meant to be used this early,
also showed poor agreement between observers. Furthermore, no associations were
found between radiological scores and actual respiratory function. Poor interobserver
agreement is a plausible cause, but the difference of pulmonary pathological aspects
being accentuated by respiratory function and chest radiography may also play an
important role.
Besides indicating the actual respiratory condition, early prediction of individual
neonatal respiratory course is important for adequate neonatal care. In infants at
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increased risk of respiratory problems during the admission period at the NICU,
increasing the priority share of measures to prevent development of pulmonary
damage early after birth may improve respiratory outcome. In Chapter 5, reliable
prediction models were presented for postnatal corticosteroid administration and
prolonged mechanical ventilation, two important aspects of neonatal respiratory
outcome in ventilated preterm infants. Previous studies mainly described prediction
models for CLD development91 at 28 days19,62,89,160,210,215,256,270 or 36 weeks87,95,160,214
and only a few were able to be applied within 2 days after birth.70,137,154 However, since
the latter studies were performed before the surfactant era, results were not
attributable to current practice. Furthermore, instead of predicting CLD development,
prediction of different aspects of neonatal respiratory course may create new
possibilities as to specific preventive measures in clinical practice as well as future
research, for example, early selection of infants at high risk of postnatal corticosteroid
therapy in order to study the effects of early administration of postnatal corticosteroid
therapy.
9.4. Importance of respiratory function in the early years after preterm
birth
Since severity of acute neonatal respiratory disease is decreasing and survival of
extremely preterm infants is increasing, long-term consequences regarding respiratory
function probably have changed considerably in ventilated preterm infants during past
decades. The severe respiratory condition, as was described by Northway and
colleagues in 1967,188 is not frequently seen nowadays. Interruption of pulmonary
development by preterm birth seems to be the main feature of neonatal respiratory
disease nowadays, leading to abnormal postnatal lung growth and development and,
eventually, hypoalveolarisation and decreased vascularisation.57 Although most
children may not notice this during normal daily activities, a substantial number of
infants will during exercise. According to respiratory function tests performed for the
studies in this thesis, the majority of infants showed increased resistance, and
decreased compliance of the respiratory system (Chapter 6). According to respiratory
function tests performed at the age of two, the majority of infants showed increased
bronchial reactivity (Chapter 7), indicating that various aspecific stimuli may cause
increased airway resistance, elevating the work of breathing.
Studying associations between early clinical and mechanical patient characteristics
and respiratory outcome during subsequent years may reveal important determinants
for respiratory course during infancy. Results in Chapter 6 indicated that inborn
properties of the respiratory system are important determinants of the need for
inhalation therapy with bronchodilators or corticosteroids during the first year of life
and respiratory function at one year of age, i.e. respiratory system resistance and
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compliance. Other factors, like degree of prematurity, expressed as gestational age or
birth weight, severity of neonatal respiratory disease and neonatal treatment, like
ventilator conditions and duration of ventilator therapy, were of minor importance.
Only the number of days requiring supplemental oxygen was additionally associated
with respiratory system compliance at one year of age. These findings resemble results
from previous studies in healthy term infants,48,166,167,232,274 revealing that premorbid
airway function was associated with the occurrence of wheezing and respiratory
function in subsequent years. The fact that also in preterm ventilated infants, long-
term respiratory sequelae seem to be mainly determined by inborn properties of the
respiratory system and less by factors associated with prematurity, suggests that long-
term respiratory course is mainly affected by intra-uterine pulmonary development.
However, in Chapter 7 severity of neonatal lung damage, indicated by respiratory
system compliance, RDS severity and inspiratory pressures, seems to be the main
factor related to the development of bronchial hyperreactivity. These results are in line
with previous findings regarding associations between prematurity79,94,195 or CLD
174,181,195,223 and subsequent development of bronchial hyperresponsiveness in
childhood. When summarizing the main findings of Chapter 6 and Chapter 7, it
appears that early neonatal determinants of long-term respiratory course may vary
according to the outcome measure studied. Evidently, respiratory symptoms of
coughing and wheezing during infancy predominantly depend on airway diameter,
which is not the main part of the lungs being irreversibly damaged after prematurity.
On the other hand, development of bronchial hyperreactivity during infancy seems to
be mainly related to degree of neonatal parenchymal damage to the lungs, which can
be irreversibly damaged by various events during the neonatal period.
These results suggest a certain degree of tracking of respiratory function
throughout the first years of life in ventilated preterm infants, which was partially
confirmed by the results in Chapter 8. Both respiratory system resistance and
compliance improved considerably during the first year of life after preterm birth.
Airway enlargement and extensive alveolarisation probably account for this. Although
interindividual differences in respiratory function declined during the first year of life,
tracking was partly present for mainly resistance of the respiratory system during the
first year of life. Additionally, bronchial responsiveness at two years of age was
consistently associated with compliance during the first year of life, but inconsistently
with respiratory system resistance, supporting the findings reported in Chapter 7.
9.5. Main conclusions
The studies in this thesis show that in the current surfactant era, the majority of
ventilated preterm infants are still suffering from respiratory morbidity and substantial
respiratory function abnormalities throughout the early years of life. Since respiratory
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function testing during mechanical ventilation does have important limitations, certain
preparatives have to be made before reliable results can be obtained and patients are
not getting extra disturbed. Inborn resistive properties of the respiratory system are
important in relation to early neonatal respiratory course as well as subsequent
respiratory morbidity and respiratory function during the first year of life. With regard
to the first-year respiratory course, inborn resistive properties are more important
determinants than degree of prematurity and neonatal lung damage. However, in
relation to the development of bronchial hyperresponsiveness during infancy, degree
of neonatal parenchymal damage to the lung is most important. Tracking of
respiratory function is partially present for the resistive properties of the respiratory
system during the early years after birth in preterm ventilated infants.
9.6. Future perspectives
Despite the fact that the respiratory function technique used during mechanical
ventilation in the studies of this thesis have been executed in research settings since
the mid-1980s and recommendations of the European Respiratory Society are
available to ensure a acceptable level of uniformity and reliability, methodological
differences between studies may still be substantial. Further standardization of the
technique is required and should focus on both practical application and correction
for effects of changes in gas viscosity and other influencing factors, like endotracheal
tube resistance.
The neonatal respiratory condition in ventilated preterm infants has changed
considerably since the 1950s, when mechanical ventilation of these infants was first
applied. It is likely that together with this evolvement, early neonatal determinants of
respiratory course have changed in these infants. Since the results in this thesis
indicate that early respiratory function measurements provide useful information with
respect to both the actual respiratory condition and neonatal respiratory course,
further studies are needed to evaluate whether implementation of early respiratory
function measurements in clinical practice will have consequences for neonatal care
and respiratory outcome. Recent evidence regarding adverse long-term effects of
postnatal dexamethason therapy, increases the need to search for alternative therapies
with, for example, less potent steroids with less unwanted long-term side effects. Early
selection of high-risk infants using our prediction model of postnatal corticosteroid
therapy, helps to limit unnecessary exposure of these vulnerable infants to new
treatment strategies. Early selection of infants at high risk of prolonged mechanical
ventilation may create possibilities for early implementation of preventive measures.
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Instead of measures indicating degree of prematurity, inborn resistive properties
of the respiratory system are the most important determinants of respiratory course
during the first year of life. To decrease the risk of persistent respiratory morbidity
and functional abnormalities, it is essential to reveal the determinants of early lung
function. This can be achieved by a large prospective multicentre trial evaluating all
pregnant women in a certain geographic area with regard to: 
- familial predisposition 
- way of conception (artificial, spontaneous) 
- maternal smoking 
- invasive procedures 
- antenatal infections 
- nutritional state
- antenatal corticosteroid therapy
- information by ultrasound about foetal growth and amniotic fluid
- inflammatory cytokines, nicotine, and IgE-level in maternal and foetal blood 
By investigating associations between these data and early postnatal respiratory
function and subsequent respiratory course, determinants of postnatal respiratory
course can be revealed in both term and preterm infants. The results of such a trial
may also increase the possibilities for prevention of persistent respiratory morbidity
and functional abnormalities.  
The degree of neonatal lung damage being important in the development of
bronchial hyperresponsiveness during infancy in ventilated preterm infants
emphasizes the need to further improve neonatal care. Hence, prospective clinical
intervention trials investigating new strategies to decrease lung damage have to be
conducted. For example, early postnatal administration of corticosteroids, using other,
less potent, agents compared to dexamethasone at lower doses, may reduce the
development of neonatal lung damage and subsequent bronchial hyperresponsiveness
and may have less severe long-term consequences.
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9.1. Inleiding
In de studies, die beschreven worden in dit proefschrift, worden de mechanische
eigenschappen van het ademhalingssysteem onderzocht tijdens de periode vlak na de
geboorte en de eerste levensjaren bij te vroeg geboren kinderen (= prematuren), die
kunstmatige beademing nodig hadden vanaf de eerste dag na de geboorte. De
overleving van deze kinderen is sterk verbeterd sinds vanaf de 50-er jaren kunstmatige
beademing voor het eerst ook bij te vroeg geboren kinderen werd toegepast. Als
gevolg hiervan werden artsen geconfronteerd met nieuwe ziektebeelden, die
gerelateerd waren aan de onrijpheid van organen bij deze nieuwe patiëntenpopulatie.
Problemen met en ziektebeelden van het ademhalingssysteem zijn veranderd door
verbeteringen in de zorg voor pasgeborenen, zoals moderne beademingsapparatuur,
die fijner afgesteld kan worden dan voorheen, en medicatie als corticosteroiden voor
de geboorte aan moeder om de longrijping bij het kind te bevorderen en surfactant na
de geboorte aan het kind om het openen van de longen te bevorderen. De resultaten
van de studies in dit proefschrift geven ons een actueel beeld van klinische en
mechanische factoren, die van belang zijn voor het beloop gedurende de eerste jaren
na de geboorte bij beademde, prematuur geboren kinderen.
9.2. Beperkingen van longfunctiemetingen bij beademde prematuren
Bij beademde prematuren zijn de mogelijkheden voor longfunctiemetingen
beperkt (Hoofdstuk 2). Dit komt met name door de verminderde lichamelijke
conditie van deze kinderen en de specifieke omgeving op de intensive care afdeling
voor pasgeborenen. Door de instabiele klinische toestand als gevolg van de onrijpheid
van verschillende orgaansystemen bij deze kinderen, kunnen kleine gebeurtenissen of
veranderingen reeds een serieuze verslechtering van hun lichamelijke conditie
veroorzaken. Het is daarom van groot belang om het aantal momenten waarop deze
patiënten gestoord worden zoveel mogelijk te beperken. Dat is de reden waarom
longfunctiemetingen voor onderzoeksdoeleinden bij voorkeur meteen na een routine
verzorgingsbeurt ingepland worden. Tijdens zo’n verzorgingsbeurt wordt ook de
beademingsbuis uitgezogen om eventuele slijmophoping in de buis te verwijderen.
Verder is het van belang dat tijdens de meting het kind geen extra inspanning hoeft te
leveren om te ademen. Daarom moet de apparatuur die gebruikt wordt voor de
longfunctiemetingen aan strenge eisen voldoen, waarbij de extra dode ruimte en
weerstand minimaal zijn.
Naast de beperkingen die voortkomen uit een verminderde lichamelijke conditie
bij beademde prematuren, worden longfunctiemetingen beperkt door specifieke
omgevingsfactoren op de intensive care voor pasgeborenen. Vaak vergroten deze
factoren het aandeel van ruissignalen, die opgevangen worden tijdens de metingen, of
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zorgen ze er op een andere manier voor dat het gewenste signaal minder duidelijk
wordt. Zo is algemeen bekend dat bij beademde kinderen de gemeten weerstand
aanzienlijk verhoogd wordt door de aanwezigheid van de beademingsbuis in de
luchtpijp.152 Correctie hiervoor is mogelijk door de weerstand van de beademingsbuis
af te trekken van de gemeten weerstand. Hiervoor moet de weerstand van de
beademingsbuis bepaald worden zonder dat deze ingebracht is in het kind (= in vitro).
In eerdere studies is echter gebleken dat deze weerstand niet goed overeenkomt met
de werkelijke weerstand van de beademingsbuis op het moment dat deze in de
luchtpijp zit (= in vivo).152,164 Dat betekent dat correcties met in vitro bepaalde
waarden niet bruikbaar zijn voor in vivo situaties. Daarom is de gemeten weerstand in
de studies in dit proefschrift niet gecorrigeerd voor de weerstand van de
beademingsbuis. De actuele longfunctie tijdens beademing wordt ook beïnvloed door
de alineaire druk-volume relatie als gevolg van het dichtvallen van de longblaasjes aan
het einde van de uitademing (= expiratie) en het overmatig uitzetten van een aantal
longgedeelten aan het einde van de inademing (= inspiratie). Het feit dat de kinderen
tijdens de longfunctiemetingen uitademen in een beademingscircuit, waarin een
positieve eind-expiratoire druk (PEEP) gehandhaafd wordt, heeft ook een effect op de
resultaten van de longfunctiemetingen. Echter, het opheffen van deze positieve druk
heeft weer negatieve klinische gevolgen voor deze kwetsbare kinderen. Een ander
belangrijk aspect is het effect van de physische samenstelling van de
beademingsgassen op de metingen van luchtstroomsnelheid (flow) door flow-meters
(pneumotachometers). Deze problematiek wordt belicht in Hoofdstuk 3. Eerdere
studies hebben de effecten van relatieve luchtvochtigheid, temperatuur, en druk van
de gebruikte gassen aangetoond op dergelijke flow-metingen.21,47,69,74,92,96,97,110,212,248,250,
263,269 Ook kenmerken van de rubberen slangen, die verbonden zijn aan
beademingsapparatuur, en de manier waarop zij aangesloten zijn hebben een effect op
flow-metingen.142 De invloed van al deze effecten op de metingen zijn minimaal
wanneer de omstandigheden tijdens de kalibratie-procedure, wanneer de apparatuur
geijkt wordt, identiek zijn aan de omstandigheden tijdens de meting zelf of wanneer
achteraf een juiste correctie wordt toegepast. De beademingsapparatuur zelf is ook
afhankelijk van flow-metingen door een pneumotachometer. Hoewel in recent
ontwikkelde beademingsmachines flow-registraties gecorrigeerd worden voor
lichaamstemperatuur en druk bij volledige verzadiging met water (BTPS), vindt tot op
heden nog geen correctie plaats voor het gebruikte zuurstofpercentage en de
luchtstroomsnelheid tijdens beademing. In dit proefschrift worden correctiefactoren
gegeven om te corrigeren voor deze effecten, waarbij specifieke omstandigheden
gelden tijdens de kalibratie-procedure. Een andere beperkende factor voor
longfunctiemetingen bij beademde prematuren is de afhankelijkheid van couveuse en
beademingsapparatuur. Verder zijn deze kinderen niet in staat om actief mee te
werken tijdens de meting of vervoerd te worden van de intensive care voor
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pasgeborenen naar de afdeling kinderlongziekten, waar gespecialiseerde apparatuur
voor de metingen beschikbaar is. 
9.3. Het belang van longfunctiemetingen tijdens de eerste maanden na
de geboorte bij beademde prematuren
Om een idee te krijgen van de conditie van het ademhalingssysteem bij beademde
prematuren wordt gebruik gemaakt van een aantal hulpmiddelen, zoals een
röntgenfoto van de longen, bloedgasanalyse voor de partiële koolzuurspanning en
zuurstofspanning in het bloed, pulse oximetrie voor een indirecte meting van de
zuurstofsaturatie in het bloed, de beademingsvoorwaarden op dat moment en een
continue registratie van de adembewegingen van het kind. Hulpmiddelen waarvan de
interpretatie redelijk objectief is, zoals bloedgasanalyse, zijn vaak ingrijpend voor het
kind. Hiervoor is namelijk bloedafname noodzakelijk. Röntgenfoto’s kunnen
eenvoudig gemaakt kunnen worden zonder dat de patiënt hier veel van merkt, maar de
interpretatie ervan is subjectief, waardoor er aanzienlijke verschillen kunnen bestaan
tussen verschillende beoordelaars.213 In een poging dit te verbeteren zijn er in het
verleden verschillende scoringssystemen ontwikkeld, waarbij nauwkeurig omschreven
aspecten van dergelijke röntgenfoto’s worden gescoord volgens een bepaalde rangorde
in ernst. Ondanks deze pogingen om de verschillen in beoordeling van röntgenfoto’s
te verkleinen, tonen de resultaten in Hoofdstuk 4 aan dat de scores van verschillende
beoordelaars niet goed met elkaar overeenkomen. Daarnaast werd geen relatie
gevonden tussen de röntgenscores en de longfunctie op dat moment. Dit kan
verklaard worden door de verschillen in de beoordelingen, maar ook door het feit dat
tijdens het meten van de longfunctie hele andere aspecten van de zieke long
onderzocht worden dan tijdens röntgenonderzoek.
Naast het bepalen van de actuele conditie van het ademhalingssysteem, is het
voorspellen van het individuele respiratoire beloop tijdens de eerste maanden na de
geboorte van belang voor een optimale zorg bij beademde prematuren. Een hogere
prioriteit voor preventieve maatregelen tijdens de behandeling van pasgeborenen met
een verhoogd risico op problemen met het ademhalingssysteem zal waarschijnlijk het
beloop bij deze kinderen verbeteren. In Hoofdstuk 5 worden betrouwbare modellen
gepresenteerd om te kunnen voorspellen welke kinderen uiteindelijk corticosteroiden
als medicatie nodig hebben en welke kinderen langdurige beademd zullen worden. Dit
zijn twee belangrijke aspecten van het respiratoire beloop bij beademde prematuren.
In eerdere studies zijn met name voorspellingsmodellen voor de ontwikkeling van
chronische longziekte91 bij deze kinderen beschreven met als criterium extra
zuurstofbehoefte na 28 dagen na de geboorte19,62,89,160,210,215,256,270 of bij 36
weken87,95,160,214 na de conceptie. Slechts enkele hiervan konden toegepast worden
binnen 48 uur na de geboorte,70,137,154 zoals bij onze studie. En aangezien deze laatste
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studies gedaan waren in de periode voordat er twee belangrijke ontwikkelingen
plaatsvonden in de behandeling van beademde prematuren (namelijk: corticosteroiden
voor de geboorte toedienen aan moeder om de longrijping bij het kind te bevorderen
en surfactant na de geboorte toedienen aan het kind om het openen van de longen te
bevorderen), zijn deze resultaten in het huidige tijdperk niet meer bruikbaar voor de
klinische praktijk. Verder creëert het voorspellen van verschillende onderdelen van het
respiratoire beloop bij deze kinderen, zoals corticosteroiden-toediening en langdurige
beademing, in plaats van een algemene voorspelling van chronische longziekte nieuwe
mogelijkheden. Preventieve maatregelen in de klinische praktijk kunnen op deze
manier gerichter ingesteld worden. Maar ook voor verder onderzoek in de toekomst
biedt dit voordelen, zoals bijvoorbeeld voor een vroege selectie van kinderen met een
verhoogd risico op corticosteroiden-toediening om de effecten van toediening van
deze medicatie in een veel vroegere fase te onderzoeken.
9.4. Het belang van longfunctiemetingen in de eerste jaren na
vroeggeboorte
Gedurende de afgelopen decennia worden een aantal ontwikkelingen gezien op
het gebied van longziekten bij beademde prematuren. De ernst van acute longziekte
na de geboorte (RDS) is in deze periode afgenomen en de overleving van steeds
vroeger geboren kinderen neemt toe. Dit heeft belangrijke consequenties voor de
longfunctie op de lange termijn. Ernstige longziektebeelden, zoals die beschreven
werden door Northway in 1967,188 worden nog nauwelijks gezien op de dag van
vandaag. Het ziektebeeld dat we op dit moment meestal zien wordt gekenmerkt door
een onderbreking in de longontwikkeling door vroeggeboorte. Dit kan leiden tot een
abnormale longgroei en -ontwikkeling vanaf de geboorte met als gevolg te weinig
longblaasjes en een gestoorde doorbloeding.57 De meeste kinderen merken hier weinig
van tijdens hun normale dagelijkse activiteiten, maar bij een toegenomen lichamelijke
inspanning merken ze vaak wel dat ze tekort komen. Uit de longfunctiemetingen die
voor de studies in dit proefschrift verricht zijn blijkt dat de meerderheid van de
beademde prematuren een afwijkende longfunctie had met een verhoogde weerstand
en een verlaagde compliantie (= toegenomen stijfheid) van het ademhalingssysteem
op de leeftijd van 1 jaar (Hoofdstuk 6). Op tweejarige leeftijd bleek de gevoeligheid
van de luchtwegen bij de meerderheid van de kinderen toegenomen te zijn
(Hoofdstuk 7). Dit betekent dat verschillende aspecifieke factoren, zoals mist of een
rokerige ruimte, ervoor kunnen zorgen dat de weerstand van de luchtwegen sterk
toeneemt, waardoor kinderen veel meer moeite hebben met ademen.
Door vroege klinische en mechanische factoren van vlak na de geboorte bij deze
kinderen te relateren aan het beloop gedurende de jaren erna, hopen we belangrijke
determinanten te vinden voor dit beloop. De resultaten in Hoofdstuk 6 geven aan dat
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de kenmerken van het ademhalingssysteem, zoals ze aanwezig zijn bij de geboorte,
belangrijke determinanten zijn voor het al dan niet nodig hebben van medicatie als
luchtwegverwijders of ontstekingsremmers tijdens het eerste levensjaar. Ook blijken
dit belangrijke determinanten te zijn voor de longfunctie op 1-jarige leeftijd. Andere
factoren, zoals de mate van vroeggeboorte, uitgedrukt in zwangerschapsduur of
geboortegewicht, de ernst van RDS en de behandeling die gegeven wordt, zoals
beademingsvoorwaarden en beademingsduur, bleken van minder groot belang. Alleen
het aantal dagen waarop extra zuurstoftoediening nodig was bleek tevens gerelateerd
te zijn aan de compliantie van het ademhalingssysteem op 1-jarige leeftijd. Deze
bevindingen komen overeen met resultaten van eerdere studies bij gezonde kinderen,
die geboren waren na een normale zwangerschapsduur (= à term).48,166,167,232,274 In deze
studies kwam naar voren dat de luchtwegfunctie vóór het doormaken van een
luchtweginfectie gerelateerd was aan het optreden van klachten van een piepende
ademhaling en/of hoesten en de longfunctie in de jaren erna. Het feit dat de
bevindingen in onze studies bij beademde prematuren overeenkomen met de
bevindingen bij gezonde kinderen, suggereert dat de lange termijn gevolgen voor het
ademhalingssysteem met name bepaald worden door de longontwikkeling tot de
geboorte en minder door factoren vlak na vroeggeboorte, zoals acute longziekte en
beademing. Echter, in Hoofdstuk 7 blijkt dat de ernst van longziekte en de daardoor
ontstane longschade wel een belangrijke determinant blijkt te zijn voor het
ontwikkelen van overgevoeligheid van de luchtwegen. Deze resultaten komen overeen
met eerdere bevindingen in de literatuur, waarin relaties worden beschreven tussen
vroeggeboorte79,94,195 of de ontwikkeling van chronische longziekte174,181,195,223 en
overgevoeligheid van de luchtwegen op de peuterleeftijd. Als we de resultaten van
Hoofdstukken 6 en 7 samenvatten valt op dat vroege determinanten van het lange
termijn beloop afhankelijk zijn van de uitkomstmaat die bestudeerd wordt. Klachten
van hoesten en piepen op de jonge kinderleeftijd zijn voornamelijk gerelateerd aan de
diameter van de luchtwegen. Dit gedeelte van het ademhalingssysteem is niet het
belangrijkste gedeelte dat onherstelbaar beschadigd wordt na vroeggeboorte. Vandaar
dat voor deze uitkomstmaten de aangeboren eigenschappen van het
ademhalingssysteem belangrijker lijken dan factoren die met name verantwoordelijk
zijn voor het ontstaan van longschade, zoals vroeggeboorte, RDS en beademing. Aan
de andere kant lijkt de ontwikkeling van overgevoeligheid van de luchtwegen wel met
name samen te hangen met de mate van longschade door deze factoren.
De longfunctieresultaten tijdens de eerste twee levensjaren bij beademde
prematuren suggereren een zekere mate van tracking, zoals beschreven wordt in
Hoofdstuk 8. Dat betekent dat de kinderen met de slechtste longfunctie vlak na de
geboorte op 1- en 2-jarige leeftijd nog steeds de slechtste longfunctie hebben binnen
deze studiepopulatie. Voor alle kinderen gold dat zowel de weerstand als de
compliantie van het ademhalingssysteem sterk verbeterden tijdens het eerste jaar na
vroeggeboorte. Dit wordt veroorzaakt door longgroei en –ontwikkeling, waarbij de
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luchtwegdiameter toeneemt en het aantal longblaasjes explosief stijgt. Hoewel de
verschillen tussen de kinderen gedurende deze periode kleiner werden, bleef er een
zekere mate van tracking bestaan voor met name de weerstand. Daarnaast bleek de
gevoeligheid van de luchtwegen op 2-jarige leeftijd gerelateerd te zijn aan het verloop
van de compliantie tijdens het eerste levensjaar en niet aan het verloop van de
weerstand tijdens dezelfde periode. Dit bevestigt de resultaten in Hoofdstuk 7.
9.5. Belangrijkste conclusies
De studies in dit proefschrift tonen aan dat tijdens het huidige tijdperk, waarin op
uitgebreide schaal corticosteroiden voor de geboorte en surfactant na de geboorte
worden toegepast, de meerderheid van de beademde prematuren klachten en
longfunctie-afwijkingen houden tijdens de eerste levensjaren. Aangezien long-
functiemetingen tijdens de beademing belangrijke beperkingen kennen, moeten
bepaalde maatregelen getroffen worden om betrouwbare resultaten te verkrijgen en te
voorkomen dat deze kwetsbare patiënten onnodig gestoord worden.
Bepaalde aangeboren eigenschappen van het ademhalingssysteem, zoals de
weerstand, blijken in belangrijke mate gerelateerd te zijn aan zowel het vroege
klinische beloop als het hebben van klachten en longfunctieafwijkingen tijdens het
eerste levensjaar. Met betrekking tot het respiratoire beloop tijdens het eerste jaar zijn
deze eigenschappen belangrijker dan determinanten als vroeggeboorte, longziekte en
beademing, die belangrijk zijn bij het ontstaan van onherstelbare longschade. Echter,
met betrekking tot gevoeligheid van de luchtwegen op 2-jarige leeftijd lijken deze
oorzakelijke factoren voor longschade wel belangrijke determinanten te zijn. Als
laatste blijkt de longfunctie tijdens de eerste 2 jaar na vroeggeboorte een zekere mate
van tracking te laten zien, waarbij de kinderen met de slechtste longfunctie aan het
begin over het algemeen de slechtste longfunctie houden.
9.6. Toekomstperspectief
De techniek die gebruikt werd om de longfunctie te meten in de studies in dit
proefschift wordt reeds vanaf halverwege de jaren 80 van de vorige eeuw toegepast
voor onderzoeksdoeleinden. Er zijn ook Europese criteria van de European
Respiratory Society beschikbaar om een acceptabel niveau van uniformiteit en
betrouwbaarheid te waarborgen. Toch worden vaak nog grote methodologische
verschillen gevonden tussen verschillende studies, wat het vergelijken van
onderzoeksresultaten bemoeilijkt. Daarom is verdere standaardisatie van de methode
wenselijk en zou het focus hierbij moeten liggen op de praktische toepassing ervan en
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correctie voor effecten van veranderingen in de eigenschappen van het gebruikte gas
en voor de weerstand van de beademingsbuis.
De respiratoire conditie van beademde prematuren is sterk veranderd sinds de
jaren 50 van de vorige eeuw, toen voor het eerst kunstmatige beademing bij deze
kinderen werd toegepast. Het is aannemelijk dat tegelijkertijd ook de determinanten
voor het respiratoire beloop bij deze kinderen veranderd zijn. De resultaten in dit
proefschrift geven aan dat vroege longfunctiemetingen nuttige informatie geven over
de actuele conditie van het ademhalingsysteem en het beloop op de langere termijn.
Of implementatie in de klinische praktijk werkelijk zinvol is voor de directe zorg van
deze kinderen en de uitkomst op de langere termijn zal in de toekomst verder
onderzocht moeten worden. Door recente bevindingen met betrekking tot de nadelige
lange termijn effecten van het toedienen van corticosteroiden na de geboorte is de
noodzaak voor het zoeken naar alternatieve behandelingsmethoden met bijvoorbeeld
minder sterke corticosteroiden met minder ongewenste bijwerkingen sterk
toegenomen. Voor toekomstige studies op dit gebied kunnen onze voorspellings-
modellen gebruikt worden om alleen prematuren te selecteren met een verhoogd
risico, zodat onnodige blootstelling aan nieuwe behandelingsmethoden met mogelijk
ongewenste bijwerkingen zoveel mogelijk voorkomen wordt. Daarnaast kan een
vroege selectie van prematuren met een verhoogd risico op langdurige beademing
extra mogelijkheden creëren voor preventieve maatregelen.
In plaats van factoren die gerelateerd zijn aan de mate van vroeggeboorte, blijken
aangeboren eigenschappen van de longen, zoals weerstand, belangrijke determinanten
te zijn voor het respiratoire beloop tijdens het eerste levensjaar bij beademde
prematuren. Om het risico op aanhoudende klachten en longfunctie-afwijkingen
zoveel mogelijk in te perken, is verder onderzoek naar de determinanten van deze
aangeboren eigenschappen van groot belang. Pas dan kunnen eventuele preventieve
maatregelen genomen worden. Hiervoor is een grote, prospectieve studie in meerdere
centra nodig, die alle zwangere vrouwen in een bepaald geografisch gebied onderzoekt
op verschillende factoren zoals: 
- familiaire aanleg 
- conceptiemethode (natuurlijk of kunstmatig) 
- roken door moeder 
- bepaalde diagnostische ingrepen 
- doormaken van infecties 
- voedingstoestand
- corticosteroiden-toediening voor de geboorte
- informatie van het echografisch onderzoek met betrekking tot de groei van het
ongeboren kind en de hoeveelheid vruchtwater
- aanwezigheid van bepaalde ontstekingsfactoren, nicotine en bepaalde antistoffen
(IgE-antistoffen) in het bloed van moeder en kind. 
Algemene beschouwing en toekomstperspectief
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Door relaties tussen deze factoren en de longfunctie vroeg na de geboorte te
bestuderen kunnen determinanten gevonden worden die bepalend zijn voor het
respiratoire beloop bij zowel te vroeg geboren als à term geboren kinderen. Het is
aannemelijk dat met deze gegevens de mogelijkheden voor het voorkomen van
aanhoudende klachten en longfunctie-afwijkingen zullen toenemen.
Het feit dat overgevoeligheid van de luchtwegen op de jonge kinderleeftijd
gerelateerd lijkt te zijn aan de mate van de longschade die ontstaan is vlak na
vroeggeboorte geeft aan dat toekomstige inzet nodig is op het verbeteren van de zorg
van deze kinderen vlak na de geboorte. Daarvoor is verder onderzoek naar nieuwe
strategieën om longschade zoveel mogelijk te voorkomen of te verminderen nodig.
Hierbij kan gedacht worden aan het vroegtijdig toedienen van andere, minder potente
corticosteroiden in lagere doseringen of andere beademingstechnieken.
___________________________________________________________________
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Registry (Integraal Kankercentrum Zuid). Later in 1998, she completed the post-
academic course in order to work as a medical doctor in infant welfare centres. In
January 1999, she started as a resident at the paediatric intensive care unit at the
Radboud Medical Centre in Nijmegen, The Netherlands. In June of the same year, she
began as a PhD-student at the Wilhelmina Children’s Hospital, University Medical
Centre Utrecht in Utrecht, The Netherlands, to study early postnatal respiratory
mechanics in ventilated preterm infants and their relationship with respiratory
morbidity and lung function during the first two years of life headed by Prof. dr. F.
van Bel of the department of Neonatology and Prof. dr. J.L.L. Kimpen of the
department of Paediatrics at the University Medical Centre Utrecht. In July 2003, she
started her specialist training in paediatrics in the Sophia Hospital of the Isala Clinics
in Zwolle, The Netherlands (head: dr. W. Baerts). From January 2005 she will
continue the specialist training in the Wilhelmina Children’s Hospital of the University
Medical Centre Utrecht (head: Prof. dr. J.L.L. Kimpen). 
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Dankwoord
“Graag wil ik iedereen bedanken die een essentiële bijdrage heeft geleverd aan de
totstandkoming van dit proefschrift. Zonder jullie....  BEDANKT!”
